Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
SCGB1D1	"LIPA, LPHA, MGC71958"	ENSG00000168515	"Secretoglobin family 1D member 1"	O95968	11	62190216-62193539	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"endometrial cancer: 23.3;ovarian cancer: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 6.0"														"Secreted in other tissues"	NA	NA									"unprognostic (6.95e-3)"						"unprognostic (9.01e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 46.1"	"Group enriched"	"Detected in some"	83	"Early spermatids: 47.8;Late spermatids: 119.0"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 152.2;hypothalamus: 60.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 132.2"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA					"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.0	0.0	46.1	0.1	33.3	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	33.5	0.0	0.0	0.0	0.0	2.2	6.1	9.6	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.6	0.0	0.0	8.3	6.5	0.2	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	33.3	0.0	44.3	41.3	33.5	2.2	6.1	9.6	4.7	12.6	6.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	119.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735396-100829944	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 29.8;kidney: 85.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.3;pons and medulla: 3.4"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.0	0.0	1.7	0.0	1.2	0.0	0.0	2.1	0.6	2.9	0.2	0.0	0.0	1.8	29.8	0.0	8.5	0.0	0.0	0.4	2.9	85.9	0.1	0.0	0.0	6.1	0.6	0.1	0.2	0.4	5.9	0.8	0.0	3.2	0.2	0.0	1.2	0.0	11.6	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.4	1.4	0.1	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	14.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	16.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	2.1	0.6	0.4	2.9	6.1	0.6	0.1	3.2	4.7	1.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	5.9	0.0	0.0	145.3	0.0	0.0	0.0	0.0	49.0	0.0	9.4	129.5	14.8	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	246.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.5	0.0	1.1	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.5	0.0	0.0	0.6	1.1	1.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0
PKHD1L1		ENSG00000205038	"PKHD1 like 1"	Q86WI1	8	109362461-109537207	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"thyroid gland: 69.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 24.4;Endometrial ciliated cells: 47.0;Endothelial cells: 14.0;Glandular and luminal cells: 49.9;Plasma cells: 28.2"	"Group enriched"	"Detected in some"	18	"endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HHSteC: 1.4;TIME: 1.6;U-266/70: 3.9"	"Not detected"	"Not detected"							HPA044458	Uncertain					NA	NA		13000000			"HPA044458: AB_2678949"	"unprognostic (9.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.76e-6)"	"unprognostic (4.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.73e-2)"	12.8	2.7	0.2	0.5	0.1	0.4	2.6	0.1	0.3	13.9	1.4	2.4	1.1	6.0	0.3	1.7	14.2	0.4	5.3	0.1	0.4	1.9	0.6	7.0	1.2	0.2	0.1	0.1	2.6	0.5	0.0	0.8	0.0	0.1	0.7	1.6	0.0	0.7	0.2	0.2	1.7	4.3	0.4	0.2	0.5	1.6	0.5	0.1	0.1	69.4	0.6	1.1	1.2	1.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.4	0.2	0.1	0.1	0.1	0.2	0.1	0.4	1.3	0.0	2.8	0.7	24.4	0.3	0.0	0.0	0.6	0.0	0.1	0.0	1.9	1.5	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	47.0	3.4	14.0	1.8	0.4	0.2	0.0	0.1	6.6	1.1	49.9	1.3	0.0	10.4	0.6	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.5	0.6	0.3	1.8	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	28.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.1	0.0
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 64.2"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA					"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.0	1.3	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.3	64.2	2.2	0.4	1.5	0.2	0.2	0.3	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.0	0.1	0.1	0.1	0.2	0.3	9.8	0.0	1.0	0.3	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"WT1 transcription factor"	P19544	11	32387775-32435564	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 68.1;fallopian tube: 52.7;ovary: 46.1"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279"	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	12.0	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.1	16.4	0.0	0.5	0.0	68.1	5.3	0.0	52.7	1.3	4.5	0.1	0.3	15.9	0.1	0.8	0.0	0.2	0.1	0.0	46.1	0.1	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	33.3	0.0	19.2	0.2	24.3	0.0	0.0	0.0	0.0	0.0	0.2	8.5	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	20.7	0.0	1.2	4.7	10.8	29.9	0.0	0.0	3.4	0.0	0.0	0.0	0.7	19.6	0.0	2.0	0.0	11.2	37.2	0.8	0.0	6.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	2.1	19.6	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	20.2	0.0	1.0	0.0	0.0	0.0	0.0	3.6	2.2	70.1	16.3	0.0	0.0	0.1	0.0	0.5	7.3	0.0	1.4	0.0	9.3	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.3	8.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	2.3	0.0	0.0	6.6	0.0	2.0	4.5	1.0	0.0	0.0	0.8	0.5	0.4	0.0	0.1
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542445-117549546	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 79.6;epididymis: 105.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1"	"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favorable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	6.3	0.1	22.0	0.2	20.8	0.2	2.8	15.8	31.6	50.0	15.8	0.4	0.1	79.6	105.2	0.4	53.4	1.5	0.5	26.0	18.1	39.5	0.1	0.1	0.6	15.7	16.4	19.9	12.0	0.0	0.1	1.8	0.4	17.6	1.1	0.1	0.3	2.4	53.1	10.9	8.8	0.1	45.3	13.2	0.2	0.1	1.2	17.3	0.1	0.3	5.3	0.4	4.8	4.5	21.8	0.0	0.0	0.0	2.6	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	25.4	31.6	0.0	0.1	0.6	0.0	0.0	0.1	2.8	0.8	0.1	0.2	0.0	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.2	31.1	9.4	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	2.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	22.0	20.8	15.8	31.6	26.0	18.1	15.7	16.4	19.9	17.6	13.2	17.3	21.8	4.6	0.0	0.0	43.4	1.0	10.7	2.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	239.1	0.0	0.2	0.0	0.1	90.1	0.0	1.4	75.6	126.5	3.1	0.0	0.0	0.1	0.0	0.3	18.0	0.0	68.6	0.0	88.3	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	8.0	2.6	60.3	2.5	21.4	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	41.0	0.0	2.5	0.1	185.0	0.0	0.1	52.6	8.6	32.1	0.3	0.3	0.0	7.5	0.1	2.2	2.2	0.3	1.7
OR1N1	"OR1-26, OR1N3"	ENSG00000171505	"Olfactory receptor family 1 subfamily N member 1"	Q8NGS0	9	122526358-122527296	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"endometrial cancer: 0.8;ovarian cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA															"unprognostic (3.63e-2)"								0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414319-111427735	"Plasma proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	134	"fallopian tube: 2089.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0"	"Region enhanced"	"Detected in many"		"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Supported	Vesicles,Microtubules	"Secreted in female reproductive system"	NA	NA			Vesicles	Microtubules	"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	3.4	1.6	7.7	1.1	8.2	1.9	3.6	8.5	10.9	3.8	6.4	3.3	1.1	15.5	5.2	3.0	2089.3	1.1	2.2	8.2	7.8	4.9	8.1	3.9	2.2	8.0	7.5	8.2	6.8	1.5	6.9	2.4	2.0	8.1	5.6	2.2	4.3	4.3	1.5	2.6	7.0	5.3	1.5	6.9	4.6	2.8	9.3	7.2	1.2	2.4	1.0	2.1	4.7	3.8	8.7	0.4	0.4	0.9	0.5	1.8	2.0	1.7	0.2	1.4	0.3	0.7	0.6	0.0	0.8	1.7	0.6	0.0	0.5	0.3	0.3	0.5	2.0	4.9	0.3	0.8	2.4	0.6	0.9	2.2	1.8	2.9	0.0	1.0	1.4	0.4	3.2	0.3	1.5	0.1	0.5	0.6	1.2	0.2	6.4	1.7	0.6	0.2	0.7	1.4	3.7	0.6	0.6	0.1	5.0	0.7	2.4	0.3	0.8	0.8	0.1	0.2	2.5	0.7	1.8	0.5	0.4	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.2	8.5	10.9	8.2	7.8	8.0	7.5	8.2	8.1	6.9	7.2	8.7	1.2	0.0	1.1	3.3	0.6	3.1	1.1	0.3	0.0	2.1	1.7	1.9	0.6	0.0	0.5	0.0	0.0	5.6	0.2	1.1	1.9	0.2	4.0	9.7	0.7	1.6	0.0	0.0	10.4	0.0	2.6	0.6	0.0	12.0	0.0	1.0	1.4	2.9	0.6	0.0	8.5	1.5	2.0	0.6	1.4	6.1	1.5	0.5	0.0	3.7	0.0	0.4	0.0	1.5	2.4	0.2	0.5	1.9	0.1	1.6	0.6	2.8	1.3	0.6	0.0	0.7	1.1	3.8	0.7	1.0	3.1	17.4	0.8	0.2	1.6	1.6
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634892	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 28.1;endometrium 1: 41.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 7.7;Breast myoepithelial cells: 15.6;Fibroblasts: 5.4;Langerhans cells: 2.9"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;THP-1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046154, HPA062923"	Uncertain		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA046154: AB_10964912, HPA062923: "	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	5.9	0.1	0.1	0.8	0.1	0.1	7.9	0.1	0.1	28.1	0.0	1.8	1.1	41.7	2.2	3.1	20.2	2.7	0.4	0.1	0.0	0.8	0.1	4.1	1.9	0.1	0.1	0.1	2.1	0.5	0.1	0.1	0.4	0.1	6.7	0.5	0.1	1.3	1.8	0.0	6.3	3.3	13.2	0.0	0.8	4.0	0.2	0.1	0.0	0.0	0.5	3.0	1.5	19.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.7	15.6	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.1
IMPG2	"IPM200, RP56, SPACRCAN"	ENSG00000081148	"Interphotoreceptor matrix proteoglycan 2"	Q9BZV3	3	101222546-101320575	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		"Heparin-binding, Receptor"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"retina: 308.1"	"Group enriched"	"Detected in some"	18	"Cone photoreceptor cells: 517.1;Rod photoreceptor cells: 329.1"	"Cancer enriched"	"Detected in single"	12	"ovarian cancer: 2.7"	"Region enriched"	"Detected in some"	8	"midbrain: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008779, HPA015907"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA008779: AB_2668138, HPA015907: AB_2669323"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.80e-5)"	"unprognostic (6.66e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-9)"	"unprognostic (7.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.08e-2)"	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.3	0.1	1.4	0.1	0.0	0.1	0.2	0.0	9.7	0.1	0.1	0.2	0.6	0.1	0.0	0.0	0.2	0.8	8.4	0.1	0.1	0.1	0.0	0.1	0.0	1.1	0.1	0.1	308.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.2	0.6	0.8	8.4	0.1	1.1	0.2	0.4	0.6	0.3	0.0	0.0	5.9	0.4	0.1	0.0	0.1	0.0	22.8	0.1	0.5	0.6	0.0	0.1	0.0	517.1	0.0	0.3	0.0	1.9	0.1	0.3	0.7	0.5	2.4	0.0	0.0	7.5	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.1	0.1	13.5	14.0	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.0	4.7	1.2	23.4	0.0	8.5	2.6	0.1	0.0	0.7	0.6	0.1	0.0	0.0	0.5	329.1	0.0	0.6	0.3	0.1	0.3	0.0	0.3	0.0	0.2	1.2	0.0	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 197.3;thyroid gland: 570.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.1	1.9	0.6	1.4	0.5	1.7	0.1	1.2	14.7	1.6	1.8	0.6	8.9	33.2	2.2	37.8	3.6	2.1	1.1	1.9	197.3	1.2	1.6	1.7	4.5	1.4	0.4	1.7	1.0	1.4	1.4	1.9	2.9	1.1	0.9	1.5	1.9	26.4	0.5	1.8	2.4	0.8	3.2	0.8	1.4	2.5	2.0	0.5	570.1	0.3	1.1	2.1	1.0	2.2	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.9	1.4	0.1	1.2	1.1	1.9	4.5	1.4	0.4	2.9	3.2	2.0	2.2	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510525-76516522	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 55.2;esophagus: 65.3;lung: 50.4;urinary bladder: 42.6"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 121.8"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1"	"Not detected"	"Not detected"							HPA010506	Approved					NA	NA					"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	55.2	0.7	0.1	0.1	0.4	0.1	1.5	0.0	0.3	4.6	0.8	1.0	0.0	0.7	0.2	65.3	10.1	0.1	5.8	0.0	0.2	0.6	1.0	50.4	0.1	0.1	0.2	0.0	7.0	1.3	0.0	1.8	0.0	0.1	2.7	0.0	0.2	8.3	0.0	0.5	4.1	1.0	0.0	0.0	2.1	2.9	4.3	0.6	0.0	1.4	0.0	1.9	42.6	12.2	0.1	1.1	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.2	0.0	0.4	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.3	3.9	0.0	0.1	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.6	0.1	0.3	121.8	3.3	0.0	0.3	1.7	0.4	18.3	4.6	0.4	0.2	0.0	0.3	20.0	20.4	3.7	4.2	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.9	1.1	0.5	1.3	0.1	0.7	0.1	0.1	1.7	0.0	0.0	6.1	0.3	2.5	0.0	12.2	0.3	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	11.1	0.2	0.0	0.0	1.1	0.0	0.1	2.1	2.8	0.1	0.4	0.0	0.2	14.2
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304752	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 20.0;salivary gland: 12.9"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046607, HPA062660"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA046607: , HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.3	0.9	6.9	0.3	13.9	0.0	0.1	0.1	9.1	1.6	0.0	2.7	0.7	0.6	0.3	0.3	1.2	0.2	0.9	15.4	5.2	0.3	0.4	0.1	0.0	5.3	9.9	9.5	0.3	0.1	0.0	1.9	0.0	4.3	1.0	0.3	0.4	12.9	1.2	0.0	0.1	1.3	0.3	0.0	0.0	0.8	0.2	20.0	0.0	1.6	0.1	0.0	0.6	0.8	5.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	13.9	0.1	9.1	15.4	5.2	5.3	9.9	9.5	4.3	0.0	20.0	5.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	1.0	4.8	0.3	0.0	0.0	7.2	0.7	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	6.6	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672673-32773023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 12.8;thyroid gland: 13.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	90	"memory B-cell: 10.5;naive B-cell: 7.3"	"Lineage enriched"	"Detected in single"	106	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"hippocampal formation: 14.9;olfactory bulb: 8.1"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.4	0.2	0.2	1.9	0.3	2.5	0.5	0.0	0.6	2.9	0.0	0.2	0.2	1.7	1.0	0.2	6.6	0.3	0.1	0.3	0.3	4.0	0.0	0.3	7.2	1.4	1.0	0.2	0.3	0.0	7.0	0.3	0.9	0.6	1.4	0.2	4.7	0.4	12.8	0.0	0.1	2.0	0.8	0.8	8.7	0.2	1.0	0.7	0.3	13.9	0.0	5.4	0.6	0.5	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	15.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.2	1.3	0.0	8.4	0.0	3.2	0.4	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.6	0.3	0.3	1.4	1.0	0.2	0.6	0.8	0.7	0.2	1.3	0.0	0.0	0.3	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.1	0.0	3.9	0.0	4.5	7.1	0.3	2.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.7	0.0	0.1	1.7	9.8	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	19.4	0.0	1.5	0.2	0.0	0.0	0.0	45.7	0.0	0.5	1.1	0.0	0.8	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.2	4.7	0.1	0.0
TRDJ4		ENSG00000211826	"T cell receptor delta joining 4"		14	22455249-22455296	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 5.9;lymphoid tissue: 13.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"ovarian cancer: 2.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Group enriched"	"Detected in many"	45	"gdT-cell: 123.0;NK-cell: 281.9"	"Group enriched"	"Detected in many"	362	"NK-cells: 281.9;T-cells: 123.0"	"Cell line enriched"	"Detected in some"	16	"NB-4: 38.7"															NA	NA																							1.0	0.0	0.1	0.0	0.3	0.9	1.7	0.6	2.3	0.0	2.1	1.4	5.9	2.4	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	0.0	1.2	1.1	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.1	0.3	13.3	1.3	0.1	0.8	4.5	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	123.0	0.0	0.3	0.2	1.9	0.6	0.3	0.0	1.5	4.5	0.0	281.9	0.5	0.0	3.0	13.1	0.1	0.3	0.6	2.3	0.5	0.4	0.3	0.3	0.2	0.6	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC3B	LRP15	ENSG00000179796	"Leucine rich repeat containing 3B"	Q96PB8	3	26622806-26717537	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 26.6;choroid plexus: 7.8;skeletal muscle: 9.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 256.9;Early spermatids: 115.3;Inhibitory neurons: 50.0;Oligodendrocyte precursor cells: 38.2"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.5;SuSa: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015568	Approved					NA	NA					"HPA015568: AB_1853282"	"unprognostic (1.22e-2)"			"unprognostic (2.94e-1)"	"unprognostic (1.87e-1)"		"unprognostic (7.42e-2)"	"unprognostic (8.82e-4)"		"unprognostic (2.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.91e-4)"	"unprognostic (3.31e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-1)"	0.2	0.1	17.7	0.0	20.1	0.0	0.4	26.6	24.7	0.2	7.8	0.4	0.0	0.8	0.0	0.4	0.4	0.0	0.3	22.2	16.0	0.0	0.1	0.0	0.0	16.3	18.0	19.8	1.6	0.0	0.0	1.5	0.0	19.7	0.1	0.5	1.1	0.5	0.1	9.6	0.1	0.3	0.4	15.6	0.1	0.5	7.2	15.6	0.7	0.1	0.2	0.0	4.8	0.2	16.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	20.1	26.6	24.7	22.2	16.0	16.3	18.0	19.8	19.7	15.6	15.6	16.8	0.8	0.0	0.0	256.9	0.0	0.1	0.0	0.0	0.0	1.6	1.2	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.3	0.2	3.2	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.0	11.6	0.6	0.1	0.0	9.4	0.0	0.8	0.0	38.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	1.6	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.1
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 16.2"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 2.1;Excitatory neurons: 1.9;Inhibitory neurons: 1.2"	"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 19.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 105.4"	"Low region specificity"	"Detected in all"			HPA014053	Uncertain					NA	NA					"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.4	0.5	4.5	1.0	2.8	0.0	0.1	1.4	3.3	0.1	0.0	0.5	0.3	1.8	0.0	0.0	0.3	0.2	0.3	4.3	5.3	0.3	1.2	0.2	2.1	16.2	11.7	2.3	0.0	0.2	0.0	0.0	0.9	4.3	0.0	0.5	0.1	0.6	0.0	0.3	0.1	0.5	1.0	5.7	1.3	0.1	0.2	4.7	0.9	0.1	0.3	0.5	0.0	0.0	7.4	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	2.8	1.4	3.3	4.3	5.3	16.2	11.7	2.3	4.3	5.7	4.7	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2A"	O14813	11	72239077-72245664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 20.1;brain: 10.2"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enhanced"	"Detected in some"		"pons: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	226	"SH-SY5Y: 569.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA			Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	20.1	0.1	1.3	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	4.4	0.0	0.0	0.2	0.0	0.5	0.0	10.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	1.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	569.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.8	1.6	4.4	0.0	10.2	0.2	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347182-93348356	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"testis: 76.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 865.6;Late spermatids: 1864.6;Spermatocytes: 424.3"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"U-937: 27.4"	"Low region specificity"	"Detected in many"							HPA003127	Approved					NA	NA					"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.1	0.1	0.0	0.0	0.6	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	76.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	0.7	0.2	0.4	0.6	0.4	0.3	0.7	0.1	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.6	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	865.6	1.2	0.0	0.8	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1864.6	11.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.3	1.2	0.0	19.7	0.0	0.1	424.3	124.5	0.0	0.1	3.4	0.0	0.1	0.0	0.1
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.7;testis: 10.1"	"Group enriched"	"Detected in some"	9	"Breast glandular cells: 17.7;Breast myoepithelial cells: 29.1"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	17.7	29.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.5	1.2	0.1	1.8	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.1
PNOC	"N/OFQ, NOP, PPNOC"	ENSG00000168081	Prepronociceptin	Q13519	8	28316986-28343355	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Neuropeptide, Neurotransmitter, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.1;fallopian tube: 18.4;lymphoid tissue: 25.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 61.5;dendritic cells: 12.6;Inhibitory neurons: 23.3;Melanocytes: 14.2;Plasma cells: 80.4"	"Cancer enriched"	"Detected in many"	8	"ovarian cancer: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"memory B-cell: 231.2;naive B-cell: 260.3;plasmacytoid DC: 194.0"	"Group enriched"	"Detected in many"	20	"B-cells: 260.3;dendritic cells: 194.0"	"Group enriched"	"Detected in some"	6	"Daudi: 38.3;Karpas-707: 29.2;RPMI-8226: 11.2;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044507, HPA056724"	Enhanced				"Secreted to blood"	NA	NA	12300				"HPA044507: AB_10795043, HPA056724: AB_2683216"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.57e-9)"	"unprognostic (2.19e-2)"	"unprognostic (5.45e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-1)"	0.2	0.8	5.6	10.0	5.5	2.7	0.7	1.5	28.1	0.2	1.5	2.9	4.3	0.1	0.0	0.6	18.4	1.1	0.1	3.1	8.3	0.5	0.2	1.0	25.3	10.7	5.8	3.1	0.5	0.0	0.0	0.0	0.0	10.0	0.2	1.6	0.0	1.6	0.1	0.0	0.1	5.8	0.5	10.6	14.5	3.3	0.6	7.7	2.8	0.4	0.0	23.8	3.7	0.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.0	4.4	23.0	0.1	0.1	0.0	0.2	11.5	2.3	0.2	7.7	0.1	231.2	0.2	0.1	1.1	260.3	0.1	0.1	1.3	1.2	3.2	194.0	0.5	11.1	5.6	5.5	1.5	28.1	3.1	8.3	10.7	5.8	3.1	10.0	10.6	7.7	7.0	0.1	0.0	1.9	1.3	61.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.4	0.4	0.2	0.0	23.3	0.1	0.0	0.0	0.3	2.8	0.3	1.7	14.2	1.0	3.0	0.0	1.0	0.0	0.9	0.1	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	1.1	0.0	0.3	0.5
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"intestine: 53.0"	"Cell type enriched"	"Detected in some"	96	"Enteroendocrine cells: 19377.2"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.9"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Low region specificity"	"Detected in single"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100				"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	1.7	0.3	1.5	0.3	0.1	0.4	0.2	0.7	0.3	0.1	53.0	2.5	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.3	1.3	0.2	0.2	0.3	0.4	0.3	0.3	0.0	0.7	0.2	0.0	0.0	0.5	0.3	37.0	0.8	0.1	0.8	0.1	0.1	42.0	0.1	0.2	0.1	0.5	1.1	0.4	0.3	0.5	0.1	0.1	0.0	0.0	0.5	0.1	0.2	0.2	0.4	0.3	0.6	0.0	0.4	0.1	0.5	0.3	0.5	0.3	0.2	0.6	0.5	0.4	0.2	0.4	0.1	0.3	1.2	0.2	0.7	0.2	0.0	0.4	0.2	2.9	0.8	0.1	0.5	0.2	0.6	0.1	0.3	0.2	0.5	0.4	0.6	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.8	0.0	0.4	0.1	0.3	0.0	0.7	0.3	0.5	0.0	0.5	0.6	0.5	0.1	0.4	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.7	0.3	0.3	0.4	0.3	0.3	0.5	0.2	0.4	0.5	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	65.0	1.9	0.0	1.0	7.9	1.3	0.1	19377.2	0.0	3.5	0.0	0.1	0.0	0.0	18.9	8.9	0.1	0.0	0.0	0.0	0.0	3.3	199.9	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	35.5	0.0	0.0	0.0	20.7	0.1	0.0	0.0	0.0	0.0	0.1	2.3	4.3	0.0	0.1	0.0	1.0	0.0	36.8	0.0
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958599-86963258	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 270.5;brain: 577.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.9;Breast myoepithelial cells: 156.1;Endothelial cells: 143.3;Hepatic stellate cells: 206.0;Smooth muscle cells: 234.3;Urothelial cells: 358.3"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 748.2;RT4: 483.5;T-47d: 151.7;TIME: 160.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 279.9"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581, CAB080022"	Enhanced	Supported				NA	NA		23000			"CAB001452: AB_564020, CAB040581: , CAB080022: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (2.29e-8)"	"prognostic unfavorable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	210.0	270.5	237.3	12.1	145.0	0.0	99.0	193.6	316.0	32.3	42.1	24.3	9.3	23.1	15.2	25.7	65.1	12.8	26.1	179.2	224.3	17.1	4.4	14.0	11.7	344.4	277.1	167.5	42.5	5.3	3.4	11.2	12.0	354.5	36.9	4.9	53.2	23.1	102.6	14.7	27.9	19.0	10.2	160.2	64.7	16.5	5.4	328.5	9.1	20.4	13.8	25.8	206.6	39.2	577.0	2.6	6.8	0.7	1.1	0.3	3.9	0.7	0.8	0.0	0.0	0.0	1.1	748.2	0.0	22.6	1.4	0.0	71.0	0.0	3.4	0.0	0.1	1.4	3.6	109.6	2.0	1.4	0.0	1.8	2.8	55.5	0.0	0.6	0.2	49.8	0.0	5.3	0.0	0.0	0.6	0.2	0.4	11.3	0.0	0.4	0.0	0.4	0.3	0.2	483.5	0.1	0.0	6.5	8.7	0.9	1.0	151.7	0.3	160.9	1.1	3.7	0.3	0.0	0.2	0.0	0.0	0.8	3.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	237.3	145.0	193.6	316.0	179.2	224.3	344.4	277.1	167.5	354.5	160.2	328.5	577.0	164.9	0.0	0.0	7.5	1.5	28.8	65.9	16.3	11.4	32.2	61.1	156.1	1.9	8.6	14.6	55.2	6.2	19.4	2.8	0.1	125.2	3.6	0.6	0.4	0.8	143.3	0.0	2.7	9.9	1.1	0.6	14.2	0.5	0.6	0.0	0.1	206.0	0.8	5.5	87.5	28.0	0.0	20.3	1.8	27.3	3.7	59.0	2.2	23.2	6.5	0.9	66.4	0.0	4.5	7.5	4.7	2.2	9.8	0.0	14.2	0.3	1.3	2.4	109.3	92.1	2.5	234.3	0.6	0.7	2.6	19.7	6.2	2.7	16.9	0.0	358.3
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Late spermatids: 1.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"HEL: 3.7;HMC-1: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Secreted in other tissues"	NA	NA					"HPA045741: AB_2679439"										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRB2	"FLJ16786, FLJ38464"	ENSG00000148204	"Crumbs cell polarity complex component 2"	Q5IJ48	9	123356170-123380324	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Gastrulation, Sensory transduction, Vision"	"Developmental protein"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 22.7;choroid plexus: 10.6;kidney: 5.6;retina: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 40.5;Bipolar cells: 29.7;Cone photoreceptor cells: 118.9;Oligodendrocytes: 26.8;Rod photoreceptor cells: 110.1"	"Group enriched"	"Detected in some"	7	"glioma: 9.4;ovarian cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"AF22: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043674	Approved	Supported			"Intracellular and membrane"	NA	NA		210000			"HPA043674: AB_10962974"	"unprognostic (1.38e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.56e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.38e-1)"	0.7	0.0	13.5	0.5	16.9	0.3	0.1	12.1	10.9	0.0	10.6	0.7	0.1	1.5	0.1	0.0	1.0	0.0	0.1	10.8	14.9	5.6	0.0	0.0	0.7	21.0	15.4	7.3	0.2	0.0	0.0	1.4	0.0	22.2	0.0	0.4	8.1	0.0	0.0	0.0	0.1	0.3	0.3	22.7	0.5	0.2	0.5	18.5	0.2	0.1	0.0	0.6	0.2	0.0	19.3	0.0	0.1	32.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.6	0.0	0.0	4.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	16.9	12.1	10.9	10.8	14.9	21.0	15.4	7.3	22.2	22.7	18.5	19.3	0.0	0.0	0.0	40.5	0.5	0.3	0.1	0.0	0.0	29.7	0.0	2.2	2.8	0.0	0.0	1.8	118.9	0.1	0.0	0.7	0.0	0.0	3.9	0.4	1.3	0.4	3.0	0.0	4.2	0.0	0.1	2.5	0.0	0.1	1.3	0.0	0.0	0.0	0.2	3.3	0.4	2.8	0.0	0.0	1.0	7.7	1.8	0.1	0.0	0.0	0.1	6.1	1.0	2.0	26.8	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	110.1	0.0	0.5	0.3	0.1	0.3	0.0	0.6	0.3	0.1	0.1	5.3	0.1
GPR12	"GPCR21, PPP1R84"	ENSG00000132975	"G protein-coupled receptor 12"	P47775	13	26755200-26760786	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.9;retina: 8.5;salivary gland: 3.0;skin 1: 4.9"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 9.7;Excitatory neurons: 9.5;Hofbauer cells: 17.6;Horizontal cells: 33.7;Inhibitory neurons: 15.7;Skeletal myocytes: 8.1"	"Group enriched"	"Detected in some"	7	"breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050972	Uncertain					NA	NA					"HPA050972: AB_2681295"	"unprognostic (2.37e-2)"				"unprognostic (9.64e-3)"			"unprognostic (3.75e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.35e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.40e-1)"	0.2	0.0	2.0	0.0	10.9	0.1	1.4	7.8	10.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	7.3	1.1	0.0	0.0	0.0	0.0	2.5	3.8	1.9	0.0	0.0	0.0	0.7	0.4	2.7	0.0	0.0	8.5	3.0	0.0	0.1	4.9	0.1	0.1	0.0	0.1	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	10.9	7.8	10.7	7.3	1.1	2.5	3.8	1.9	2.7	0.0	5.1	2.8	0.4	0.0	0.0	1.6	0.0	0.1	0.2	0.0	0.0	2.8	2.7	2.8	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	9.7	0.0	9.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	17.6	33.7	15.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2	3.6	0.0	0.0	1.9	0.0	5.0	0.9	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	3.5	0.0	8.1	0.2	0.1	0.3	0.0	0.1	0.3	0.2	0.0	0.0	0.2
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113974881-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.0;pancreas: 2.6;salivary gland: 5.0"	"Group enriched"	"Detected in some"	11	"Ductal cells: 23.9;Exocrine glandular cells: 53.3;Pancreatic endocrine cells: 34.7"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 15.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	15	"memory B-cell: 3.9;naive B-cell: 13.8;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	127	"B-cells: 13.8;dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;Daudi: 5.9;NTERA-2: 3.6;SCLC-21H: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"amygdala: 1.7;cerebral cortex: 2.7;hippocampal formation: 2.5"	HPA069442	Supported					NA	NA					"HPA069442: AB_2732132"	"unprognostic (6.46e-3)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.36e-3)"	"unprognostic (8.36e-3)"	"unprognostic (1.65e-5)"	"unprognostic (1.46e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.40e-2)"	0.0	0.4	0.7	2.2	1.0	0.0	0.0	0.4	0.9	0.0	0.5	1.9	0.6	0.1	0.0	0.5	0.0	0.0	0.0	1.0	0.6	0.1	0.0	0.0	6.6	0.8	0.5	1.0	0.0	2.6	0.0	0.0	0.0	0.5	0.0	0.4	0.0	5.0	0.0	0.0	0.4	1.7	0.7	0.4	0.5	0.8	0.1	0.5	0.4	0.0	0.0	8.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	13.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.7	1.0	0.4	0.9	1.0	0.6	0.8	0.5	1.0	0.5	0.4	0.5	0.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.0	0.0	3.0	0.1	0.0	23.9	0.0	0.3	0.0	0.0	0.0	0.0	0.3	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	34.7	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745865-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Collecting duct cells: 9.2;Exocrine glandular cells: 7.0;Granulosa cells: 6.3;Leydig cells: 6.5;Prostatic glandular cells: 5.6;Urothelial cells: 7.4"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"MCF7: 48.9"	"Region enriched"	"Detected in single"	18	"olfactory bulb: 6.8"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 3.9"	HPA064861	Uncertain					NA	NA					"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	3.1	2.1	0.2	0.2	0.5	0.0	3.0	0.1	0.5	2.9	0.3	0.5	0.2	2.4	0.2	0.7	5.2	1.0	1.2	0.2	0.8	1.4	0.3	2.0	0.0	0.2	0.4	0.2	2.2	1.6	0.1	3.5	0.1	0.2	1.6	0.0	0.2	1.7	1.4	0.4	1.3	0.6	1.1	0.1	0.1	2.8	3.3	0.2	0.0	2.7	0.2	0.0	1.0	1.5	0.3	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.4	0.3	0.1	0.1	0.3	0.0	0.0	0.8	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.4	0.0	1.4	0.6	4.6	0.0	0.5	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.5	0.2	0.8	0.2	0.4	0.2	0.2	0.1	0.2	0.3	1.0	0.0	0.0	0.0	0.1	0.5	1.9	0.0	0.6	0.1	1.6	1.0	0.7	15.7	0.4	9.2	0.0	0.0	0.0	0.3	0.0	3.9	0.2	1.7	2.3	2.5	1.2	0.0	1.0	7.0	0.0	3.9	1.1	1.6	0.0	6.3	1.4	0.3	0.1	0.0	0.5	0.4	0.0	0.0	0.3	0.3	6.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	1.5	0.3	0.4	0.0	5.6	0.0	0.2	0.1	0.1	0.0	0.5	0.6	0.2	0.4	1.4	0.9	0.0	0.1	0.3	1.0	7.4
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040546-6054060	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.8;lung: 9.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 3.9;Collecting duct cells: 1.8;Ductal cells: 3.8;Proximal tubular cells: 2.4"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"RPTEC TERT1: 79.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA075974			Uncertain	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		73000	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA075974: AB_2686770"	"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	3.8	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.2	0.4	2.2	0.1	9.8	0.0	0.6	0.1	0.1	0.4	1.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	1.4	0.0	3.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	79.6	0.0	0.3	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.7	0.2	0.4	0.6	0.1	0.1	0.6	0.1	0.4	0.0	0.0	9.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ANTXRL		ENSG00000274209	"ANTXR like"	A6NF34	10	46286345-46330207	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 12.8"	"Group enriched"	"Detected in some"	27	"Early spermatids: 58.5;Late spermatids: 28.8"	"Cancer enriched"	"Detected in single"	6	"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"		"unprognostic (3.65e-3)"	"unprognostic (2.59e-2)"			"unprognostic (3.40e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.43e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARID3C		ENSG00000205143	"AT-rich interaction domain 3C"	A6NKF2	9	34621379-34628086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 11.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"liver cancer: 2.2;ovarian cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;Karpas-707: 2.6;T-47d: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.05e-3)"	"unprognostic (4.42e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.28e-14)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.91e-2)"	"unprognostic (4.26e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.9	0.0	11.8	0.0	0.0	1.3	0.5	0.2	0.0	0.1	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.2	0.9	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.0	2.0	0.2	0.0	0.3	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.2	0.0	0.4	0.0	2.6	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.6	0.2	0.0	2.6	0.1	0.0	0.0	0.1	0.5	0.0	0.5	0.4	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.1	0.1	0.9	1.3	0.5	0.2	1.5	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746200-12763699	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 14.9;fallopian tube: 26.9;testis: 49.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 223.3;Endometrial ciliated cells: 50.3;Late spermatids: 92.8;Respiratory ciliated cells: 88.1;Spermatocytes: 70.7"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028396			Uncertain	Cytosol		NA	NA			Cytosol		"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	5.9	0.0	1.2	0.3	0.0	2.1	0.6	0.6	14.9	0.0	0.0	0.4	0.1	0.1	26.9	0.0	0.0	1.0	5.0	0.0	0.0	1.9	0.1	3.6	5.2	0.3	0.1	0.1	0.0	0.6	0.1	3.3	0.0	0.0	0.1	0.1	0.0	1.2	0.2	0.0	0.0	4.2	0.1	0.1	49.3	1.8	0.0	0.6	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.9	1.2	2.1	0.6	1.0	5.0	3.6	5.2	0.3	3.3	4.2	1.8	3.8	0.0	3.2	0.5	0.3	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.3	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	223.3	50.3	0.4	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	92.8	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	88.1	0.0	6.6	0.1	1.3	70.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"fallopian tube: 107.4;testis: 149.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2151.8;Endometrial ciliated cells: 931.5;Late spermatids: 3412.7;Respiratory ciliated cells: 808.8;Spermatocytes: 514.1"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;SCLC-21H: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.0	0.1	2.7	0.0	2.0	0.0	0.2	2.1	2.8	1.1	11.8	0.3	0.3	1.1	1.2	0.1	107.4	0.0	0.0	2.4	3.1	0.2	0.0	4.4	0.0	3.3	2.5	1.6	0.1	0.9	0.2	2.5	0.0	2.7	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	2.2	0.0	0.3	149.0	2.1	0.3	0.4	0.0	0.0	0.3	0.0	2.4	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.7	2.0	2.1	2.8	2.4	3.1	3.3	2.5	1.6	2.7	2.2	2.1	2.4	0.0	0.0	4.1	0.7	0.2	0.0	0.2	53.9	0.0	0.6	0.8	0.9	3.5	0.0	61.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2151.8	931.5	6.1	1.8	0.0	0.0	1.1	0.2	0.0	0.7	0.0	11.2	3.8	0.0	0.0	0.0	0.1	0.0	1.0	0.4	57.0	0.0	0.3	3412.7	21.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	18.8	0.0	2.4	0.0	0.8	808.8	0.0	6.6	0.2	9.0	514.1	20.2	0.0	0.1	0.0	1.1	0.0	0.2	0.4
C20orf204	"DKFZp434G015, FLJ27267, LINC00176, NCRNA00176, PRR17"	ENSG00000196421	"Chromosome 20 open reading frame 204"	A0A1B0GTL2	20	64034344-64039962	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Breast glandular cells: 1.3;Endometrial stromal cells: 2.0;Endothelial cells: 4.3;Glandular and luminal cells: 1.8;T-cells: 1.1"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 7.2"	"Group enriched"	"Detected in some"	5	"cerebellum: 4.0;pons: 1.1"	"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 5.8;naive CD8 T-cell: 4.7;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	9	"T-cells: 5.8"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 49.0"	"Low region specificity"	"Detected in single"													NA	NA						"unprognostic (2.84e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.43e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.49e-6)"	"unprognostic (5.83e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.79e-4)"	0.3	0.1	0.3	0.1	0.3	0.0	0.3	4.0	0.4	0.4	0.1	0.2	0.0	0.3	0.0	0.4	0.8	0.0	0.3	0.2	0.3	0.4	0.2	0.2	0.0	0.3	0.5	0.2	0.4	0.3	0.1	0.9	0.0	1.1	0.5	0.0	0.0	0.1	0.0	0.2	0.2	0.7	0.0	0.2	0.3	0.1	0.6	0.2	1.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.2	0.0	0.0	49.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.8	0.0	0.0	5.8	4.7	0.2	0.6	0.0	0.0	1.4	0.4	0.3	0.3	4.0	0.4	0.2	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.8	2.0	4.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781019-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	90	"epididymis: 612.9;pancreas: 179.9"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 39.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 8.4"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.3	0.8	0.0	2.2	0.0	4.3	0.3	2.3	0.0	0.2	0.0	0.0	0.0	612.9	0.0	0.0	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.8	0.5	1.2	0.1	179.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.3	2.3	2.9	0.4	0.8	0.5	1.2	0.6	0.3	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	39.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
COL26A1	"EMI6, EMID2, Emu2"	ENSG00000160963	"Collagen type XXVI alpha 1 chain"	Q96A83	7	101362875-101559024	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.3;liver: 5.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 68.4;Inhibitory neurons: 18.5"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	45	"plasmacytoid DC: 9.2"	"Lineage enriched"	"Detected in single"	45	"dendritic cells: 9.2"	"Cell line enhanced"	"Detected in some"		"AF22: 30.0;BEWO: 23.9;HAP1: 10.7;NTERA-2: 25.4;SuSa: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA027059	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA027059: AB_1848142"	"unprognostic (5.94e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.48e-4)"	"unprognostic (2.83e-3)"	0.0	4.5	5.4	0.1	8.1	0.2	0.1	0.5	13.3	0.2	0.6	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	9.9	3.8	2.1	5.6	0.4	0.5	1.5	1.3	7.3	0.5	2.2	3.9	0.9	0.3	4.5	2.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.3	0.2	0.3	1.0	1.9	1.2	0.1	0.0	0.1	0.2	0.1	5.8	0.0	0.8	30.0	1.9	0.0	0.0	23.9	0.0	0.0	0.0	0.0	1.3	0.0	0.1	4.7	0.0	0.1	0.0	10.7	0.0	0.0	1.0	1.3	0.0	0.0	7.9	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	25.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.2	19.2	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	5.4	8.1	0.5	13.3	9.9	3.8	1.5	1.3	7.3	4.5	0.3	1.9	5.8	0.0	0.0	0.0	3.3	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.2	1.5	0.1	1.7	0.1	0.0	0.0	68.4	0.6	0.4	0.5	0.0	0.2	0.0	1.0	0.0	3.6	0.1	0.0	18.5	0.0	0.0	0.0	0.0	3.5	0.0	0.5	0.0	5.6	0.0	0.0	0.0	3.5	2.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.4	0.0	0.9	0.0	0.4
CRYGB	CRYG2	ENSG00000182187	"Crystallin gamma B"	P07316	2	208142573-208146158	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.1"	"Group enriched"	"Detected in some"	6	"ovarian cancer: 1.1;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"hippocampal formation: 3.3;hypothalamus: 2.2;thalamus: 2.0"					HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (6.73e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475593-54651169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.4;tongue: 24.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 110.7;Distal tubular cells: 39.2;Excitatory neurons: 49.7;Horizontal cells: 38.7;Inhibitory neurons: 79.6;Muller glia cells: 63.9;Oligodendrocyte precursor cells: 58.3"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;ASC diff: 13.1;ASC TERT1: 11.0;hTEC/SVTERT24-B: 13.7;U-138 MG: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	2.9	2.0	13.9	1.7	13.7	0.0	1.9	13.6	15.8	1.1	11.9	1.2	0.3	1.8	0.3	1.7	12.3	9.9	18.6	14.7	14.5	2.8	2.3	1.0	0.6	14.3	14.6	12.8	0.9	1.2	0.2	1.2	1.8	15.9	1.0	0.7	11.8	1.5	0.8	46.4	0.5	0.7	2.8	13.2	0.3	0.8	1.7	14.7	0.4	5.2	24.5	0.4	4.7	0.9	13.4	0.0	0.0	32.9	0.0	13.1	11.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	4.3	0.0	13.7	0.0	0.6	1.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	3.6	7.0	0.0	8.6	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	51.3	3.2	1.4	0.0	0.0	0.0	0.1	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	13.7	13.6	15.8	14.7	14.5	14.3	14.6	12.8	15.9	13.2	14.7	13.4	4.8	0.0	0.0	110.7	0.3	0.3	2.3	0.0	0.0	12.3	6.7	6.2	7.3	12.8	0.0	11.0	6.2	0.3	0.1	0.0	39.2	17.7	2.3	0.4	1.5	3.3	0.0	0.0	49.7	1.2	0.6	14.4	0.0	10.6	0.0	28.6	17.5	0.0	29.0	38.7	79.6	0.0	0.0	0.6	2.5	4.5	2.5	0.6	0.0	9.4	14.5	63.9	0.0	58.3	2.1	2.2	0.0	1.2	0.1	2.0	0.0	0.2	0.0	8.1	0.0	2.8	5.3	3.7	1.5	0.0	0.4	0.8	0.2	1.6	0.0	0.9
FAM181A	C14orf152	ENSG00000140067	"Family with sequence similarity 181 member A"	Q8N9Y4	14	93918894-93929608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 9.1;testis: 32.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 48.9;Spermatocytes: 35.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"AF22: 4.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 31.9"	HPA001603	Enhanced					NA	NA					"HPA001603: AB_1078326"		"unprognostic (8.19e-2)"		"unprognostic (6.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.31e-1)"		"unprognostic (2.05e-2)"		"unprognostic (1.84e-2)"					"unprognostic (6.27e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.37e-2)"	0.0	0.0	5.5	0.0	5.1	0.0	0.0	5.6	7.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.9	9.1	0.0	0.0	0.9	0.0	6.8	5.3	4.5	0.0	0.0	0.0	2.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	6.0	0.0	0.0	32.8	5.5	0.0	1.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.1	5.6	7.6	4.9	9.1	6.8	5.3	4.5	5.8	6.0	5.5	5.5	0.0	3.2	3.1	8.8	0.0	0.0	0.0	1.6	0.0	0.1	0.1	0.4	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	6.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.7	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.1	35.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF18	"FGF-18, ZFGF5"	ENSG00000156427	"Fibroblast growth factor 18"	O76093	5	171419647-171457626	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 19.8;Cardiomyocytes: 24.4;Endometrial ciliated cells: 13.0;Glandular and luminal cells: 24.9"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.0;ovarian cancer: 21.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"EFO-21: 188.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	HPA018795	Uncertain				"Secreted in other tissues"	NA	NA					"HPA018795: AB_1848523"	"unprognostic (3.01e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-8)"	"unprognostic (7.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.76e-2)"	2.9	0.3	1.0	0.3	0.9	0.0	2.1	0.9	2.3	0.7	2.4	0.7	0.6	0.9	0.1	0.3	1.5	0.7	10.3	1.0	1.0	0.5	0.1	2.6	0.3	1.2	1.1	0.8	0.4	0.5	0.1	1.6	0.5	1.4	1.2	0.1	0.1	1.1	0.3	3.9	1.2	0.7	0.4	0.8	0.5	0.6	0.8	1.4	0.3	1.9	0.4	0.3	0.9	0.5	1.0	0.0	0.3	0.3	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.1	3.4	0.4	0.2	188.2	0.0	0.2	0.2	0.0	0.1	0.0	3.1	0.3	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.9	0.1	3.4	0.0	0.1	0.0	0.3	2.1	0.1	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.5	0.1	0.5	0.0	0.2	0.6	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.9	2.3	1.0	1.0	1.2	1.1	0.8	1.4	0.8	1.4	1.0	6.9	6.4	0.0	0.0	2.0	2.4	2.6	0.5	6.2	0.1	6.6	19.8	24.4	1.5	1.3	1.8	0.0	0.1	3.4	0.5	0.0	0.0	6.2	13.0	3.1	4.2	1.8	0.0	0.8	0.0	0.3	9.4	0.5	24.9	0.0	0.0	2.9	0.0	0.1	0.0	2.1	1.0	0.0	0.0	2.1	0.7	0.3	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.4	3.2	1.1	0.0	0.0	0.0	0.0	5.4	4.6	0.7	1.6	5.6	3.1	0.0	2.4	0.5	1.8	0.9
GAL3ST2	GP3ST	ENSG00000154252	"Galactose-3-O-sulfotransferase 2"	Q9H3Q3	2	241776822-241804287	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"intestine: 9.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 3.7;HMC-1: 10.5"	"Not detected"	"Not detected"							HPA071809	Enhanced				"Intracellular and membrane"	NA	NA					"HPA071809: AB_2686450"	"unprognostic (5.22e-3)"	"unprognostic (6.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.04e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.87e-11)"	"unprognostic (4.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.49e-1)"	0.2	0.3	0.5	0.8	0.2	0.2	0.0	0.0	0.4	0.3	0.0	9.5	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.1	3.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.5	0.1	0.2	0.7	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685738	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Distal enterocytes: 18.1;Excitatory neurons: 57.8;Horizontal cells: 52.2;Inhibitory neurons: 40.0;Oligodendrocyte precursor cells: 39.2"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.3;NTERA-2: 18.0;RPMI-8226: 29.0;SuSa: 9.8;T-47d: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	3.3	4.5	17.9	2.8	17.9	1.7	2.5	7.0	17.9	3.0	16.3	7.2	1.2	5.5	0.3	1.8	7.6	4.3	5.4	20.6	13.5	10.9	1.0	2.8	2.1	11.1	14.6	18.6	2.5	1.9	14.8	13.0	0.8	10.4	1.5	5.4	3.9	3.0	2.3	1.6	0.4	4.9	7.2	4.8	7.6	2.1	4.2	18.1	3.1	3.2	3.2	0.7	1.4	2.2	12.5	0.0	4.3	3.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	9.3	0.6	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	1.5	0.0	18.0	0.0	0.1	0.2	0.0	29.0	0.0	0.2	2.4	0.4	5.6	0.1	0.0	9.8	10.1	0.0	0.0	0.0	3.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	17.9	7.0	17.9	20.6	13.5	11.1	14.6	18.6	10.4	4.8	18.1	12.5	3.9	0.0	0.0	22.2	0.3	0.4	0.7	0.1	0.0	7.0	0.6	1.9	1.5	0.0	0.1	1.8	2.1	0.1	0.0	18.1	0.0	3.8	0.0	0.5	0.2	2.3	11.4	2.7	57.8	0.9	0.1	2.9	0.0	0.8	0.0	0.1	3.3	0.0	7.0	52.2	40.0	2.3	2.0	0.3	1.1	0.5	0.0	0.2	0.0	9.4	0.2	4.6	0.0	39.2	1.6	4.9	5.6	0.0	0.1	0.3	0.0	5.5	0.0	1.1	0.0	0.9	0.5	0.1	0.3	0.5	0.1	0.4	0.2	1.4	1.0	0.4
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.9;brain: 100.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.9	0.7	55.2	0.1	44.1	0.0	1.7	46.1	100.2	0.0	0.4	0.2	0.1	0.3	1.3	0.1	1.0	0.1	0.8	45.9	29.0	5.3	0.0	0.0	0.2	55.6	45.5	32.7	0.2	2.4	0.9	1.8	0.1	62.2	1.0	0.1	3.8	2.3	1.6	5.8	1.0	0.2	0.2	27.4	0.3	0.4	9.0	86.7	0.2	0.3	2.6	0.0	0.0	0.0	39.5	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	55.2	44.1	46.1	100.2	45.9	29.0	55.6	45.5	32.7	62.2	27.4	86.7	39.5	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
OBP2A	"hOBPIIa, LCN13, OBP"	ENSG00000122136	"Odorant binding protein 2A"	Q9NY56	9	135546126-135549969	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"fallopian tube: 25.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 2.4;Breast myoepithelial cells: 3.4;Late spermatids: 1.8;Leydig cells: 1.5;Melanocytes: 1.8"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 18.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-266/70: 1.6;U-266/84: 6.4"									HPA055955	Uncertain				"Secreted in other tissues"	NA	NA					"HPA055955: AB_2682985"	"unprognostic (2.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.20e-1)"		"unprognostic (2.75e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.83e-11)"	"unprognostic (5.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.84e-1)"	0.0	0.0	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.1	0.0	6.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1
SCX	"bHLHa41, bHLHa48, SCXA, SCXB"	ENSG00000260428	"Scleraxis bHLH transcription factor"	Q7RTU7	8	144266453-144268481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.7;thyroid gland: 38.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 14.2;Horizontal cells: 16.8"	"Group enriched"	"Detected in all"	6	"endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;HaCaT: 5.3"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Low region specificity"	"Detected in some"			HPA043183	Uncertain					NA	NA					"HPA043183: AB_2678357"	"unprognostic (5.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.89e-3)"	1.2	3.4	2.9	0.9	2.1	0.6	1.4	7.7	6.9	6.7	2.5	7.0	0.9	2.9	0.5	3.4	3.9	0.1	8.2	2.5	2.5	6.0	2.1	3.5	0.4	5.3	2.4	2.3	2.6	3.8	0.8	19.7	0.2	5.3	4.5	0.2	0.1	2.7	0.1	14.0	3.1	5.0	0.2	0.7	4.6	5.9	5.2	2.4	0.7	38.4	1.2	0.1	2.7	3.3	3.8	2.0	0.4	0.1	0.5	0.0	0.0	4.8	0.1	0.0	0.1	0.0	0.1	1.4	1.3	1.4	0.2	0.2	5.3	0.0	0.0	0.0	0.9	0.8	0.3	1.9	0.2	0.2	0.1	2.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.2	0.6	0.1	3.0	0.5	1.1	1.1	0.4	2.3	1.6	0.2	0.8	0.1	2.0	0.2	0.9	0.5	1.8	2.2	0.1	2.3	0.9	0.3	0.4	3.5	1.6	0.3	1.8	0.6	0.3	0.8	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.1	7.7	6.9	2.5	2.5	5.3	2.4	2.3	5.3	0.7	2.4	3.8	3.4	0.0	2.7	8.5	2.5	0.0	1.2	0.0	0.6	14.2	6.7	8.3	6.2	1.5	1.3	3.7	0.0	1.5	7.5	2.2	1.9	0.6	0.2	5.7	1.4	1.2	2.4	0.0	5.9	1.4	0.6	1.2	8.2	7.1	0.0	3.2	0.4	0.4	0.4	16.8	8.5	2.3	0.0	0.6	0.0	0.9	0.3	0.9	0.0	1.0	0.0	8.2	1.0	2.5	0.3	1.5	2.1	0.7	0.7	2.7	1.5	0.2	0.0	1.5	0.0	4.2	6.4	2.5	9.0	0.6	0.0	1.1	3.1	0.3	1.8	1.0
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652675-63679020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"fallopian tube: 174.9"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 410.9;Respiratory ciliated cells: 726.5"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA043322, HPA058399"	Enhanced					NA	NA					"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.1	0.2	0.4	0.6	0.6	0.8	0.2	3.7	2.1	3.2	0.0	0.3	0.4	3.0	0.4	0.2	174.9	0.5	0.0	0.7	0.4	0.1	0.1	13.6	0.8	0.9	0.2	0.6	0.3	0.9	0.1	0.0	0.2	1.7	0.4	0.5	1.0	0.3	0.2	0.3	1.2	0.5	0.3	0.0	0.3	0.8	0.3	0.4	0.1	17.9	0.1	0.2	0.1	0.0	1.1	0.2	0.1	0.2	0.4	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.2	1.0	0.2	0.1	0.7	0.1	0.2	0.6	0.1	0.0	0.2	0.5	0.9	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.3	1.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.4	0.6	3.7	2.1	0.7	0.4	0.9	0.2	0.6	1.7	0.0	0.4	1.1	0.0	3.2	4.2	0.3	0.0	0.0	0.1	34.0	0.0	0.0	0.3	0.1	0.3	0.0	60.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	3.6	410.9	2.3	0.3	0.0	0.0	0.1	0.4	0.0	1.4	0.0	4.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	38.7	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	726.5	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.5	0.2
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.9;fallopian tube: 32.9;pancreas: 30.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA			"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	15.4	0.0	0.0	0.4	4.6	5.1	0.4	32.9	5.1	0.2	0.0	0.1	17.5	1.1	0.7	0.0	0.0	0.0	0.0	0.1	30.3	0.0	0.1	0.9	0.0	3.0	0.0	0.0	22.2	7.9	0.2	2.6	0.0	0.1	0.0	0.0	3.7	1.1	0.1	0.1	0.0	0.0	0.0	3.2	0.1	0.0	1.0	0.1	1.7	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	7.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	4.2	0.1	1.2	0.0	0.0	244.8	0.1	29.9	14.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.5	6.9	0.0	0.0	62.3	18.4	1.1	0.0	22.6	55.2	0.0	3.4	1.1	0.0	0.0	83.6	2.5	42.7	4.4	0.6	0.0	0.0	0.8	34.2	1.4	0.4	0.0	79.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	6.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	11.3	0.0	0.0	0.0	1.6	0.0	0.3	8.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	3.0	0.5	0.0	0.0	4.8
ADCY8	"AC8, ADCY3, HBAC1"	ENSG00000155897	"Adenylate cyclase 8"	P40145	8	130780301-131040909	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 30.3;epididymis: 23.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 151.8;Inhibitory neurons: 250.9;Oligodendrocyte precursor cells: 138.7"	"Group enriched"	"Detected in some"	5	"glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;GAMG: 8.2;U-138 MG: 17.6;U-87 MG: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018652, HPA024291"	Supported					NA	NA					"CAB018652: AB_633654, HPA024291: AB_1844597"	"unprognostic (5.59e-3)"				"unprognostic (3.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.22e-3)"	"unprognostic (4.91e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.67e-2)"		0.0	0.0	15.5	0.0	13.6	0.0	0.5	22.3	9.8	0.4	1.6	0.0	0.0	0.0	23.0	0.0	3.9	0.0	0.0	11.3	13.0	0.2	0.0	1.2	0.0	17.1	19.6	8.1	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	3.1	1.1	1.4	0.1	2.0	0.0	0.5	23.4	0.0	0.1	0.5	30.3	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.1	1.3	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.6	0.4	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	13.6	22.3	9.8	11.3	13.0	17.1	19.6	8.1	16.8	23.4	30.3	24.2	0.0	0.0	1.5	151.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.1	0.0	138.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL589987.1		ENSG00000230707	"Novel protein (LOC389895)"		X	140091415-140092911	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.4;brain: 3.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"endometrial cancer: 2.0;glioma: 1.0;ovarian cancer: 0.9;testis cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HAP1: 2.1;NTERA-2: 1.7;U-251 MG: 2.2"									HPA041568	Uncertain					NA	NA					"HPA041568: AB_10796677"				"unprognostic (1.27e-1)"	"unprognostic (3.32e-2)"					"unprognostic (2.17e-1)"		"unprognostic (4.08e-2)"			"unprognostic (5.26e-1)"	"unprognostic (1.28e-2)"		0.1	6.4	2.5	0.1	3.0	0.0	0.0	2.4	3.8	0.9	1.2	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	2.8	2.6	0.0	0.0	0.0	0.0	2.4	2.2	2.7	0.3	0.0	0.1		0.0	2.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	0.0	1.4	2.3	0.0	0.1	0.0	0.0	0.0		2.4	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	2.4	3.8	2.8	2.6	2.4	2.2	2.7	2.4	2.3	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 10.8"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 31.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	0.3	0.6	2.2	0.2	2.2	0.0	0.1	0.7	2.8	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.3	10.8	0.0	0.0	0.1	0.0	3.8	5.2	1.6	0.0	0.0	0.0	1.3	0.0	7.2	0.0	0.2	0.7	0.1	0.1	0.0	0.1	0.3	0.1	2.2	0.0	0.1	1.2	2.2	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.4	31.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.2	0.7	2.8	1.3	10.8	3.8	5.2	1.6	7.2	2.2	2.2	2.3	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.5	0.1	0.2	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	274.2	0.0	0.0	0.0	0.0	41.2	0.0	0.5	0.0	7.5	0.0	0.6	0.0	433.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ARMC3	"CT81, FLJ32827"	ENSG00000165309	"Armadillo repeat containing 3"	Q5W041	10	22928024-23038523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 13.7;choroid plexus: 29.3;fallopian tube: 44.9;testis: 33.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 364.4;Endometrial ciliated cells: 169.1;Late spermatids: 90.1;Respiratory ciliated cells: 204.6;Spermatocytes: 70.0"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 4.0;ovarian cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"CAPAN-2: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037823, HPA037824"	Enhanced					NA	NA					"HPA037823: AB_2675689, HPA037824: AB_10671634"	"unprognostic (8.11e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"		"unprognostic (5.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.37e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.21e-3)"	"unprognostic (9.53e-4)"	"unprognostic (1.40e-2)"	0.0	0.0	8.4	0.0	4.0	0.0	0.0	4.9	2.8	1.2	29.3	0.0	0.0	1.5	0.1	0.1	44.9	0.0	0.1	2.2	13.7	0.4	0.0	3.6	0.0	10.3	9.1	0.9	0.0	0.3	0.0	1.3	0.0	8.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	9.9	0.0	0.0	33.9	4.9	0.1	0.3	0.1	0.0	0.0	0.0	8.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.4	4.0	4.9	2.8	2.2	13.7	10.3	9.1	0.9	8.0	9.9	4.9	8.8	0.0	0.0	1.1	8.1	0.0	0.0	0.0	6.0	0.0	0.0	0.1	0.1	0.3	0.0	22.4	0.0	6.2	0.0	0.1	0.0	0.0	0.4	364.4	169.1	1.4	0.8	0.0	0.0	9.1	0.0	0.0	0.4	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	12.2	0.0	0.0	90.1	3.4	1.5	0.0	2.8	0.0	0.0	0.0	1.5	9.0	0.0	0.0	3.8	0.0	0.3	0.0	1.5	204.6	1.1	0.0	0.0	3.0	70.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 124.7;salivary gland: 141.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA			"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	1.8	0.5	0.5	0.2	0.3	0.0	11.9	0.8	0.9	31.4	0.0	0.5	0.5	1.4	1.2	1.6	12.9	0.2	1.0	0.3	0.1	124.7	0.2	1.8	0.5	0.2	0.0	0.2	1.2	3.4	0.8	4.2	18.1	0.3	2.0	0.1	3.9	141.0	1.4	0.5	29.8	0.6	0.8	0.0	0.0	0.3	0.3	0.1	0.1	0.3	0.2	0.0	0.6	0.8	0.5	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.8	0.9	0.3	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.5	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
C19orf84		ENSG00000262874	"Chromosome 19 open reading frame 84"	I3L1E1	19	51388289-51390591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 22.2"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 31.9"	"Group enriched"	"Detected in some"	5	"ovarian cancer: 1.3;testis cancer: 3.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA068082	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA068082: AB_2685949"	"unprognostic (5.94e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.13e-3)"	"unprognostic (9.28e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.99e-3)"	0.0	0.0	0.4	0.2	0.4	0.7	0.0	0.4	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.1	0.3	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	22.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.4	0.7	0.5	0.4	0.5	0.4	0.2	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.3	0.3	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	31.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.4;prostate: 11.8"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocyte precursor cells: 145.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 387.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 118.1"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.2	0.8	26.4	0.1	33.4	0.0	5.4	6.0	22.6	0.4	3.3	0.5	0.2	0.5	0.1	0.2	4.2	0.4	0.1	13.0	15.4	0.1	0.0	5.8	0.0	15.7	15.1	15.8	0.1	0.4	1.2	0.3	0.7	21.4	11.8	0.1	0.8	1.7	1.3	0.1	0.4	0.1	1.1	10.0	0.0	1.5	0.2	21.1	0.0	0.1	0.0	0.0	0.4	0.7	10.6	6.4	4.1	15.6	0.0	0.0	0.0	4.4	0.0	0.0	1.4	0.0	4.6	0.2	0.0	0.2	0.0	41.2	64.1	0.1	0.0	0.0	0.0	0.3	0.0	1.8	3.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	34.5	0.1	0.3	15.7	7.3	0.0	0.0	0.4	8.7	0.0	11.1	15.8	387.4	3.6	10.4	0.0	38.1	38.5	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	33.4	6.0	22.6	13.0	15.4	15.7	15.1	15.8	21.4	10.0	21.1	10.6	0.0	3.2	1.3	0.0	0.0	0.0	1.1	0.3	0.0	0.2	6.4	3.4	1.3	0.0	1.4	0.0	0.0	0.3	0.1	0.6	0.0	0.1	2.6	1.0	0.2	0.1	7.7	0.0	1.8	0.2	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.0	3.4	0.0	145.3	0.3	0.7	0.2	0.0	0.0	2.6	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7
CCDC33	"CT61, FLJ32855"	ENSG00000140481	"Coiled-coil domain containing 33"	Q8N5R6	15	74202705-74336472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 23.8;testis: 20.3"	"Group enriched"	"Detected in some"	9	"Early spermatids: 54.2;Endometrial ciliated cells: 70.1;Late spermatids: 54.6;Respiratory ciliated cells: 56.7"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.4;ovarian cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 4.4;SCLC-21H: 2.4;SH-SY5Y: 2.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 7.4"							NA	NA						"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (2.16e-1)"		"unprognostic (3.16e-3)"		"unprognostic (3.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.05e-2)"		"unprognostic (4.46e-1)"	"unprognostic (4.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.37e-2)"	0.0	0.2	1.8	0.0	0.7	0.0	0.0	0.7	0.4	1.2	0.4	0.0	0.0	0.3	0.1	0.0	23.8	0.0	0.0	0.3	0.8	0.0	0.0	2.7	0.0	1.7	1.9	0.0	0.1	0.0	0.0	0.4	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.1	20.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.4	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.7	0.7	0.4	0.3	0.8	1.7	1.9	0.0	1.5	2.8	0.6	0.7	0.2	0.0	1.5	0.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	54.2	70.1	1.5	0.2	0.0	0.0	0.6	0.0	0.0	0.5	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.1	0.0	0.0	54.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.4	56.7	0.0	0.0	0.0	1.1	0.6	0.2	0.0	0.0	1.8	0.1	0.2	0.0	0.1
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193686-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 14.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 477.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		9600000	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	5.0	1.1	3.6	1.4	7.2	0.2	2.6	2.4	3.6	4.3	1.9	1.1	1.3	2.3	1.8	2.5	6.9	9.3	2.0	1.9	6.8	14.9	0.8	4.6	0.6	4.8	5.7	1.8	0.7	0.7	1.1	1.0	3.6	4.5	1.1	0.9	1.6	0.7	1.8	1.2	0.8	1.2	2.6	3.4	0.8	1.1	0.3	11.2	0.4	2.3	1.6	0.7	2.4	1.9	4.5	0.1	1.9	62.2	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.2	0.0	0.1	477.1	0.3	0.0	0.0	49.6	0.1	0.0	0.6	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	17.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	9.4	0.0	0.2	0.0	10.9	0.1	14.0	0.0	1.8	0.0	0.0	0.1	0.2	19.3	0.1	0.2	0.0	0.1	1.8	5.9	1.5	0.1	0.4	1.1	0.1	0.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	7.2	2.4	3.6	1.9	6.8	4.8	5.7	1.8	4.5	3.4	11.2	4.5	5.7	0.0	0.5	7.2	2.4	0.9	0.1	36.5	0.0	10.8	0.1	0.4	3.1	48.6	7.0	11.0	0.0	0.0	0.0	0.0	27.4	37.2	0.2	2.9	0.6	5.3	0.0	0.0	67.1	3.0	0.0	2.9	0.0	2.9	0.0	4.1	0.0	0.1	0.1	0.0	33.6	0.0	0.0	0.0	2.5	0.1	0.3	1.3	0.0	39.4	1.0	0.3	0.0	60.8	5.5	63.8	0.0	0.4	0.0	1.2	0.0	171.1	1.1	0.8	46.0	0.6	69.5	0.0	0.4	0.1	1.0	0.0	1.8	0.2	0.0	0.1
EIF3CL		ENSG00000205609	"Eukaryotic translation initiation factor 3 subunit C like"	B5ME19	16	28379579-28403841	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.0;Cardiomyocytes: 35.1;Club cells: 37.9;Respiratory ciliated cells: 38.2"	"Group enriched"	"Detected in some"	5	"glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA047097, HPA049495, HPA050112"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.75e-5)"	"unprognostic (6.56e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.58e-2)"	40.3	35.7	21.9	1.0	19.0	6.3	41.6	19.5	33.8	35.8	15.5	35.8	1.3	29.6	3.5	44.7	34.1	1.9	45.4	21.1	18.9	43.2	40.2	31.0	1.6	20.4	19.1	19.5	50.9	73.5	4.0	32.4	2.5	22.7	35.9	2.3	5.5	38.9	3.4	99.4	52.5	30.5	2.0	17.6	32.3	43.4	30.9	19.5	1.8	41.0	6.9	3.0	38.1	36.1	22.1	3.0	6.9	6.6	5.5	9.1	5.2	4.3	3.8	4.6	9.5	8.2	7.7	3.5	4.1	6.8	5.8	7.6	5.5	11.0	10.9	14.1	1.9	6.5	4.7	12.7	15.3	2.7	6.9	8.3	5.7	7.3	5.7	6.0	5.7	3.6	6.8	7.6	7.8	3.6	9.4	8.2	17.3	15.1	5.7	4.0	10.9	8.0	7.4	8.1	5.1	13.1	8.5	3.2	6.4	6.0	1.8	16.4	6.8	5.2	4.2	7.9	5.2	7.6	4.2	3.8	7.2	7.3	7.2	7.7	2.9	1.3	0.7	1.1	1.8	1.3	0.9	1.4	1.2	1.7	0.9	1.2	1.6	0.1	1.1	2.3	0.8	1.2	1.3	21.9	19.0	19.5	33.8	21.1	18.9	20.4	19.1	19.5	22.7	17.6	19.5	22.1	0.1	22.4	44.0	0.7	2.2	1.3	2.0	0.3	1.8	0.0	0.5	0.6	35.1	0.0	37.9	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.1	0.2	0.2	4.9	0.0	8.4	0.5	1.2	0.6	10.5	3.1	0.1	10.1	0.0	1.8	0.2	0.5	0.0	0.6	0.7	0.0	1.3	2.3	0.7	0.3	5.2	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.1	1.7	0.4	5.2	1.1	0.9	1.7	38.2	0.0	0.0	0.5	7.4	0.3	0.6	2.5	1.6	0.8	2.6	0.1	0.7	1.0
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"adrenal gland: 272.2;fallopian tube: 83.8;skeletal muscle: 187.7"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 108.0;Respiratory ciliated cells: 126.4"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045540	Enhanced					NA	NA					"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	5.3	272.2	4.0	0.0	1.5	0.0	2.5	2.4	1.4	2.1	7.2	0.3	0.0	1.3	9.0	0.6	83.8	0.1	0.5	1.2	2.9	0.7	0.6	4.2	0.1	3.8	5.6	0.4	0.3	0.2	0.1	0.4	0.0	4.4	0.4	0.2	0.1	0.7	0.6	187.7	0.6	0.6	0.1	6.1	0.2	0.4	0.2	2.8	0.0	0.3	18.5	0.3	0.2	0.2	2.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.5	2.4	1.4	1.2	2.9	3.8	5.6	0.4	4.4	6.1	2.8	2.8	0.3	0.0	0.5	0.0	0.0	4.7	1.2	9.2	2.2	0.0	0.3	2.4	0.3	0.0	10.1	0.0	2.1	0.2	0.3	0.0	0.0	0.2	0.3	108.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.1	0.4	0.5	0.1	0.0	0.1	0.0	24.4	0.0	0.7	0.3	0.3	0.3	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	3.3	126.4	0.2	0.0	3.1	3.3	0.2	0.2	2.0	2.0	0.0	0.3	2.1	0.2	0.5
FGF9		ENSG00000102678	"Fibroblast growth factor 9"	P31371	13	21671073-21704498	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.9;kidney: 10.9;retina: 8.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Excitatory neurons: 36.7;Horizontal cells: 40.4;Inhibitory neurons: 54.7;Muller glia cells: 138.8"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 3.7;ovarian cancer: 1.2;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;HEK 293: 1.4;JURKAT: 2.1;RPMI-8226: 2.1;RPTEC TERT1: 3.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067007	Enhanced	Approved			"Secreted in other tissues"	NA	NA					"HPA067007: AB_2732755"	"unprognostic (6.59e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.42e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.38e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (1.70e-6)"	"unprognostic (5.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.92e-2)"	1.2	4.0	1.6	0.1	1.6	0.2	0.2	5.9	4.8	1.6	0.5	0.8	0.7	1.6	0.2	0.2	0.4	0.4	2.7	1.6	2.0	10.9	0.0	0.9	0.1	3.5	2.2	1.3	1.1	0.5	0.1	2.2	0.1	4.5	0.3	1.2	8.3	0.3	0.5	0.5	0.1	1.8	0.3	1.4	0.1	0.8	0.5	3.4	0.1	0.1	0.5	0.0	1.3	0.8	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.6	2.1	3.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	5.9	4.8	1.6	2.0	3.5	2.2	1.3	4.5	1.4	3.4	4.3	0.9	9.6	5.6	12.1	1.8	1.7	0.2	0.6	0.0	14.4	0.7	2.7	25.7	0.0	1.3	3.7	0.0	0.1	3.2	1.7	39.2	0.4	9.4	13.1	2.6	1.6	18.6	0.0	36.7	0.0	0.0	3.9	0.0	26.6	0.0	1.2	0.0	0.0	0.1	40.4	54.7	2.7	0.0	0.0	1.6	2.9	0.6	0.5	1.8	1.9	1.6	138.8	3.1	9.5	1.7	0.2	0.5	0.0	1.9	0.1	10.9	1.1	0.0	5.9	0.0	1.0	0.7	6.3	6.2	0.1	1.4	0.3	3.2	0.1	7.5	0.1
GAL3ST3	GAL3ST2	ENSG00000175229	"Galactose-3-O-sulfotransferase 3"	Q96A11	11	66040765-66049161	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 17.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.9;Cardiomyocytes: 3.6;Cone photoreceptor cells: 10.4;Excitatory neurons: 3.7;Horizontal cells: 5.0;Inhibitory neurons: 4.7;Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 15.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;ovarian cancer: 5.5;thyroid cancer: 10.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 6.5;SH-SY5Y: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA									"prognostic unfavorable (6.53e-6)"	"unprognostic (1.24e-1)"			"unprognostic (3.30e-1)"		"unprognostic (1.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.29e-1)"	0.0	0.0	3.3	0.0	5.4	0.0	0.0	4.6	5.1	2.5	0.0	0.0	0.0	3.9	0.1	0.0	2.6	0.0	4.3	4.6	2.0	2.3	0.0	0.0	0.0	2.1	2.3	4.7	0.2	0.6	0.3	4.1	0.0	3.2	0.8	0.0	5.7	0.0	1.6	0.3	0.1	0.0	2.8	0.6	0.0	0.0	2.1	2.1	0.0	17.2	0.3	0.0	0.0	0.3	3.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.4	4.6	5.1	4.6	2.0	2.1	2.3	4.7	3.2	0.6	2.1	3.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.6	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	7.5	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	15.4	0.0	0.0	0.3	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GALNT9	GALNAC-T9	ENSG00000182870	"Polypeptide N-acetylgalactosaminyltransferase 9"	Q9HCQ5	12	132196372-132329589	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.9;thyroid gland: 13.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.7;Collecting duct cells: 27.6;Excitatory neurons: 37.1;Inhibitory neurons: 13.1;Proximal tubular cells: 8.2"	"Group enriched"	"Detected in some"	5	"glioma: 0.9;ovarian cancer: 0.5;renal cancer: 1.6;thyroid cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-87 MG: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075016			Approved	Vesicles		NA	NA			Vesicles		"HPA075016: AB_2686729"	"unprognostic (1.13e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.69e-2)"	4.3	1.2	6.6	0.1	11.5	0.0	0.1	18.3	21.9	3.5	0.0	1.2	0.2	0.8	2.3	0.1	1.9	0.0	0.4	10.9	3.7	7.7	0.2	0.5	0.3	6.1	5.6	10.1	1.3	0.1	0.2	8.5	0.0	8.7	1.0	0.0	0.6	0.2	0.3	0.1	0.1	0.5	0.0	0.5	0.9	0.6	0.7	10.0	0.1	13.1	0.0	0.0	0.5	0.8	10.7	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.5	18.3	21.9	10.9	3.7	6.1	5.6	10.1	8.7	0.5	10.0	10.7	0.0	0.0	0.6	2.6	0.0	0.0	0.5	0.0	0.0	7.7	0.1	0.0	1.6	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	1.3	0.0	0.0	37.1	0.0	0.0	2.7	0.0	0.8	1.3	0.0	0.0	0.0	0.2	3.3	13.1	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	5.6	0.0	1.7	0.0	2.0	2.9	0.1	0.0	1.9	0.0	0.6	0.0	8.2	0.0	3.3	0.0	0.9	0.6	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.8
GMNC	GEMC1	ENSG00000205835	"Geminin coiled-coil domain containing"	A6NCL1	3	190852737-190892429	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 8.1;liver: 4.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Endometrial ciliated cells: 5.9;Hepatocytes: 6.1;Proximal tubular cells: 11.5;Respiratory ciliated cells: 4.4"	"Cancer enriched"	"Detected in some"	5	"ovarian cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"SCLC-21H: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA043663	Uncertain					NA	NA					"HPA043663: AB_10959313"				"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.73e-2)"		"unprognostic (2.55e-3)"		0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.4	0.2	0.2	2.3	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.3	2.2	1.9	4.2	0.0	0.0	0.5	0.9	0.1	0.1	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.4	0.2	0.3	2.2	0.5	0.9	0.1	0.5	1.0	0.7	2.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	14.6	5.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.5	4.4	0.2	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;testis: 33.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Bipolar cells: 23.0;Excitatory neurons: 32.4;Horizontal cells: 18.5;Inhibitory neurons: 31.1;Oligodendrocyte precursor cells: 31.7;Rod photoreceptor cells: 21.2"	"Group enriched"	"Detected in many"	5	"glioma: 15.4;ovarian cancer: 6.6;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.7;hTERT-RPE1: 21.2;NTERA-2: 13.1;REH: 37.5;SCLC-21H: 10.3;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.3	4.0	19.3	1.7	15.8	3.0	1.3	5.3	26.9	4.5	0.0	11.8	0.8	7.3	1.8	1.6	6.9	1.9	3.3	36.5	10.1	5.6	0.3	0.6	0.7	5.0	5.1	18.3	3.6	2.7	14.9	18.4	0.0	7.1	6.3	1.0	12.6	0.7	6.6	0.5	0.9	3.4	5.2	1.0	1.3	5.4	33.2	9.0	0.9	11.4	0.7	0.6	5.0	2.7	6.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	13.7	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	21.2	0.0	0.6	0.1	0.6	0.0	0.2	0.2	0.0	13.1	0.1	0.0	37.5	0.0	0.1	5.8	0.1	10.3	22.7	0.1	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	15.8	5.3	26.9	36.5	10.1	5.0	5.1	18.3	7.1	1.0	9.0	6.3	0.2	0.0	0.0	17.9	0.1	0.4	0.1	0.0	0.0	23.0	0.2	0.8	3.1	0.0	0.0	1.8	2.1	0.0	0.0	0.1	0.0	0.8	1.6	0.2	0.2	0.4	0.0	0.0	32.4	0.0	0.0	0.6	0.0	0.3	4.5	7.2	0.0	0.0	0.0	18.5	31.1	0.0	0.0	0.0	0.0	2.3	0.9	0.1	0.0	2.8	0.0	9.1	0.0	31.7	0.9	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	21.2	0.0	4.9	1.7	4.2	2.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188668-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;epididymis: 7.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 18.5;Distal enterocytes: 20.3;Distal tubular cells: 25.4;Endothelial cells: 18.8;Intestinal goblet cells: 20.6;Oligodendrocytes: 28.0;Proximal enterocytes: 22.0;Undifferentiated cells: 28.6"	"Cancer enriched"	"Detected in many"	5	"ovarian cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;Hep G2: 7.2;RPTEC TERT1: 21.3;RT4: 16.9;SCLC-21H: 5.7"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.1"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	1.6	0.2	4.1	0.5	5.3	0.0	1.6	6.1	4.7	0.3	1.4	2.9	0.3	0.4	7.6	0.5	4.9	0.7	0.1	2.3	4.1	6.5	0.0	3.3	0.4	16.7	6.5	1.7	0.4	0.2	0.0	0.0	0.0	9.1	1.0	2.0	0.0	0.2	2.6	0.1	0.5	3.3	0.3	8.7	1.1	0.4	1.7	5.7	0.1	0.1	0.3	0.1	2.2	0.4	11.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	6.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	21.3	16.9	5.7	1.0	0.0	0.0	1.2	0.8	0.0	0.0	3.9	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	5.3	6.1	4.7	2.3	4.1	16.7	6.5	1.7	9.1	8.7	5.7	11.3	14.2	3.2	18.5	0.0	0.1	4.2	0.2	0.0	0.0	0.0	0.9	1.3	0.1	0.0	2.5	7.3	0.0	0.0	0.1	20.3	25.4	0.0	0.1	0.2	0.2	18.8	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	5.6	0.4	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	28.0	0.1	13.2	0.4	0.9	0.7	22.0	3.2	0.0	0.0	0.0	0.6	1.1	3.4	9.5	0.3	2.6	0.0	0.5	0.5	28.6	2.7
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.2;retina: 14.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Horizontal cells: 79.1;Inhibitory neurons: 17.6;Spermatogonia: 9.7"	"Group enriched"	"Detected in many"	5	"glioma: 9.2;ovarian cancer: 3.5;testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 35.0;NTERA-2: 16.0;SH-SY5Y: 23.0;SuSa: 9.9;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041994	Approved				"Secreted in brain"	NA	NA		15000			"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	1.2	1.7	17.0	0.2	9.7	0.7	0.9	23.1	21.5	0.3	1.5	0.4	0.2	0.1	0.7	4.2	0.1	0.2	0.3	12.2	17.2	0.1	1.9	0.2	0.0	40.3	19.8	9.4	1.2	0.2	1.8	1.3	0.4	44.3	0.2	0.0	14.1	0.7	0.7	0.0	0.6	0.3	0.1	14.9	0.1	0.2	8.0	26.7	0.0	0.2	0.0	0.0	0.4	1.2	49.2	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	16.0	0.2	0.0	0.0	0.0	3.5	0.0	0.1	0.1	23.0	0.0	0.0	0.0	9.9	0.2	2.2	0.0	0.0	6.4	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	9.7	23.1	21.5	12.2	17.2	40.3	19.8	9.4	44.3	14.9	26.7	49.2	2.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.8	0.1	0.3	79.1	17.6	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.7	0.0	2.5	0.0	5.5	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.9	0.9	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KLK5	"KLK-L2, SCTE"	ENSG00000167754	"Kallikrein related peptidase 5"	Q9Y337	19	50943303-50953093	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 185.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 85.4;Late spermatids: 193.2"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 73.1;melanoma: 32.1;ovarian cancer: 112.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	41	"A-431: 485.1;HaCaT: 455.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014343, CAB025503, CAB026341, HPA073512"	Enhanced				"Secreted in other tissues"	NA	NA		2500000			"CAB025503: , CAB026341: , HPA014343: AB_1852603, HPA073512: "	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"		"prognostic unfavorable (2.33e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.01e-1)"		"prognostic unfavorable (9.79e-4)"	"unprognostic (3.04e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	"unprognostic (2.21e-1)"		"unprognostic (2.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.16e-3)"	"prognostic unfavorable (3.85e-6)"	2.2	0.0	1.1	0.0	1.1	0.0	30.5	0.4	2.6	7.5	0.6	0.0	0.1	0.1	0.0	23.2	0.5	0.0	0.1	1.0	0.9	0.5	0.1	6.1	0.0	0.9	1.1	1.2	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.0	0.0	23.8	0.0	1.1	185.1	0.0	0.0	0.5	0.3	0.0	14.3	1.0	0.1	0.1	0.0	0.6	0.0	13.6	1.2	485.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.1	455.4	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.0	1.1	0.0	1.5	0.1	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.4	2.6	1.0	0.9	0.9	1.1	1.2	1.3	0.5	1.0	1.2	0.2	16.0	0.0	0.0	0.0	26.8	1.8	2.4	12.0	0.0	33.0	27.2	0.3	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	85.4	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	193.2	1.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	1.6	0.8	2.8	10.9	0.0	0.3	0.0	0.0	0.1
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 189.9;lymphoid tissue: 144.0"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 12.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.0	189.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	36.1	0.0	0.0	21.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	144.0	0.1	14.2	12.2	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	1.3	0.0	0.0	0.1	0.1	0.1	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206053173-206102449	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.6"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 202.9;Glandular and luminal cells: 337.5;granulocytes: 334.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 42.8;ovarian cancer: 41.1;renal cancer: 27.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	152	"basophil: 1312.1"	"Lineage enriched"	"Detected in single"	1544	"granulocytes: 1312.1"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 1562.9"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	3.2	0.4	0.0	3.0	0.0	1.4	4.7	0.0	0.0	24.6	0.0	7.6	3.3	12.9	16.4	7.8	5.4	16.4	0.9	0.0	0.0	14.2	1.0	10.8	4.2	0.0	0.1	0.0	0.2	1.4	0.3	0.4	0.6	0.0	2.9	7.5	0.0	2.8	20.2	1.0	4.1	6.7	7.4	0.0	3.0	6.5	1.0	0.2	3.1	2.0	2.6	4.6	7.8	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	143.8	0.0	0.9	0.0	75.2	1562.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	330.8	0.0	0.0	0.0	0.1	0.2	0.7	20.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.6	0.9	1.1	0.8	1312.1	0.0	8.6	0.0	0.1	0.1	0.5	0.2	0.0	0.6	0.2	0.1	0.2	0.5	0.0	0.2	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	13.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	20.2	0.0	2.3	0.7	0.0	1.9	3.6	0.0	202.9	17.6	1.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	337.5	334.3	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0
ROPN1L	"ASP, FLJ25776, RSPH11"	ENSG00000145491	"Rhophilin associated tail protein 1 like"	Q96C74	5	10441524-10472029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 325.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 3125.2;Late spermatids: 3173.9;Spermatocytes: 987.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 9.6;ovarian cancer: 3.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"basophil: 45.1;eosinophil: 55.0;neutrophil: 105.3"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 105.3"	"Cell line enriched"	"Detected in some"	5	"NB-4: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039193, HPA041830"	Enhanced					NA	NA					"HPA039193: AB_10673415, HPA041830: AB_2677695"	"unprognostic (2.39e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.22e-2)"	0.7	0.2	3.8	0.3	1.4	4.4	0.8	2.4	1.2	1.2	5.3	0.2	0.0	0.8	0.0	0.1	27.7	0.3	0.6	1.6	3.6	0.7	0.3	5.4	0.4	4.4	4.1	0.3	0.2	1.1	0.0	1.2	0.2	4.7	0.6	0.0	1.0	0.1	0.1	0.2	0.3	0.3	0.0	5.5	4.5	0.3	325.5	1.6	0.2	0.8	0.3	0.0	0.2	0.2	2.2	0.1	0.4	0.0	0.0	0.4	0.0	0.5	0.0	0.6	0.5	0.5	0.1	0.1	0.0	1.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.7	0.0	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.1	0.0	0.1	0.0	13.4	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.9	1.5	0.1	0.1	0.4	0.0	1.5	1.6	0.3	45.1	0.8	55.0	4.0	0.3	2.7	0.0	3.5	4.7	0.1	0.0	2.3	2.7	105.3	0.4	1.4	0.0	5.8	2.1	3.8	1.4	2.4	1.2	1.6	3.6	4.4	4.1	0.3	4.7	5.5	1.6	2.2	2.0	3.2	2.0	1.6	0.1	0.3	0.0	38.0	0.0	0.2	0.4	0.4	0.4	0.0	45.3	0.0	0.0	0.0	2.2	0.0	0.0	1.0	3125.2	311.3	2.0	4.0	0.0	0.0	5.4	0.0	0.1	0.9	0.0	3.4	1.3	0.0	7.5	0.2	0.1	3.3	4.0	0.0	38.7	0.6	0.3	3173.9	36.1	2.2	0.0	0.0	0.2	0.2	0.0	1.0	0.3	0.1	0.0	18.4	0.1	0.3	0.0	1.3	482.3	3.3	13.1	0.4	14.1	987.8	35.8	0.0	0.1	0.1	0.8	2.9	0.0	0.1
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3105.8;skeletal muscle: 3089.2;tongue: 4955.1"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	181.3	8.3	724.3	6.5	774.6	2.3	78.0	766.5	960.2	2.4	564.9	11.2	11.2	4.2	1.0	81.7	42.1	4.9	3105.8	695.3	710.4	192.2	4.5	4.0	5.1	844.2	800.4	660.0	2.0	16.9	162.4	55.1	18.2	802.7	29.2	1.2	36.8	627.5	9.4	3089.2	22.5	7.0	1.7	813.2	4.3	23.3	6.0	811.0	9.5	169.4	4955.1	4.0	4.4	3.0	920.4	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	724.3	774.6	766.5	960.2	695.3	710.4	844.2	800.4	660.0	802.7	813.2	811.0	920.4	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 102.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.7	17.1	25.6	18.8	27.7	0.1	19.7	26.7	22.5	44.2	7.7	32.1	31.9	36.8	15.3	17.5	63.6	102.3	19.6	25.3	34.8	11.7	2.0	49.6	1.6	26.1	32.6	17.0	24.1	4.6	0.8	10.1	41.6	25.6	17.0	47.0	64.4	7.0	8.8	0.8	7.7	28.6	47.3	15.4	8.4	29.1	2.5	30.0	1.8	5.3	1.6	1.2	52.0	12.6	21.4	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.6	27.7	26.7	22.5	25.3	34.8	26.1	32.6	17.0	25.6	15.4	30.0	21.4	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810024-24949101	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 58.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.8;monocytes: 17.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		97000			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	6.7	5.9	5.2	7.1	7.1	2.4	2.1	9.8	9.7	3.7	1.0	2.8	0.8	8.7	1.0	2.0	7.3	4.5	1.5	2.5	15.1	1.2	1.3	9.7	6.4	17.0	18.2	2.3	7.3	58.7	0.4	6.6	15.3	19.4	0.9	2.6	14.6	1.7	0.8	0.7	0.6	3.6	5.8	6.6	2.0	1.8	7.1	13.6	5.3	1.2	2.0	5.3	4.2	1.3	23.1	30.3	12.1	106.8	0.2	30.5	59.0	54.9	60.9	40.6	33.4	55.2	67.1	83.1	114.0	0.3	100.7	6.5	12.0	77.2	0.5	88.2	261.3	15.4	91.1	2.0	37.3	112.3	105.9	31.6	77.4	2.0	85.1	17.8	73.0	114.3	56.9	88.5	1.1	28.7	0.6	65.2	30.1	287.4	0.0	8.1	0.1	310.3	1.4	0.1	10.4	0.1	60.1	0.1	0.2	0.5	114.8	0.2	45.2	150.8	19.7	72.9	80.4	58.1	13.2	13.9	152.7	69.9	62.4	0.3	0.0	2.3	0.0	0.0	3.6	0.1	1.1	0.0	0.1	5.8	0.0	0.0	0.0	1.0	0.1	17.1	3.4	0.2	1.0	5.2	7.1	9.8	9.7	2.5	15.1	17.0	18.2	2.3	19.4	6.6	13.6	23.1	1.7	16.0	26.0	1.6	1.3	8.7	0.1	2.5	0.0	203.2	0.3	0.3	1.6	1.5	2.2	0.0	2.1	61.2	4.3	0.0	1.9	1.8	161.4	41.5	92.6	16.8	0.0	20.8	39.6	139.9	23.2	27.6	0.0	89.1	11.4	117.4	7.9	0.3	72.3	42.1	81.8	0.0	14.2	87.1	265.8	370.3	7.2	59.9	7.2	38.4	22.3	7.1	0.0	84.4	57.4	49.6	0.0	4.1	0.7	0.2	0.0	0.1	3.3	12.2	6.6	14.9	17.4	1.9	1.6	0.5	7.2	22.4	2.8	41.3	0.1	0.1
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589667-47594411	"Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;ovary: 12.1;pituitary gland: 17.3"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0"	"Group enriched"	"Detected in some"	4	"glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"REH: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041032	Approved		Uncertain	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA			"Golgi apparatus, Vesicles"		"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	1.7	1.5	6.8	0.0	28.4	1.1	2.2	13.2	14.5	4.9	0.0	2.9	0.1	5.9	0.0	0.5	4.3	0.0	0.9	5.7	3.0	1.1	0.9	0.7	0.0	17.2	5.8	12.0	12.1	0.4	0.7	17.3	0.0	11.1	2.8	0.0	0.1	1.2	0.1	0.9	1.7	1.5	0.1	0.4	1.0	1.5	5.9	8.5	0.0	1.5	0.0	0.0	1.3	2.0	4.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	28.4	13.2	14.5	5.7	3.0	17.2	5.8	12.0	11.1	0.4	8.5	4.4	2.4	0.0	0.0	18.9	0.0	2.4	6.5	0.2	0.0	15.8	1.3	25.8	0.7	1.5	0.3	3.7	16.7	1.3	0.1	0.2	3.9	0.1	11.3	0.8	21.2	4.5	0.0	2.5	15.5	0.2	2.7	20.7	0.5	0.6	0.0	31.3	2.5	0.2	3.3	5.0	17.8	0.1	0.0	0.3	3.0	51.7	46.0	0.7	10.6	4.7	0.0	54.5	0.0	5.0	8.0	0.1	0.1	38.4	0.0	4.3	0.1	0.6	0.6	24.7	26.3	12.8	8.5	13.5	44.5	0.3	1.8	3.6	0.6	39.0	0.2	2.4
C2orf88	"MGC13057, smAKAP"	ENSG00000187699	"Chromosome 2 open reading frame 88"	Q9BSF0	2	189879609-190203484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 496.6;Early spermatids: 1138.7;Late spermatids: 1344.3;Proximal enterocytes: 462.3"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 16.2;glioma: 4.8;ovarian cancer: 14.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.7;naive B-cell: 2.8;neutrophil: 7.1;plasmacytoid DC: 3.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.8;dendritic cells: 3.0;granulocytes: 7.1"	"Group enriched"	"Detected in many"	6	"HEL: 108.4;K-562: 92.2;RT4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049549	Approved					NA	NA		160000			"HPA049549: AB_2680812"	"unprognostic (1.20e-4)"	"unprognostic (9.17e-2)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (6.09e-3)"	"unprognostic (4.55e-2)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (9.39e-4)"	"unprognostic (5.29e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.64e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-3)"	4.2	6.6	11.3	4.5	12.6	9.9	9.3	11.6	13.7	48.7	3.6	36.4	35.0	16.0	2.2	2.7	21.1	2.8	11.7	11.2	11.8	6.5	4.7	3.6	3.3	10.9	11.4	7.8	1.9	12.9	35.4	2.7	1.7	12.2	7.2	39.0	4.5	14.2	9.5	13.6	5.7	44.8	3.9	13.2	4.9	5.1	73.7	10.7	0.5	3.6	29.1	5.4	4.8	11.9	20.5	0.1	0.3	0.9	0.3	3.6	11.7	0.8	0.4	0.5	0.2	1.1	3.5	0.2	0.7	14.2	1.1	5.9	0.3	3.0	0.0	1.4	0.6	1.9	108.4	0.4	6.9	0.3	0.7	0.0	5.4	0.3	5.8	0.3	0.2	0.3	0.4	92.2	7.1	1.6	0.4	0.3	0.8	0.4	0.3	0.1	0.4	4.2	0.5	2.2	58.8	0.9	2.2	0.2	0.2	11.6	2.0	0.0	1.1	0.8	0.7	0.7	0.3	0.3	0.5	2.0	2.1	1.0	0.5	0.1	0.0	0.5	0.9	0.0	0.0	0.0	2.7	0.0	0.1	0.1	2.8	0.0	0.0	7.1	0.1	0.0	3.0	0.0	16.5	11.3	12.6	11.6	13.7	11.2	11.8	10.9	11.4	7.8	12.2	13.2	10.7	20.5	4.1	3.2	0.5	15.3	6.4	1.5	12.9	0.6	2.2	9.1	25.0	36.4	41.5	1.5	0.0	3.7	25.0	0.1	1.1	496.6	19.6	0.5	1138.7	164.4	23.8	21.0	4.2	51.8	28.1	15.3	0.5	7.8	2.6	228.4	0.0	21.7	83.9	3.8	0.2	8.4	26.9	67.9	0.0	5.9	1.8	1344.3	9.9	57.9	26.6	12.2	4.2	2.7	7.2	22.1	44.9	3.9	227.4	6.0	27.8	3.2	462.3	33.2	0.0	12.4	0.0	9.2	3.9	37.9	6.0	2.5	2.3	0.4	3.8	6.1	35.0	3.3
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720003-29731833	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 35.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 28.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1"	"Group enriched"	"Detected in all"	4	"cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 51.0"	HPA016439	Uncertain					NA	NA					"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.1	5.6	4.6	0.0	4.2	0.2	0.1	18.8	35.2	0.1	0.6	0.6	0.4	0.1	0.0	0.1	0.1	0.0	0.1	34.2	3.6	0.1	0.3	0.1	0.1	26.1	10.6	3.4	0.1	3.2	0.0	0.4	0.0	27.0	0.4	0.0	1.0	0.2	0.0	0.1	0.2	1.5	0.0	20.4	0.4	0.3	0.6	4.8	0.0	0.3	0.0	0.0	0.1	0.1	18.5	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	10.3	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	9.7	3.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	3.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	4.6	4.2	18.8	35.2	34.2	3.6	26.1	10.6	3.4	27.0	20.4	4.8	18.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	28.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0
CCDC146	"KIAA1505, MBO2"	ENSG00000135205	"Coiled-coil domain containing 146"	Q8IYE0	7	77122434-77329533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.3;Endometrial ciliated cells: 460.8;Oligodendrocyte precursor cells: 151.3;Respiratory ciliated cells: 417.9;Spermatocytes: 149.4"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 8.8;ovarian cancer: 13.6;renal cancer: 15.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 14.3;neutrophil: 15.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;NK-cells: 5.3;T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA020082, HPA020105"	Uncertain					NA	NA					"HPA020082: AB_1852410, HPA020105: AB_2072056"	"unprognostic (3.07e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.02e-3)"	"unprognostic (4.05e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.58e-3)"	2.2	1.1	11.0	2.5	4.0	1.7	2.4	4.1	2.6	4.1	15.8	3.4	2.5	4.6	2.5	3.6	34.3	3.2	1.8	2.2	7.3	4.2	1.8	5.3	3.0	10.4	9.1	1.0	3.3	2.5	4.0	3.9	1.9	7.3	3.7	2.8	14.6	4.2	2.3	1.1	9.5	2.8	3.0	11.4	3.7	3.4	21.7	5.4	3.1	7.7	1.6	2.7	3.1	3.9	6.8	0.6	0.9	2.7	1.4	1.7	1.7	0.3	0.7	0.6	0.7	1.1	0.0	4.6	1.4	0.1	0.2	2.6	0.9	0.4	0.8	1.1	1.9	0.3	1.8	1.5	0.8	0.5	1.8	1.3	0.8	1.3	1.2	0.2	2.2	0.6	1.4	0.0	1.4	0.1	0.2	1.5	2.9	0.3	0.6	0.6	4.0	0.4	0.2	2.8	0.5	2.0	1.3	1.0	0.9	0.6	0.8	0.8	0.6	0.9	1.0	0.4	1.4	0.4	2.7	4.5	1.2	2.3	2.7	2.3	0.9	0.6	14.3	4.4	0.9	3.0	1.2	1.9	3.1	0.8	0.2	1.2	2.0	15.4	5.3	0.4	2.0	1.6	0.8	11.0	4.0	4.1	2.6	2.2	7.3	10.4	9.1	1.0	7.3	11.4	5.4	6.8	6.9	3.2	9.7	34.0	3.6	7.1	2.6	16.9	6.2	8.6	2.7	4.6	32.0	2.8	56.9	5.5	62.6	1.2	9.3	2.8	21.5	3.2	308.3	460.8	11.1	4.8	1.8	0.4	49.0	1.6	0.7	15.4	6.1	106.0	6.3	6.1	23.6	0.8	1.6	5.0	48.8	1.4	24.4	3.5	7.1	52.4	12.2	4.5	5.4	50.6	2.0	12.1	20.6	151.3	62.8	1.7	5.2	6.4	3.7	5.8	2.9	30.1	417.9	55.1	6.6	15.6	11.6	149.4	10.8	5.5	3.4	2.5	8.6	7.2	4.0	5.4
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442870	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.4;testis: 82.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	103	"basophil: 49.2"	"Lineage enriched"	"Detected in single"	301	"granulocytes: 49.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.9	7.0	0.5	6.6	2.1	0.7	3.2	7.6	5.9	4.1	0.5	0.4	3.8	7.1	0.4	18.2	0.7	0.3	6.0	7.5	0.5	0.1	1.4	0.3	5.6	6.5	6.4	0.5	0.1	22.4	8.2	0.0	8.6	0.5	0.1	1.0	0.6	0.1	1.2	0.3	0.3	8.2	4.5	0.6	0.4	82.1	5.6	0.4	0.6	0.4	0.6	0.6	1.1	6.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	15.2	0.1	15.5	1.2	12.9	1.4	0.1	0.0	0.7	0.0	0.4	0.0	0.6	8.0	350.9	0.3	34.1	0.7	2.8	5.5	0.9	1.7	0.0	0.5	0.2	4.4	0.4	71.4	2.5	0.0	8.8	0.0	8.3	0.0	2.3	0.0	2.5	5.8	0.0	8.4	0.2	1.8	0.0	71.5	4.5	0.0	0.0	0.1	2.9	0.8	0.0	0.0	0.3	90.3	0.6	49.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.0	6.6	3.2	7.6	6.0	7.5	5.6	6.5	6.4	8.6	4.5	5.6	6.1	0.1	0.0	0.6	0.3	0.3	0.6	0.6	19.1	0.0	0.4	0.5	1.4	0.4	0.0	10.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	162.4	119.1	1.8	0.4	0.0	0.0	3.5	0.0	0.8	1.1	0.0	31.9	5.1	2.2	0.0	0.0	0.2	0.0	3.0	0.0	6.1	0.0	1.8	91.1	3.1	1.1	0.0	0.0	0.0	1.4	0.0	0.5	0.4	0.0	0.0	2.6	0.0	0.7	0.0	0.1	29.3	0.8	6.6	0.5	1.5	285.7	2.4	0.0	0.4	0.3	0.9	0.0	0.1	1.1
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 15.0;fallopian tube: 58.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.0	0.3	8.1	0.0	4.2	0.0	0.1	4.4	3.9	1.3	15.0	0.1	0.7	1.1	0.1	0.2	58.3	0.2	0.0	2.8	6.4	0.3	0.2	4.4	0.0	9.2	8.6	1.9	0.2	0.2	0.3	3.2	0.2	8.0	0.3	0.0	2.4	1.3	0.2	0.0	0.2	0.7	0.0	11.4	0.0	0.1	12.3	4.8	0.3	0.6	0.3	0.0	0.1	0.1	6.6	0.8	0.8	0.0	0.3	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.3	0.1	2.7	0.0	1.4	0.0	0.0	0.2	0.4	0.3	0.0	0.3	0.5	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	4.2	4.4	3.9	2.8	6.4	9.2	8.6	1.9	8.0	11.4	4.8	6.6	0.2	0.0	2.3	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.3	0.0	9.9	0.0	6.2	0.8	0.0	0.0	1.9	0.1	32.4	99.6	0.9	0.3	0.0	0.0	9.7	0.2	0.2	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	6.4	1.8	0.0	0.0	1.0	0.0	0.7	0.0	7.1	1.1	0.1	0.0	1.9	0.0	0.3	0.0	0.5	81.6	3.1	0.0	0.1	0.2	33.9	0.8	0.0	0.0	1.0	0.1	0.1	0.0	0.1
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924491-7926135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 226.7;endometrium 1: 86.4"	"Cell type enriched"	"Detected in many"	4	"Endometrial ciliated cells: 127.7"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	4.0	12.6	171.8	0.9	226.7	0.1	3.2	0.0	174.4	32.8	0.0	39.6	0.9	86.4	2.9	2.6	43.4	0.2	1.0	201.2	27.3	10.7	0.4	7.0	0.0	91.0	17.7	137.0	6.3	2.2	1.1	57.4	0.3	150.1	16.4	0.4	0.2	6.5	12.5	0.5	4.0	4.8	4.9	0.0	1.4	8.9	28.0	43.6	0.3	2.8	0.1	0.0	21.4	13.3	52.9	33.5	8.1	20.5	96.4	0.0	0.3	4.8	8.5	2.3	4.1	2.4	2.4	5.0	0.2	16.2	2.0	2.2	35.9	4.7	0.9	0.2	3.0	67.5	0.7	5.3	1.5	0.9	1.8	1.9	0.0	2.7	1.4	0.9	9.8	5.4	9.1	21.3	0.3	0.5	40.5	18.5	13.6	72.4	2.4	34.1	57.3	0.0	6.4	15.0	1.4	56.2	94.5	5.2	2.8	9.9	1.7	21.2	0.6	8.3	2.1	33.1	3.9	4.8	0.7	1.0	4.8	8.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.8	226.7	0.0	174.4	201.2	27.3	91.0	17.7	137.0	150.1	0.0	43.6	52.9	0.6	0.0	0.0	3.3	0.7	1.1	4.1	1.5	2.2	0.3	15.3	6.7	0.4	1.5	1.0	9.2	4.2	0.2	0.2	0.5	3.9	7.8	9.5	127.7	22.4	1.6	9.1	0.0	20.6	0.4	0.4	3.0	0.0	7.9	0.0	13.3	0.7	0.1	0.3	0.0	3.5	0.5	2.0	0.3	0.5	27.1	1.2	0.5	1.8	4.7	0.0	0.6	0.0	1.5	2.9	1.7	1.2	1.9	0.0	19.9	0.0	11.9	21.0	0.4	0.0	0.2	17.7	6.0	16.0	0.3	2.0	0.3	0.6	3.2	0.2	6.4
EMID1	"EMI5, EMU1, hEmu1"	ENSG00000186998	"EMI domain containing 1"	Q96A84	22	29205896-29259597	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;lymphoid tissue: 55.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.1;Granulosa cells: 32.7;Oligodendrocyte precursor cells: 51.8;Theca cells: 151.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 23.1;glioma: 7.8;ovarian cancer: 10.9;thyroid cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HEL: 28.8;NB-4: 102.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000592	Uncertain				"Secreted in other tissues"	NA	NA					"HPA000592: AB_1078737"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-1)"	2.6	29.3	31.2	4.3	31.6	14.9	2.5	24.6	49.9	5.9	21.5	5.8	5.1	10.1	1.7	1.3	10.5	4.8	1.7	33.5	26.2	14.8	3.4	13.1	7.6	27.3	27.9	31.5	7.1	14.1	12.5	2.1	4.9	26.0	6.1	3.5	0.3	3.7	3.9	0.9	5.4	8.4	2.3	23.4	55.2	7.8	2.3	24.6	4.8	13.3	0.3	2.4	5.0	2.2	29.8	0.0	0.2	4.9	10.5	0.0	0.0	0.7	0.0	0.0	0.4	0.3	5.7	0.7	0.0	4.7	0.1	0.0	0.0	2.5	0.1	0.0	11.5	8.6	28.8	0.1	1.1	0.7	4.1	2.2	0.3	0.2	0.2	0.0	0.0	0.0	6.4	2.5	0.0	0.0	8.0	0.2	102.0	1.1	0.1	0.4	0.0	0.2	11.3	0.0	0.1	13.2	6.3	0.4	0.1	0.2	0.8	4.2	5.4	0.0	0.0	8.0	0.0	0.1	0.5	0.0	0.0	0.0	14.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.2	31.6	24.6	49.9	33.5	26.2	27.3	27.9	31.5	26.0	23.4	24.6	29.8	0.4	0.0	2.5	92.1	0.1	2.8	1.0	0.1	0.0	1.7	5.3	3.9	0.7	4.3	0.6	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.2	10.8	22.6	6.2	0.0	18.5	5.6	1.3	0.1	11.8	0.5	20.0	11.4	32.7	11.4	2.1	0.3	0.0	6.2	0.4	0.0	0.3	5.2	0.5	3.1	0.6	0.0	10.3	0.6	1.1	0.0	51.8	1.0	0.4	0.0	1.9	1.0	1.9	0.1	1.9	0.0	0.4	0.0	17.5	4.0	0.1	1.5	0.0	2.0	0.3	1.1	151.0	0.3	0.4
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963682-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"placenta: 6.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"breast cancer: 2.4;ovarian cancer: 7.7;pancreatic cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 3.0"	"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in some"	5	"amygdala: 1.7;basal ganglia: 2.9;cerebral cortex: 2.7;hippocampal formation: 2.2"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA038212: AB_10672739, HPA045455: AB_2679330"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;fallopian tube: 11.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.2	0.4	10.3	0.0	13.4	0.0	5.6	10.5	11.3	3.0	0.0	0.0	0.0	0.2	0.0	0.1	11.3	0.0	3.0	9.6	28.6	5.2	0.0	0.9	0.0	6.8	15.4	9.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.8	1.2	1.5	0.3	0.0	0.0	2.2	0.0	0.4	3.3	7.1	0.0	1.6	1.7	0.0	0.1	0.1	9.0	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	13.4	10.5	11.3	9.6	28.6	6.8	15.4	9.9	7.6	2.2	7.1	9.0	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 24541.9"	"Cell type enriched"	"Detected in many"	51	"Erythroid cells: 224916.4"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 142.6;plasmacytoid DC: 101.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.1;granulocytes: 142.6"	"Group enriched"	"Detected in some"	36	"HEL: 3355.8;K-562: 2416.8"									"CAB032534, HPA043780"	Enhanced					NA	NA		14000000000			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	563.6	184.5	89.5	82.7	213.9	24541.9	319.3	152.8	802.0	157.9	2244.8	128.0	10.7	41.8	2.4	246.9	353.9	60.6	1410.3	51.0	108.5	1386.9	1109.3	2221.0	5.0	164.5	327.4	35.4	161.1	101.4	5.2	469.4	2009.5	282.8	171.6	11.6	3.1	139.4	44.1	235.9	193.3	85.8	7.1	198.0	5572.2	137.1	105.6	283.2	20.9	614.3	1133.1	3.6	168.6	354.2	403.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	58.1	0.0	5.7	2.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.2	3355.8	0.0	37.1	0.0	1.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.7	2416.8	0.0	0.0	14.7	0.5	0.3	0.4	1.0	0.0	0.1	1.4	79.1	0.0	1.0	7.4	5.3	2.8	0.0	0.0	0.0	1.1	0.0	8.3	0.0	0.0	0.9	0.0	0.0	0.4	0.8	0.0	0.2	0.0	8.5	7.4	48.2	26.3	0.2	0.7	7.5	3.1	8.7	10.0	4.5	8.3	25.7	142.6	13.4	0.8	101.1	0.3	2806.3	89.5	213.9	152.8	802.0	51.0	108.5	164.5	327.4	35.4	282.8	198.0	283.2	403.4	72.7	0.0	0.0	0.0	56.8	10.6	0.1	0.0	0.0	0.4	11.3	12.3	1.8	55.8	0.1	0.0	0.0	0.0	93.2	3.2	7.9	0.0	6.0	0.5	0.5	20.4	1.2	224916.4	0.0	0.0	0.0	57.9	0.0	0.4	0.0	0.1	151.0	78.8	0.0	0.0	0.0	5.7	0.0	436.7	64.1	22.4	0.0	234.0	4338.2	0.0	12.7	1.3	1166.9	0.0	0.0	0.1	2.8	0.4	0.5	0.2	0.2	11.1	0.0	16.5	0.0	8.7	58.7	1.5	7.6	0.0	13.2	0.0	155.7	0.0	3.2	0.0
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	10.7	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.8	0.4	0.2	0.0	0.5	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LKAAEAR1	C20orf201	ENSG00000171695	"LKAAEAR motif containing 1"	Q8TD35	20	64083380-64084359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 32.6"	"Group enriched"	"Detected in some"	14	"Early spermatids: 496.7;Late spermatids: 694.8"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;glioma: 1.2;ovarian cancer: 1.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 8.6;non-classical monocyte: 13.5"	"Lineage enriched"	"Detected in many"	13	"monocytes: 13.5"	"Group enriched"	"Detected in some"	4	"REH: 5.6;SCLC-21H: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056463			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056463: AB_2683139"	"unprognostic (5.47e-3)"	"unprognostic (1.18e-1)"		"unprognostic (1.20e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.78e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.16e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.30e-2)"	0.1	0.1	1.5	0.0	0.8	0.1	0.1	0.3	1.9	0.2	0.0	0.0	0.1	0.1	0.0	0.0	2.6	0.0	0.1	1.1	1.5	0.0	0.0	0.6	0.0	1.2	0.9	1.5	0.0	0.2	0.0	0.7	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	32.6	1.4	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.4	0.2	0.0	0.9	5.6	0.0	0.1	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.1	8.6	0.6	0.1	0.6	0.1	1.0	0.0	0.7	0.2	0.0	0.0	13.5	0.2	0.0	0.9	1.5	0.8	0.3	1.9	1.1	1.5	1.2	0.9	1.5	0.9	0.5	1.4	1.4	0.5	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	1.1	0.6	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	496.7	40.3	1.3	0.5	0.0	0.8	1.1	0.0	0.0	0.6	0.0	0.5	0.0	0.1	1.4	0.1	1.6	0.0	0.9	0.0	0.0	1.8	0.0	694.8	3.7	2.2	0.0	0.0	1.4	0.7	0.0	1.0	0.5	0.1	0.0	3.0	0.4	0.2	0.0	0.2	0.0	1.0	13.1	0.3	0.4	24.0	6.6	0.1	0.0	0.1	0.8	0.1	0.0	0.2
MORN5	"C9orf113, C9orf18, FLJ46909"	ENSG00000185681	"MORN repeat containing 5"	Q5VZ52	9	122159908-122200088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 112.0;testis: 82.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 490.3;Endometrial ciliated cells: 240.0;Late spermatids: 692.9;Respiratory ciliated cells: 454.7;Spermatocytes: 142.1"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 9.2;glioma: 4.0;ovarian cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.6;U-87 MG: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.24e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.12e-1)"			"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-1)"	0.0	0.1	10.5	0.6	8.3	0.0	0.2	8.6	8.8	2.7	14.6	17.1	0.9	6.2	2.3	2.2	112.0	0.6	0.0	7.7	11.5	1.3	0.0	5.8	0.0	12.5	11.2	6.8	0.5	0.3	2.8	3.9	0.0	11.5	0.8	5.5	10.0	1.0	3.7	0.0	0.0	2.3	17.2	10.9	0.0	3.9	82.3	8.7	0.1	0.0	0.0	0.0	2.3	0.5	9.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	8.3	8.6	8.8	7.7	11.5	12.5	11.2	6.8	11.5	10.9	8.7	9.6	0.1	0.0	3.6	0.3	0.0	0.0	0.2	30.3	0.0	1.1	0.1	0.5	0.1	0.0	36.9	3.7	2.1	0.0	0.0	0.0	0.0	0.1	490.3	240.0	1.6	0.7	0.0	0.0	1.8	0.0	0.0	0.7	0.0	3.0	0.0	0.2	0.0	0.0	0.1	1.7	1.5	0.0	63.1	0.0	0.0	692.9	6.5	0.7	0.0	0.0	0.0	5.6	0.0	1.0	0.3	0.0	0.0	4.1	0.0	1.2	0.0	4.9	454.7	8.1	0.0	0.0	8.4	142.1	6.4	0.0	0.0	0.0	0.3	0.1	0.0	0.1
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3506.9;liver: 7016.2;thyroid gland: 2912.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	124.7	21.7	342.2	106.7	413.9	2.9	28.3	393.5	919.5	12.4	301.5	828.7	518.4	8.4	2.4	257.4	76.2	12.1	6.8	338.0	346.5	3506.9	7016.2	50.3	5.6	403.6	361.9	358.6	3.2	1822.1	0.3	21.8	2.1	372.5	428.9	521.1	43.0	44.5	5.9	8.5	56.7	1105.7	77.0	331.0	3.9	1272.7	4.0	363.1	0.9	2912.8	1.0	2.6	14.3	26.1	402.5	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	342.2	413.9	393.5	919.5	338.0	346.5	403.6	361.9	358.6	372.5	331.0	363.1	402.5	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 16.1;fallopian tube: 6.0;salivary gland: 6.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 40.3;Club cells: 81.8;Endometrial ciliated cells: 74.3;Glandular and luminal cells: 157.8;Ionocytes: 99.7;Respiratory ciliated cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"ovarian cancer: 21.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 23.3;HeLa: 45.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"	NA	NA		25000			"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	16.1	0.0	0.0	0.0	2.1	0.0	0.3	6.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	6.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.6	2.8	0.0	0.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.3	0.1	40.3	0.0	0.0	4.1	0.9	3.4	1.5	81.8	0.0	0.0	2.1	0.2	0.0	0.0	0.2	14.3	74.3	14.8	1.2	0.0	0.0	0.4	0.0	0.4	1.0	0.0	157.8	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	99.7	0.3	0.0	16.4	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	197.4	0.0	0.0	0.0	8.6	0.3	0.2	0.0	0.3	3.3	0.6	0.0	0.0	0.7
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934396-33820863	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in many"	6	"Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075337	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	0.7	0.8	17.5	0.1	19.3	0.0	0.9	16.8	14.3	6.0	0.0	1.1	0.3	3.9	0.9	0.3	4.0	0.7	0.4	15.0	14.5	0.7	0.1	0.2	0.1	23.5	15.7	10.9	2.7	0.4	0.5	1.0	0.5	15.7	0.8	0.3	1.4	0.8	1.3	0.2	0.2	0.4	0.7	17.2	1.1	1.0	1.4	15.2	0.4	1.9	0.2	0.2	0.5	0.5	19.2	0.0	0.0	9.3	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	23.6	7.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	19.3	16.8	14.3	15.0	14.5	23.5	15.7	10.9	15.7	17.2	15.2	19.2	5.1	0.0	0.0	3405.1	0.1	1.0	1.0	0.0	0.6	8.9	3.8	5.1	2.1	0.0	0.1	1.8	0.0	1.5	0.1	0.1	1.9	0.1	22.2	24.6	5.7	3.2	1.2	0.0	341.9	0.0	0.1	3.5	0.0	72.3	0.0	0.7	4.2	0.1	0.5	10.1	1408.3	0.0	0.0	0.0	1.4	17.0	7.2	0.7	0.0	116.2	0.0	7.4	0.0	1893.0	1772.0	0.2	0.0	5.3	0.1	0.5	0.0	0.5	1.8	0.7	0.0	11.5	3.1	0.2	0.8	0.1	0.4	0.3	1.0	1.1	0.0	0.5
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678688-153693992	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.7"	"Group enriched"	"Detected in many"	6	"Adipocytes: 99.6;Endothelial cells: 52.5;Hepatic stellate cells: 132.8"	"Group enriched"	"Detected in all"	4	"ovarian cancer: 39.2;renal cancer: 12.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 158.5"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 18.7"	"Low region specificity"	"Detected in many"			HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	67.7	8.8	1.5	3.4	1.2	0.0	44.6	1.2	2.3	8.8	2.3	10.1	1.5	31.2	5.6	4.3	36.7	5.9	14.5	1.2	1.2	28.8	4.3	24.5	2.3	1.4	1.4	0.9	27.9	3.9	8.5	3.8	17.8	1.3	4.5	2.0	0.1	3.7	12.3	7.3	6.1	9.4	9.7	1.6	2.2	8.8	1.3	2.3	1.9	14.2	11.2	1.3	12.9	9.8	1.3	0.0	1.3	0.1	0.0	158.5	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	28.0	0.0	19.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	15.9	0.0	0.0	2.1	0.0	0.1	0.0	1.9	0.0	5.7	1.0	0.1	0.0	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	1.2	2.3	1.2	1.2	1.4	1.4	0.9	1.3	1.6	2.3	1.3	99.6	0.0	6.9	0.0	0.2	1.5	0.5	0.0	0.6	0.0	0.5	0.5	4.5	2.8	0.0	14.7	0.0	0.2	0.1	0.0	0.0	0.7	9.1	6.2	8.8	52.5	0.0	0.0	0.0	0.0	1.3	15.2	0.0	15.4	0.0	0.0	132.8	2.4	0.3	0.0	0.0	0.0	0.0	4.7	4.0	11.5	10.2	0.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	4.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	1.4	2.2	0.5	0.1	0.2	1.0	0.7	0.3	1.4	0.2	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 759.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.3	0.8	0.0	0.3	0.0	0.0	19.3	2.1	0.2	67.1	5.5	0.0	16.6	34.9	0.1	1.5	70.5	9.1	0.1	0.1	0.6	16.8	1.2	759.7	0.1	0.0	0.2	0.0	1.4	7.3	0.0	2.1	4.8	0.2	1.0	0.0	0.5	91.0	16.9	0.1	2.3	4.4	0.2	0.0	0.7	2.5	2.7	0.2	2.1	33.9	0.0	7.5	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.6	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SOX17		ENSG00000164736	"SRY-box transcription factor 17"	Q9H6I2	8	54457935-54460892	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 38.4;breast: 32.9"	"Group enriched"	"Detected in many"	8	"Adipocytes: 464.9;Endometrial ciliated cells: 377.3;Endothelial cells: 171.5;Glandular and luminal cells: 520.0"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 122.8;ovarian cancer: 96.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"EFO-21: 108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025594, HPA068399"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025594: , HPA068399: AB_2685981"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.76e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.98e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.88e-1)"	38.4	1.6	3.1	1.4	2.3	0.0	32.9	2.6	2.9	20.6	2.2	7.1	0.7	19.0	1.2	3.7	23.2	7.8	14.4	2.2	2.6	3.1	1.3	10.0	0.7	2.9	2.6	1.6	4.2	1.9	0.8	2.3	5.7	3.5	6.1	0.8	0.1	4.0	1.1	10.4	5.1	5.0	4.4	2.5	13.3	5.8	3.4	2.8	0.4	5.8	5.9	0.4	8.5	9.5	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.3	2.6	2.9	2.2	2.6	2.9	2.6	1.6	3.5	2.5	2.8	2.7	464.9	0.0	0.0	0.0	0.2	13.9	0.3	0.0	0.0	0.1	0.7	1.3	2.1	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	2.6	377.3	44.5	171.5	0.0	2.7	0.0	0.2	0.1	7.7	0.0	520.0	0.0	0.0	46.8	0.1	0.1	0.0	0.0	0.0	0.0	0.9	16.6	1.8	2.5	3.5	19.6	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	7.3	5.1	3.2	6.4	0.3	13.5	0.0	4.5	0.2	0.0	3.7
STAR	STARD1	ENSG00000147465	"Steroidogenic acute regulatory protein"	P49675	8	38142700-38150992	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Steroidogenesis, Transport"		"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"adrenal gland: 5115.5"	"Cell type enriched"	"Detected in some"	44	"Theca cells: 2243.4"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.0;lung cancer: 0.8;ovarian cancer: 1.4;testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"K-562: 436.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023644, HPA027318, CAB032598"	Enhanced					NA	NA					"CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574"	"unprognostic (1.60e-4)"	"unprognostic (3.20e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.12e-5)"	"unprognostic (3.30e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.75e-9)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.16e-2)"	1.7	5115.5	2.3	3.2	1.9	2.1	0.4	1.7	3.4	0.7	0.8	0.4	0.2	0.5	0.6	2.2	6.4	0.2	0.7	1.5	3.8	0.4	1.2	0.5	1.0	3.6	2.6	2.0	501.3	0.9	0.0	2.2	0.5	4.6	0.5	0.1	0.6	1.8	0.3	0.4	4.5	0.6	0.4	1.6	1.0	0.7	89.0	3.2	3.1	0.4	0.0	1.9	0.5	3.3	3.6	0.1	0.0	0.8	0.2	0.3	3.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	88.9	0.8	5.3	1.3	3.8	0.1	12.4	0.3	0.1	0.1	0.8	0.0	0.3	436.1	0.2	0.0	0.0	0.4	43.7	9.6	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.2	0.0	0.2	0.0	0.1	43.0	1.5	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.3	9.3	0.2	2.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	2.3	1.9	1.7	3.4	1.5	3.8	3.6	2.6	2.0	4.6	1.6	3.2	3.6	0.0	0.0	0.0	0.7	0.1	9.4	0.7	0.8	4.0	1.1	0.1	1.1	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.9	10.7	0.6	0.0	0.0	1.4	0.0	0.0	25.7	0.0	0.3	0.0	1.4	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.7	10.2	50.1	0.2	3.6	0.0	0.0	0.6	0.0	0.5	0.3	0.1	0.0	4.1	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.2	3.0	4.8	0.8	1.7	11.2	0.1	0.1	2243.4	0.0	0.1
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.9"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 217.3;Microglial cells: 160.2;Oligodendrocyte precursor cells: 580.6"	"Group enriched"	"Detected in some"	4	"glioma: 1.6;ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"AF22: 3.7;ASC diff: 5.2;Daudi: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Approved	Centrosome,Cytosol		NA	NA		78000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	31.9	2.7	9.0	0.3	7.2	0.1	14.1	6.5	7.4	16.9	13.6	1.3	0.3	5.5	3.8	3.1	11.9	1.1	2.8	6.4	7.0	0.4	0.1	1.5	1.1	9.1	13.6	6.0	8.7	2.7	0.1	0.7	2.5	8.7	2.4	0.4	3.7	1.7	4.1	0.5	1.9	1.8	1.0	6.7	0.3	1.3	1.3	9.4	1.0	0.9	3.4	0.4	4.8	9.3	8.5	0.0	0.0	3.7	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	7.2	6.5	7.4	6.4	7.0	9.1	13.6	6.0	8.7	6.7	9.4	8.5	1.9	0.0	0.0	70.2	0.0	0.4	0.0	0.0	0.0	18.6	0.0	0.0	1.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.1	0.2	7.6	26.1	1.0	0.0	0.0	32.2	0.0	0.0	6.3	0.0	9.8	0.0	3.7	0.0	0.0	0.1	0.0	217.3	0.1	0.0	0.0	1.1	0.2	9.0	0.1	1.8	160.2	0.0	0.4	0.0	580.6	42.3	0.1	0.0	15.1	0.0	0.0	0.1	0.1	0.0	2.3	0.0	0.8	2.5	0.1	0.4	0.1	0.0	0.0	0.3	0.0	0.1	0.0
TMEM88B		ENSG00000205116	"Transmembrane protein 88B"	A6NKF7	1	1426128-1427787	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	186	"brain: 416.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.2;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065743	Enhanced					NA	NA					"HPA065743: AB_2685552"	"unprognostic (3.17e-2)"	"unprognostic (1.42e-2)"		"unprognostic (1.63e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.30e-5)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"			"unprognostic (3.53e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	82.9	0.1	229.2	0.0	0.0	164.2	127.4	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	56.6	129.0	1.0	0.0	0.1	0.0	288.1	214.3	28.9	0.1	0.0	0.0	0.0	0.0	342.8	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	146.9	0.0	0.0	2.2	187.0	0.0	0.0	0.0	0.0	0.3	0.1	416.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.9	229.2	164.2	127.4	56.6	129.0	288.1	214.3	28.9	342.8	146.9	187.0	416.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMOD1	"D9S57E, ETMOD, TMOD"	ENSG00000136842	"Tropomodulin 1"	P28289	9	97501180-97601743	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 252.4;tongue: 258.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 60.0;Erythroid cells: 138.9;Horizontal cells: 102.6"	"Group enriched"	"Detected in many"	4	"glioma: 21.6;ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 38.0;HDLM-2: 155.7;K-562: 53.3;SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"							HPA051202	Enhanced					NA	NA		9400			"HPA051202: AB_2681387"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.88e-5)"	17.9	65.7	18.2	4.5	20.9	24.4	15.9	26.5	22.2	45.5	18.1	25.7	4.2	54.7	5.6	17.5	27.6	7.5	145.5	18.9	31.0	9.2	28.8	15.6	2.6	21.8	14.3	19.5	51.7	23.2	14.0	31.9	2.6	18.6	17.3	6.3	9.3	10.5	9.2	252.4	6.5	12.3	36.6	20.0	3.6	18.6	2.9	14.6	1.0	22.0	258.1	2.4	38.6	25.7	24.3	5.4	1.4	0.0	0.7	6.3	0.6	1.9	1.0	9.1	0.1	0.2	1.2	1.6	0.1	38.0	0.1	8.5	0.4	1.6	0.0	0.0	155.7	5.6	7.4	8.8	0.6	0.2	0.1	12.5	0.5	0.0	0.4	0.0	0.1	0.7	0.2	53.3	0.1	0.1	2.3	0.0	1.0	2.0	1.5	0.6	0.0	5.1	0.1	0.0	1.1	0.6	157.4	4.8	0.1	2.7	2.1	2.0	7.7	0.8	0.0	5.7	4.3	1.1	19.1	4.1	0.2	7.0	5.1	8.4	0.8	0.3	0.5	1.2	0.3	1.1	1.2	1.0	0.7	0.5	2.0	0.6	0.7	0.0	0.7	0.4	0.1	2.2	1.1	18.2	20.9	26.5	22.2	18.9	31.0	21.8	14.3	19.5	18.6	20.0	14.6	24.3	4.7	6.4	4.2	2.3	1.9	2.3	1.0	0.0	0.0	1.1	1.6	1.3	60.0	4.3	0.0	0.0	6.2	0.2	1.1	0.0	0.0	0.3	0.8	10.2	14.5	13.0	3.0	138.9	27.6	6.5	0.4	12.8	4.6	27.7	10.8	0.1	27.5	20.2	0.9	102.6	19.3	0.4	0.0	13.7	4.2	0.6	10.2	6.5	17.8	6.5	0.1	2.2	0.0	31.2	5.9	4.7	0.0	6.8	0.4	2.1	0.0	0.2	0.0	1.3	19.7	8.8	23.9	2.6	6.8	0.2	1.0	0.1	3.2	0.1	0.1	0.9
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532215-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 205.6"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 1282.0;Extravillous trophoblasts: 582.3;Syncytiotrophoblasts: 1788.6"	"Group enriched"	"Detected in many"	4	"ovarian cancer: 13.7;urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 130.7;BEWO: 189.5;CAPAN-2: 72.7;RT4: 328.6;SK-BR-3: 328.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042403: AB_2677980, HPA064616: AB_2685300"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.4	1.5	1.3	0.6	0.1	0.0	0.0	3.8	0.1	2.2	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.4	205.6	0.0	1.4	0.0	0.0	5.2	6.7	0.0	0.2	0.2	0.0	0.0	0.1	0.9	0.1	0.0	0.2	0.0	0.0	1.1	22.9	1.6	0.0	130.7	0.0	0.0	0.1	0.0	0.0	189.5	0.0	0.0	0.0	0.0	18.1	72.7	0.0	0.0	0.0	0.0	5.9	0.0	7.5	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.3	0.4	0.1	2.1	0.0	0.1	0.0	0.1	0.0	328.6	0.2	0.2	0.0	328.7	0.3	13.2	5.6	0.4	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	4.9	1.8	0.2	0.0	16.6	36.8	0.0	1282.0	0.1	0.0	0.0	2.1	0.0	3.3	0.1	2.7	0.0	0.0	0.0	0.2	582.3	5.8	0.0	2.0	1.3	0.0	0.0	0.0	108.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.3	0.0	0.1	8.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1788.6	0.0	0.0	0.0	30.5
VWA3A	"FLJ40941, FLJ46765"	ENSG00000175267	"Von Willebrand factor A domain containing 3A"	A6NCI4	16	22092538-22156964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.8;choroid plexus: 45.1;fallopian tube: 40.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Club cells: 16.7;Endometrial ciliated cells: 45.6;Excitatory neurons: 33.8;Late spermatids: 15.2;Respiratory ciliated cells: 88.0"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 3.2;glioma: 1.4;ovarian cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041696, HPA042044"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA041696: AB_10964202, HPA042044: AB_10968997"	"unprognostic (2.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.75e-4)"	"prognostic favorable (8.15e-4)"	"unprognostic (2.70e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.79e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.06e-4)"	0.3	0.3	24.8	0.0	11.8	0.4	0.4	8.2	13.3	6.2	45.1	0.3	0.1	2.5	0.1	0.1	40.0	0.0	0.5	6.8	14.5	0.5	0.1	8.9	0.1	17.3	23.3	6.5	0.5	0.4	0.1	16.7	0.1	13.0	0.4	0.1	0.3	0.1	0.1	0.1	2.0	0.3	0.1	20.5	0.3	0.2	8.3	9.9	0.1	0.5	0.2	0.2	0.1	0.1	10.8	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	11.8	8.2	13.3	6.8	14.5	17.3	23.3	6.5	13.0	20.5	9.9	10.8	0.3	0.0	1.1	25.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	45.6	0.3	0.0	0.0	0.0	33.8	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	15.2	0.3	0.2	0.0	3.7	0.0	0.0	0.0	4.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	88.0	0.0	0.0	0.0	1.2	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469753-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 5255.3;salivary gland: 2005.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4507.8;Club cells: 6299.8;Collecting duct cells: 1988.1;Endometrial ciliated cells: 3253.3;Glandular and luminal cells: 4817.5;Respiratory ciliated cells: 2935.3;Urothelial cells: 3783.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 1815.6;ovarian cancer: 1086.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"A-431: 115.8;CAPAN-2: 210.6;EFO-21: 171.3;HaCaT: 151.9;RPTEC TERT1: 165.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042302	Enhanced				"Secreted in other tissues"	NA	NA		1600000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	11.8	1.6	6.6	11.1	12.0	0.0	81.9	6.2	9.4	5255.3	18.8	165.2	9.7	242.3	950.2	55.3	682.5	167.6	3.9	6.8	7.2	907.9	23.8	145.9	0.9	7.3	7.4	6.6	10.5	30.7	82.6	153.5	0.7	7.0	223.6	227.0	6.9	2005.6	832.7	2.0	30.9	60.6	29.2	6.4	0.7	44.5	15.0	7.1	12.4	255.9	0.5	8.9	162.5	25.2	6.9	115.8	0.0	0.3	0.4	0.0	0.1	4.7	0.0	0.0	0.0	0.0	4.9	210.6	0.0	171.3	0.0	0.7	151.9	0.0	0.0	0.0	0.8	1.9	0.0	1.2	0.3	0.0	0.2	0.7	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	6.7	0.3	2.7	18.4	0.6	0.0	0.1	0.0	0.0	165.6	1.3	5.0	1.0	10.6	0.0	1.1	2.0	3.1	0.6	0.0	0.3	2.8	0.6	0.5	0.7	0.6	1.6	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	12.0	6.2	9.4	6.8	7.2	7.3	7.4	6.6	7.0	6.4	7.1	6.9	2.8	169.9	273.8	2.6	4.2	8.9	1190.9	4507.8	35.3	30.3	340.4	238.5	2.0	94.4	6299.8	1988.1	22.9	1.0	4.3	239.8	221.1	308.2	1.6	3253.3	359.3	21.7	422.7	0.0	4.7	129.2	0.8	23.4	31.6	4817.5	10.1	12.5	3.9	3.3	1.9	0.0	7.6	1764.7	1328.5	0.6	1.1	5.0	36.1	26.8	10.6	1.9	5.7	31.3	0.0	2.0	3.4	179.0	424.6	0.0	0.8	1169.7	1.7	113.9	2935.3	6.1	6.6	1.1	319.1	12.4	11.9	110.2	14.1	0.7	36.8	0.0	318.2	3783.3
ZNF208	"PMIDP, ZNF95"	ENSG00000160321	"Zinc finger protein 208"	O43345	19	21932958-22010949	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 14.1;Oligodendrocytes: 26.3"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 0.6;testis cancer: 1.9;thyroid cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.3;NTERA-2: 33.1;SuSa: 6.9;U-266/84: 11.2"									HPA077100			Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA077100: "	"unprognostic (4.06e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-3)"	4.2	1.1	4.5	2.0	7.0	1.5	3.4	3.2	4.9	4.1	3.1	3.6	1.4	6.7	4.7	2.3	4.9	3.5	11.5	6.5	7.4	3.4	0.7	1.4	2.8	9.4	7.0	3.6	3.4	2.6	13.4	7.1	2.7	8.6	3.6	1.5	2.4	2.8	3.3	1.0	4.1	2.2	6.0	3.7	2.7	1.7	8.7	6.1	0.5	8.0	1.3	1.7	3.2	2.7	7.5	0.4	0.3	0.5	1.1	0.0	0.2	1.5	0.3	0.1	0.2	0.1	1.8	0.6	0.6	0.3	0.3	9.3	0.7	1.2	0.2	0.4	0.2	0.2	0.6	1.5	0.8	0.0	0.4	0.2	1.0	0.3	0.0	0.2	0.7	0.4	0.4	0.5	1.6	0.0	0.5	0.4	0.6	33.1	0.0	1.1	0.2	0.0	1.9	1.1	1.8	0.8	1.6	0.2	0.8	0.3	6.9	0.9	0.8	0.0	0.5	0.3	1.9	0.1	1.0	11.2	0.2	0.1	0.4	0.7	2.4	0.6	0.7	0.8	0.4	0.4	1.3	1.5	0.5	0.3	1.6	0.6	0.9	2.6	1.0	0.3	1.6	1.5	0.3	4.5	7.0	3.2	4.9	6.5	7.4	9.4	7.0	3.6	8.6	3.7	6.1	7.5	6.7	0.0	0.0	11.4	4.3	0.0	1.0	0.0	0.6	6.6	4.2	2.5	11.4	0.0	1.3	5.5	0.0	6.8	0.5	0.0	3.9	6.6	15.4	0.2	3.7	3.4	0.0	1.3	11.5	0.2	3.1	5.9	0.5	0.1	0.0	2.7	1.1	0.5	0.7	3.3	1.7	0.0	0.0	0.0	0.7	14.1	1.5	0.2	0.0	9.4	0.0	0.8	1.0	11.1	26.3	0.7	0.0	1.2	0.4	1.2	0.0	2.6	0.0	0.4	0.0	2.5	1.7	8.7	6.2	0.9	0.3	5.3	2.2	0.3	0.0	2.0
AC007906.2		ENSG00000277639	"Novel protein"		16	53035690-53052873	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	6	"choroid plexus: 72.4;fallopian tube: 78.5"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 224.8;Respiratory ciliated cells: 209.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 31.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 8.3;ASC TERT1: 7.0;BEWO: 11.6;HSkMC: 7.1;RPTEC TERT1: 7.5"															NA	NA						"unprognostic (1.97e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.46e-3)"	0.8	0.3	3.0	0.4	1.3	0.0	6.0	1.9	1.7	11.3	72.4	4.5	0.6	2.8	1.4	9.0	78.5	10.6	1.1	3.2	3.1	11.2	1.4	9.6	0.1	5.5	5.1	0.2	0.3	11.7	0.3	0.3	1.5	3.8	9.5	5.1	0.0	3.6	2.7	1.1	4.6	0.4	0.8	4.3	0.0	0.9	0.2	3.1	0.8	0.3	1.0	1.2	6.8	2.7	1.4	0.1	2.5	4.1	2.1	8.3	7.0	11.6	1.2	0.9	0.1	0.0	0.3	1.7	0.2	2.1	1.7	0.8	0.7	0.0	1.6	0.5	0.2	0.1	0.0	0.1	0.6	1.6	0.0	1.8	7.1	6.2	2.3	0.7	2.3	1.7	0.1	0.1	0.1	3.8	0.1	0.1	0.0	4.6	0.4	0.6	1.0	0.0	0.0	7.5	1.6	0.2	0.0	0.3	0.0	0.1	3.4	0.8	0.1	2.0	2.7	2.7	0.1	0.0	0.0	0.0	0.0	3.3	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.3	1.9	1.7	3.2	3.1	5.5	5.1	0.2	3.8	4.3	3.1	1.4	0.1	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.7	12.7	0.0	0.0	30.3	25.8	0.0	0.1	0.5	0.0	5.9	4.9	0.0	224.8	1.7	0.8	0.0	0.0	0.0	0.0	0.3	3.2	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	209.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
AC109583.1		ENSG00000206549	"Novel protein identical to PRSS50"		3	46712115-46812574	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.6;skeletal muscle: 4.9;thyroid gland: 6.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040768	Supported					NA	NA					"HPA040768: AB_2677126"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.32e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.66e-3)"	0.1	0.3	0.3	0.0	0.2	0.0	0.7	0.9	0.2	1.5	0.4	0.4	0.1	0.7	3.0	0.1	1.1	0.0	0.9	0.1	0.9	1.6	0.8	0.3	0.0	0.3	0.4	0.1	0.7	1.5	1.8	4.6	0.0	0.4	1.5	0.0	0.1	0.8	0.7	4.9	0.1	0.2	0.1	0.3	0.1	0.3	1.8	0.3	0.0	6.0	0.2	0.0	0.6	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.9	0.2	0.1	0.9	0.3	0.4	0.1	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1238.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.4	0.5	1.1	1238.4	0.5	16.6	1.7	0.9	0.7	0.6	0.4	0.7	1.3	5.0	0.3	0.9	0.0	0.2	1.2	164.7	1.1	0.5	0.3	2.2	0.4	0.9	8.6	3.7	0.2	0.3	1.2	0.4	0.1	2.4	9.1	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.1	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.7	0.6	0.3	0.9	0.0	0.3	0.1	0.3	0.1	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 67.9;endometrium 1: 58.1"	"Cell type enriched"	"Detected in some"	5	"Endometrial stromal cells: 135.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 22.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 13.3;MCF7: 21.9;NTERA-2: 7.4;OE19: 8.6;SCLC-21H: 8.0;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"basal ganglia: 34.3"	HPA057688	Uncertain					NA	NA					"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	14.8	3.7	7.0	0.5	17.6	0.0	8.3	3.3	7.8	67.9	3.3	2.8	0.4	58.1	2.2	2.0	22.9	0.4	5.5	6.3	7.9	22.9	0.6	4.1	0.8	12.2	5.2	7.6	8.3	3.9	0.2	4.8	3.7	10.8	22.6	0.2	0.8	1.2	18.8	3.5	6.2	3.2	2.2	3.5	22.1	2.4	3.8	6.9	0.4	1.4	1.8	0.1	4.3	14.2	5.9	0.0	4.6	0.1	0.1	0.5	0.0	0.2	0.5	0.0	0.1	0.0	2.4	1.4	0.0	2.3	0.4	0.8	0.0	0.2	0.0	0.0	0.0	6.6	0.0	0.0	13.3	0.6	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	21.9	0.0	0.0	7.4	8.6	0.0	0.0	6.8	0.0	0.0	0.4	8.0	9.7	3.0	0.0	0.1	1.9	7.0	0.1	0.0	0.0	5.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	17.6	3.3	7.8	6.3	7.9	12.2	5.2	7.6	10.8	3.5	6.9	5.9	26.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.2	1.7	0.8	0.9	1.0	2.8	0.0	12.9	0.0	0.9	0.1	0.1	3.9	0.4	0.0	4.7	135.9	5.4	0.0	0.0	1.2	0.0	0.2	1.4	0.0	2.4	0.0	10.7	1.1	0.0	0.3	3.3	0.6	0.2	0.0	0.0	0.7	0.4	1.5	0.6	0.0	1.0	0.0	5.8	0.0	0.0	0.2	0.1	0.0	3.8	0.0	0.3	0.0	2.4	0.0	0.1	0.0	0.9	5.8	0.1	1.6	0.0	0.0	1.6	0.6	0.0	0.1	0.2
AMY1B	AMY1	ENSG00000174876	"Amylase alpha 1B"	P04745	1	103687415-103696680	"Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	53	"salivary gland: 4644.3"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 19.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		70000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	87.2	0.0	0.0	0.0	0.1	0.0	0.6	56.8	0.0	0.9	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.4	32.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4644.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Predicted intracellular proteins"	Fertilization	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 4.1;brain: 4.4"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 1.0;Macrophages: 1.2;T-cells: 1.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Intracellular and membrane"	NA	NA					"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.1	0.0	0.9	0.3	0.3	4.1	0.1	0.9	4.4	0.0	0.3	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.2	1.0	0.0	0.9	0.4	0.0	0.0	0.7	0.2	0.3	0.2	0.7	0.0	0.0	0.3	0.5	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.9	4.4	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.1	0.0	0.0	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809071-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 318.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 374.9;Basal respiratory cells: 454.1;Collecting duct cells: 548.1;Cytotrophoblasts: 705.4;Syncytiotrophoblasts: 433.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 142.7;HaCaT: 298.4;SK-BR-3: 276.8;T-47d: 157.2;U-2 OS: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		18000000	"Nucleoli fibrillar center"		"HPA005654: AB_2667378"	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	102.1	23.5	22.8	10.0	17.4	3.8	126.7	18.7	39.9	80.0	34.4	32.0	13.6	78.8	21.5	29.4	116.1	15.9	100.7	17.4	24.2	318.8	38.7	89.8	9.8	22.5	18.9	15.8	50.6	52.0	20.2	38.6	44.4	21.0	131.2	5.4	3.1	66.1	49.7	45.1	50.9	31.5	19.8	18.2	36.7	39.6	20.8	22.3	13.9	217.5	31.1	7.1	53.2	72.6	21.9	34.7	44.3	1.2	120.8	0.6	0.8	142.7	13.3	6.3	10.7	7.1	66.8	83.5	0.0	65.7	1.6	0.6	298.4	10.4	74.5	3.2	0.1	7.3	0.2	8.8	93.9	23.6	0.0	15.9	11.6	28.6	3.7	4.4	34.2	6.6	0.0	7.3	0.5	1.6	17.7	0.4	1.2	13.5	10.0	15.1	0.5	14.2	3.6	90.4	21.9	0.4	0.5	54.0	276.8	3.4	13.1	157.2	5.1	17.4	2.7	130.2	3.4	6.5	0.6	1.4	0.1	1.1	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	17.4	18.7	39.9	17.4	24.2	22.5	18.9	15.8	21.0	18.2	22.3	21.9	374.9	6.4	12.3	5.5	4.4	40.7	118.0	454.1	80.2	2.5	109.5	185.4	12.8	52.9	48.5	548.1	0.0	705.4	3.2	8.6	82.2	34.0	1.3	62.9	8.2	214.0	52.0	4.8	0.5	4.0	36.9	21.7	15.8	45.3	0.0	14.3	73.2	31.0	44.7	0.0	1.2	5.6	40.7	8.0	21.3	2.1	29.5	3.5	16.0	9.4	0.1	23.6	0.0	1.0	0.3	14.3	21.4	15.1	2.5	80.4	4.9	149.6	20.7	1.1	157.8	14.1	240.6	3.2	18.3	8.9	24.6	433.3	3.5	6.4	13.0	40.7
C19orf81		ENSG00000235034	"Chromosome 19 open reading frame 81"	C9J6K1	19	50649445-50659310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 2.1;testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 20.2;Early spermatids: 30.7;Muller glia cells: 65.4;Rod photoreceptor cells: 29.3;Spermatocytes: 17.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HMC-1: 1.5;JURKAT: 1.2;K-562: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060238	Enhanced		Approved	Vesicles,Aggresome		NA	NA			"Vesicles, Aggresome"		"HPA060238: AB_2684228"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.01e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.04e-2)"	0.0	0.0	0.5	0.0	0.4	0.1	0.0	2.1	1.3	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.6	0.4	0.6	0.0	0.0	0.3	0.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.5	4.3	0.4	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.0	0.8	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	2.1	1.3	0.7	0.5	0.6	0.4	0.6	0.8	0.2	0.4	0.7	0.2	0.0	0.0	0.3	0.5	2.2	1.7	0.0	12.0	14.9	4.0	4.3	1.3	1.5	0.0	20.2	8.4	0.1	3.0	0.1	13.7	7.9	30.7	2.3	1.4	1.5	0.0	0.8	1.5	1.3	0.3	0.9	0.0	5.4	0.0	1.4	1.8	0.0	0.9	11.8	2.1	0.0	0.0	0.3	0.8	6.4	0.6	0.9	5.4	1.0	2.6	65.4	0.0	1.5	3.5	4.4	0.0	0.7	0.1	6.0	0.0	0.2	0.0	29.3	0.0	1.1	1.8	17.1	5.0	0.9	4.3	0.0	0.8	2.7	0.0	0.4
CCDC194		ENSG00000269720	"Coiled-coil domain containing 194"	A0A1B0GVG4	19	17390509-17394158	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 4.4;ovary: 2.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"ovarian cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.87e-4)"	"unprognostic (2.75e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.22e-14)"	"unprognostic (1.04e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.86e-2)"	0.2	0.3	1.5	0.0	0.7	0.0	0.1	0.5	4.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.8	0.1	0.1	0.1	0.0	1.3	0.5	0.0	2.2	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.5	4.4	2.1	0.8	1.3	0.5	0.0	1.0	1.0	1.4	2.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0
CDH18	"CDH14, EY-CADHERIN"	ENSG00000145526	"Cadherin 18"	Q13634	5	19471296-20575873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 36.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 923.8;Inhibitory neurons: 694.3;Oligodendrocyte precursor cells: 248.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 36.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.4;GAMG: 7.6;hTERT-RPE1: 4.2;U-2 OS: 6.8;U-2197: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014416	Uncertain				"Intracellular and membrane"	NA	Yes					"HPA014416: AB_2668996"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"		"unprognostic (5.26e-7)"	"unprognostic (6.36e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.44e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.30e-2)"		"unprognostic (1.51e-2)"	"unprognostic (8.69e-2)"		"unprognostic (1.76e-2)"	0.0	4.7	1.7	0.0	7.1	0.0	0.0	36.7	12.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	9.7	0.1	0.0	0.0	0.0	0.1	3.1	6.9	0.0	0.3	0.9	4.0	0.0	8.4	0.1	0.0	2.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.2	0.0	0.3	0.0	0.6	2.9	2.5	0.1	1.6	0.1	0.5	0.0	0.0	0.0	4.4	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	1.7	4.2	0.0	0.0	0.1	0.5	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	6.8	6.2	0.0	1.7	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.1	36.7	12.8	5.6	9.7	0.1	3.1	6.9	8.4	0.0	2.8	5.9	0.0	0.0	0.0	22.9	0.0	0.0	1.3	0.0	0.0	6.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	109.9	0.0	0.0	0.0	0.0	0.0	923.8	0.0	5.3	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	694.3	0.0	0.0	0.0	0.0	19.2	0.3	0.1	0.0	17.8	0.0	0.2	0.0	248.3	15.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.1	0.1	6.4	3.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.5;pituitary gland: 34.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.2	7.1	1.7	7.4	1.3	3.1	5.5	8.0	1.0	26.5	1.7	0.8	0.7	1.0	7.4	2.3	0.5	0.6	6.3	7.3	0.4	0.8	2.3	2.2	7.3	5.7	5.8	0.8	1.5	2.1	34.0	2.6	7.9	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	5.9	5.5	3.9	14.9	6.0	2.1	1.3	0.0	2.6	2.4	2.4	8.3	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.1	7.4	5.5	8.0	6.3	7.3	7.3	5.7	5.8	7.9	5.9	6.0	8.3	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.2;testis: 31.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 38.6;Oligodendrocytes: 50.1;Skeletal myocytes: 28.3;Theca cells: 26.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.8;U-266/70: 2.8;U-266/84: 7.2;U-87 MG: 7.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.9;hypothalamus: 12.3;pons and medulla: 10.9"	"Group enriched"	"Detected in all"	4	"olfactory bulb: 66.4;spinal cord: 38.6"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	1.7	2.1	2.4	1.1	1.4	0.0	1.1	0.7	3.5	0.2	0.9	2.6	1.7	0.6	1.1	0.9	0.5	0.9	2.0	1.8	4.3	3.6	0.0	0.3	0.4	8.6	3.0	0.9	0.6	0.1	0.3	2.5	1.9	10.3	5.6	3.5	0.6	0.6	1.8	0.6	2.3	1.0	0.3	1.7	14.2	0.7	31.3	6.8	0.3	1.1	1.7	1.2	0.7	1.1	4.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.4	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.6	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.8	7.2	0.2	7.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	2.4	1.4	0.7	3.5	1.8	4.3	8.6	3.0	0.9	10.3	1.7	6.8	4.0	1.7	0.0	0.0	5.2	1.0	4.0	0.8	0.8	3.4	1.1	1.0	1.3	0.5	0.0	0.9	0.0	0.0	0.2	0.9	0.0	1.9	0.4	5.0	1.4	38.6	1.5	0.0	0.0	5.5	0.0	0.2	4.6	0.0	0.8	0.0	12.3	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.8	4.0	3.1	0.1	1.8	4.7	0.0	0.4	0.0	12.5	50.1	0.0	0.0	1.9	3.1	0.2	0.0	0.3	0.3	0.1	0.0	28.3	10.5	1.3	1.7	0.5	2.3	0.5	1.3	26.7	0.1	0.3
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 170.9;pancreas: 97.4;thyroid gland: 117.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.8	7.9	0.4	0.2	26.9	4.5	0.6	8.0	30.0	149.3	54.9	7.5	1.5	1.3	29.8	2.2	0.1	1.2	1.5	46.4	40.8	10.8	0.2	0.9	1.6	0.0	0.5	97.4	1.5	27.9	1.0	1.3	58.8	17.7	0.4	73.5	8.4	0.1	8.9	170.9	0.8	0.6	0.2	1.4	0.7	0.7	1.1	117.3	0.0	1.2	1.5	0.2	0.3	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	4.5	0.6	1.2	1.5	0.9	1.6	0.0	1.3	0.6	0.7	0.3	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CLDN6		ENSG00000184697	"Claudin 6"	P56747	16	3014712-3020071	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;pancreas: 1.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 35.8;Ductal cells: 23.7;Extravillous trophoblasts: 144.2;Syncytiotrophoblasts: 44.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 73.6;testis cancer: 112.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 477.8;CACO-2: 134.6;NTERA-2: 443.1;SuSa: 328.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.59e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.50e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.66e-4)"	"unprognostic (1.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.78e-4)"	0.0	0.2	0.8	0.0	1.0	0.1	0.0	1.2	0.7	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.5	0.1	0.0	0.2	0.0	0.5	0.4	0.8	0.0	1.0	0.0	0.3	0.7	0.8	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.9	0.3	0.7	0.0	477.8	0.1	0.0	0.0	0.0	134.6	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.2	0.1	60.2	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.1	1.0	0.0	0.3	443.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.6	0.6	0.0	328.9	0.2	0.1	0.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.2	0.7	0.7	0.5	0.5	0.4	0.8	0.8	0.2	0.5	1.3	0.2	3.2	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.8	1.3	0.3	0.0	0.1	0.0	0.0	35.8	0.0	0.0	0.0	23.7	0.2	1.4	0.1	0.2	0.0	0.0	0.1	0.0	144.2	0.6	0.0	1.6	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	1.8	0.4	0.6	5.4	0.0	0.4	44.1	0.2	0.0	0.1	0.2
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012923-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.7;pituitary gland: 25.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 9.5;Endometrial ciliated cells: 8.6;Pancreatic endocrine cells: 8.1;Respiratory ciliated cells: 18.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.7;CAPAN-2: 7.3;MCF7: 24.2;SCLC-21H: 20.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076613			Supported	"Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	Vesicles	"HPA076613: AB_2686808"	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.2	4.1	0.2	3.9	2.7	0.2	9.7	5.3	0.2	2.2	0.4	0.7	0.0	0.0	0.1	1.2	0.2	1.1	3.4	3.3	0.5	5.3	1.2	0.0	4.7	4.2	2.8	0.0	6.4	1.4	25.4	0.1	6.3	0.3	0.0	1.9	0.6	0.0	1.2	0.2	0.5	0.0	3.6	2.3	0.5	0.3	4.4	0.3	0.4	0.1	0.0	0.2	0.1	5.3	4.7	0.2	0.0	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	7.3	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	24.2	0.0	2.0	0.1	0.3	0.2	0.0	0.0	0.2	0.2	0.1	20.8	0.0	0.6	0.9	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.9	9.7	5.3	3.4	3.3	4.7	4.2	2.8	6.3	3.6	4.4	5.3	0.0	0.0	0.0	0.0	0.0	0.1	2.6	1.4	0.0	1.3	1.1	0.4	0.3	15.7	2.3	0.0	0.0	0.3	0.0	0.6	0.0	9.5	0.1	8.6	0.3	0.1	1.8	0.0	0.8	1.7	0.9	0.1	0.0	2.7	0.0	0.0	0.4	0.3	0.1	0.0	0.4	0.4	2.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	3.4	8.1	1.5	0.0	0.0	1.2	0.4	0.1	18.1	0.7	0.0	0.0	0.6	0.1	0.2	0.0	0.4	1.1	0.1	0.0	0.6	1.8
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.7;skeletal muscle: 292.4;tongue: 99.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	12.5	1.5	3.0	4.3	4.4	0.2	6.6	1.6	2.9	19.1	0.6	28.9	21.0	2.1	0.9	2.9	4.5	3.0	103.7	2.1	5.5	53.2	0.3	71.4	1.7	2.3	2.4	1.5	0.5	1.1	1.7	3.0	16.6	3.0	2.6	26.0	17.1	2.7	1.4	292.4	1.1	36.9	2.3	1.5	44.9	1.7	1.4	4.0	1.0	7.4	99.2	1.9	2.0	2.7	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.0	4.4	1.6	2.9	2.1	5.5	2.3	2.4	1.5	3.0	1.5	4.0	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340353-78348225	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 548.8;thyroid gland: 174.9"	"Cell type enriched"	"Detected in some"	24	"Muller glia cells: 4845.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 1022.7;NTERA-2: 307.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4"	"Low region specificity"	"Detected in all"			HPA017203	Enhanced	Supported				NA	NA					"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.6	1.7	18.7	2.5	26.0	0.2	56.7	26.2	26.6	1.3	26.7	6.4	0.8	2.4	2.0	0.6	0.3	1.6	0.4	9.6	40.4	15.1	0.0	0.7	0.2	59.1	49.5	11.3	0.4	0.7	0.0	27.8	15.1	54.2	2.6	1.7	548.8	1.1	47.9	0.2	26.9	5.0	1.8	24.5	75.8	7.2	0.5	52.7	1.7	174.9	0.2	1.2	0.6	2.5	95.4	0.0	0.2	1022.7	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	65.3	0.9	0.0	6.3	0.0	0.3	0.0	9.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	57.9	0.4	307.4	1.0	0.8	0.0	0.0	0.0	0.0	1.5	85.5	58.0	0.0	0.2	0.1	24.8	1.4	35.9	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	26.0	26.2	26.6	9.6	40.4	59.1	49.5	11.3	54.2	24.5	52.7	95.4	1.0	0.0	0.0	0.3	0.8	9.7	0.1	0.0	0.0	31.1	112.6	199.0	0.0	0.0	0.0	0.0	33.3	1.1	2.9	1.1	70.5	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.2	0.0	0.8	11.3	0.0	0.1	0.0	4.2	0.0	0.0	1.5	10.1	1.5	0.4	0.0	0.0	5.3	0.0	0.0	0.5	192.1	0.0	0.0	4845.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.0	91.2	0.0	0.0	1.0	0.1	2.2	0.0	2.6	1.4	0.9	0.0	1.6	0.1
CRYGC	CRYG3	ENSG00000163254	"Crystallin gamma C"	P07315	2	208128137-208129828	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 1.9;Granulosa cells: 3.7;Late spermatids: 3.2;Spermatocytes: 2.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8;ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"hippocampal formation: 3.2;hypothalamus: 1.5;thalamus: 1.2"	"Group enriched"	"Detected in some"	14	"cerebral cortex: 1.2;hippocampal formation: 1.5"	HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (1.89e-1)"					"unprognostic (2.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 7.9"	"Group enriched"	"Detected in some"	50	"Spermatocytes: 3.5;Spermatogonia: 6.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 246.0;Karpas-707: 112.8"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	246.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	112.8	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.5	0.0	0.3	1.7	33.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.6	0.2	0.3	0.2	0.3	0.1	0.3	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 9.3"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 47.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 85.4;K-562: 26.9;Karpas-707: 94.7;U-266/84: 88.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.5	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.1	0.0	1.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	85.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	94.7	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	18.5	88.6	0.1	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.3	1.2	1.5	1.3	0.8	0.3	2.0	0.6	1.3	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTCFL	"BORIS, CT27, dJ579F20.2"	ENSG00000124092	"CCCTC-binding factor like"	Q8NI51	20	57495966-57525652	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 11.1"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 61.3;Spermatogonia: 143.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.3"	"Region enhanced"	"Detected in some"		"white matter: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HMC-1: 79.6;K-562: 116.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001472	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001472: AB_1078583"	"unprognostic (2.50e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.85e-5)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.00e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.75e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.84e-2)"		0.1	0.2	0.3	0.2	0.3	1.0	0.2	1.0	0.7	0.0	0.0	0.1	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.0	0.1	0.2	0.5	0.1	0.2	0.3	0.6	0.2	0.2	0.9	0.1	0.1	0.2	0.5	0.3	0.1	0.0	0.3	0.2	11.1	0.2	0.1	0.4	0.1	0.1	0.1	0.0	1.9	0.1	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.4	0.2	0.1	0.3	0.4	0.2	0.1	0.0	0.4	0.2	0.3	0.7	0.1	0.2	0.2	79.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	116.1	0.6	0.0	0.1	0.3	0.4	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.3	0.3	0.3	0.1	0.2	0.3	0.4	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.3	0.1	2.9	0.3	0.3	0.4	0.5	0.1	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.1	0.9	0.2	0.2	0.2	0.1	0.0	0.3	0.3	1.0	0.7	0.3	0.2	0.2	0.0	0.1	0.6	0.0	0.2	1.9	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.0	0.0	6.6	0.1	0.2	61.3	143.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 198.7;esophagus: 243.9;skin 1: 280.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 212.9;Muller glia cells: 913.0;Squamous epithelial cells: 736.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;hTCEpi: 23.2;SCLC-21H: 5.9;U-87 MG: 8.4"									"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"		NA	NA			"Nucleoplasm, Nuclear bodies, Microtubules"		"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	1.4	56.6	2.0	0.1	2.1	0.8	29.0	1.8	5.8	23.6	3.6	2.2	0.5	0.6	198.7	243.9	81.2	0.6	0.5	1.6	6.5	3.5	0.2	1.6	0.6	1.7	5.4	1.9	1.0	23.0	0.0	24.6	0.1	2.2	9.3	0.7	116.6	30.4	1.1	1.0	280.9	1.1	0.5	1.6	0.3	1.5	1.6	3.6	4.8	34.6	0.0	25.2	8.7	108.9	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	0.1	0.2	23.2	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.6	0.0	0.7	1.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.0	1.2	0.8	0.5	0.1	0.6	0.2	0.4	0.2	0.1	0.3	0.4	0.1	0.1	0.5	0.7	0.1	1.2	0.4	0.1	2.0	2.1	1.8	5.8	1.6	6.5	1.7	5.4	1.9	2.2	1.6	3.6	1.6	0.6	0.0	0.0	0.0	4.1	106.9	51.8	74.8	212.9	7.2	15.0	19.6	0.1	2.8	29.8	9.2	6.2	6.0	4.9	2.0	3.9	7.6	13.8	5.6	2.2	2.0	3.0	0.0	0.2	6.0	12.8	2.4	0.0	5.4	4.5	148.1	0.7	14.3	14.7	3.3	0.4	2.0	14.2	9.1	9.3	56.1	4.1	5.0	12.4	0.0	5.4	913.0	2.1	1.0	0.1	5.8	7.1	2.2	3.4	11.8	5.9	13.3	4.8	23.8	0.0	1.9	10.9	10.8	4.2	736.5	126.6	4.5	3.1	1.7	2.3	67.4
DEFB126	"bA530N10.1, C20orf8, DEFB-26"	ENSG00000125788	"Defensin beta 126"	Q9BYW3	20	142590-145751	"Disease related genes, Predicted secreted proteins"	Fertilization	"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	297	"epididymis: 1296.6"	"Cell type enhanced"	"Detected in single"		"Prostatic glandular cells: 1.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;OE19: 3.4"														"Secreted in male reproductive system"	NA	NA											"unprognostic (1.16e-1)"		"unprognostic (1.21e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.41e-2)"			"unprognostic (2.32e-1)"		"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1296.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	3.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.6	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.1
DNAJB13	"RSPH16A, TSARG6"	ENSG00000187726	"DnaJ heat shock protein family (Hsp40) member B13"	P59910	11	73951026-73970366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Chaperone	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 53.7;testis: 19.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052465, HPA061330"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA052465: AB_2681842, HPA061330: AB_2732659"	"unprognostic (1.07e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.72e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.40e-2)"	0.1	0.1	3.3	1.2	1.7	4.5	0.2	1.9	1.5	4.7	10.0	0.1	0.6	2.0	5.3	0.1	53.7	2.2	0.1	1.4	3.7	1.0	0.1	3.1	2.1	3.7	3.9	0.7	0.3	0.8	0.1	1.1	0.5	3.2	0.9	0.0	0.5	0.6	2.9	0.3	0.1	2.9	0.1	4.5	1.3	0.2	19.0	1.9	0.0	0.2	0.0	0.0	0.2	0.1	1.7	0.0	0.4	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.7	0.2	0.9	2.1	0.2	0.3	0.5	0.1	0.0	0.0	2.7	0.3	1.0	0.9	0.3	0.0	0.2	0.6	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.2	2.6	0.4	0.3	0.6	0.9	0.2	0.2	1.5	0.4	1.2	1.1	4.5	0.5	0.3	1.0	0.5	2.2	0.2	0.4	0.3	0.7	0.0	0.0	0.6	0.6	0.0	2.2	2.0	1.9	0.0	0.3	0.1	0.7	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.1	3.3	1.7	1.9	1.5	1.4	3.7	3.7	3.9	0.7	3.2	4.5	1.9	1.7	0.2	3.2	0.0	2.0	0.0	0.0	1.9	11.1	0.0	0.2	0.1	0.3	0.2	0.0	7.6	1.8	0.0	0.1	0.0	0.1	0.0	1.7	90.6	114.8	2.4	0.2	0.0	0.0	0.4	0.0	0.1	0.5	0.0	13.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	10.2	0.0	0.0	62.9	1.2	0.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	1.2	0.0	1.3	1.4	1.0	104.2	0.9	0.0	1.1	3.3	19.5	1.5	0.0	0.0	0.0	0.3	0.0	0.0	1.2
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 38.8;skeletal muscle: 29.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.3	0.2	3.3	0.2	0.4	7.4	3.0	1.4	9.0	0.2	0.1	1.0	1.7	0.3	5.9	0.3	38.8	1.4	1.1	2.7	1.2	1.6	0.7	3.5	2.0	0.2	0.3	5.9	0.1	15.8	0.0	4.8	1.8	0.1	0.0	1.9	1.0	29.8	1.1	1.4	0.0	0.4	1.9	2.7	4.8	2.3	0.0	0.7	8.8	0.4	1.2	0.6	3.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.3	3.3	7.4	3.0	1.4	1.1	3.5	2.0	0.2	4.8	0.4	2.3	3.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
DPEP3		ENSG00000141096	"Dipeptidase 3"	Q9H4B8	16	67975663-67980549	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 47.4"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 290.4;Spermatogonia: 289.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 6.7;NK-cell: 1.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 6.7;NK-cells: 1.8"	"Cell line enriched"	"Detected in single"	10	"U-266/70: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031870, HPA058607"	Enhanced					NA	NA		27000000			"HPA031870: AB_2674079, HPA058607: AB_2683775"	"unprognostic (9.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.49e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.51e-1)"	0.4	0.1	0.2	0.2	0.3	1.7	0.0	0.2	0.4	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.3	0.4	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.3	2.0	0.3	47.4	0.3	0.1	0.0	0.6	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.5	0.5	0.2	6.7	1.8	0.1	0.0	0.0	0.2	0.2	0.3	0.2	0.4	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	41.3	4.4	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.4	0.0	0.0	0.1	0.7	0.0	26.3	0.0	0.0	290.4	289.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0
DRD4		ENSG00000069696	"Dopamine receptor D4"	P21917	11	637269-640706	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Bipolar cells: 168.8;Cone photoreceptor cells: 87.6;Rod photoreceptor cells: 206.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062682			Uncertain	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	Centrosome	"HPA062682: "	"unprognostic (8.83e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.81e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-1)"	0.9	0.8	0.8	0.0	0.5	0.0	0.8	1.3	0.8	2.3	0.1	1.4	0.0	1.6	0.0	1.1	2.6	0.0	0.9	0.7	0.1	1.3	1.5	1.3	0.0	1.6	0.4	0.2	3.5	1.5	0.0	4.2	0.0	1.1	2.3	0.0	0.0	0.5	0.0	1.0	1.4	1.1	0.0	0.8	0.6	0.8	2.6	0.7	0.0	1.8	0.0	0.0	1.7	1.7	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.5	1.3	0.8	0.7	0.1	1.6	0.4	0.2	1.1	0.8	0.7	1.1	0.5	0.0	0.5	4.2	0.2	0.0	0.3	0.2	0.0	168.8	0.3	0.4	1.7	0.0	0.1	1.8	87.6	0.6	8.6	0.8	0.0	0.1	0.7	0.3	0.4	1.5	0.0	0.0	0.8	0.4	0.3	0.5	2.0	0.7	0.0	1.5	0.0	0.1	0.2	6.7	1.2	1.3	0.0	0.3	0.3	0.2	0.6	0.9	0.0	0.0	0.1	26.0	0.0	0.0	2.6	0.4	0.2	0.7	0.1	1.1	8.3	1.9	0.1	206.9	0.0	0.8	0.6	1.2	2.6	0.8	0.4	0.1	0.1	0.5	1.3	0.3
ERAS	"HRAS2, HRASP"	ENSG00000187682	"ES cell expressed Ras"	Q7Z444	X	48826513-48830138	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 1.7;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.1;ovarian cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (2.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.72e-4)"	"unprognostic (9.40e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-2)"	0.1	0.0	1.2	0.0	0.9	0.1	0.1	1.1	1.5	0.4	0.7	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.8	1.9	0.5	0.6	0.1	0.0	1.0	1.1	0.9	0.4	0.0	0.0	1.0	0.0	1.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	1.0	1.9	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	1.1	1.5	0.8	1.9	1.0	1.1	0.9	1.0	0.8	1.9	1.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.1	1.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0
FAM171A2	MGC34829	ENSG00000161682	"Family with sequence similarity 171 member A2"	A8MVW0	17	44353215-44363853	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.6;pituitary gland: 7.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 40.1;Horizontal cells: 43.7;Muller glia cells: 131.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 14.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.9;REH: 23.2;SCLC-21H: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019770	Uncertain					NA	NA					"HPA019770: AB_1848383"	"unprognostic (1.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.14e-3)"	"unprognostic (8.47e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.62e-4)"	"unprognostic (5.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.76e-2)"	1.1	1.0	6.9	0.1	10.9	0.1	0.4	0.2	11.4	3.8	0.0	0.5	0.1	2.5	2.8	2.2	1.8	0.7	0.6	10.3	3.0	0.7	0.1	0.5	0.2	3.7	1.7	15.6	3.4	0.2	2.9	7.9	0.4	5.9	1.0	0.0	1.6	0.6	0.9	0.1	0.6	0.4	0.3	0.0	0.2	0.3	0.4	0.8	0.1	1.5	0.0	0.1	0.2	2.0	6.8	1.5	2.2	6.7	9.4	1.1	1.3	4.7	2.6	0.3	2.1	2.6	0.2	0.2	3.1	5.8	0.7	1.2	0.1	2.4	0.6	0.2	2.6	12.9	0.9	0.2	1.3	0.7	0.2	0.5	1.6	0.2	0.8	0.0	3.8	3.3	6.9	2.1	0.1	0.7	8.0	7.3	1.2	10.0	0.1	4.9	23.2	4.4	1.9	0.4	0.5	15.9	11.9	0.9	0.1	1.2	1.6	2.6	1.6	2.1	3.1	5.8	5.2	0.8	1.0	0.3	1.1	0.2	1.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	10.9	0.2	11.4	10.3	3.0	3.7	1.7	15.6	5.9	0.0	0.8	6.8	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.2	40.1	0.3	1.7	1.4	0.0	0.0	3.7	12.5	0.0	0.7	0.0	0.0	0.2	0.0	2.8	7.4	2.0	0.0	0.0	1.6	0.0	0.2	1.4	0.0	11.3	0.0	2.7	2.5	0.0	0.2	43.7	0.7	0.0	0.0	0.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	131.2	0.0	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.0	0.0	0.0	7.8	0.0	0.2	1.6	0.1	1.2	0.5	0.1	0.0	0.7	0.5	0.1	0.1
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;choroid plexus: 9.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 9.3;Cone photoreceptor cells: 14.6;Excitatory neurons: 10.6;Inhibitory neurons: 13.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6;testis cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;RPMI-8226: 1.8"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	HPA052600	Uncertain				"Secreted in brain"	NA	NA					"HPA052600: AB_2681881"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.3	3.9	11.8	0.0	13.5	0.1	0.4	19.7	25.9	3.0	9.1	0.3	0.0	1.1	0.1	0.2	1.5	0.2	0.4	13.0	11.9	1.4	0.4	0.7	0.0	10.8	11.0	12.9	1.5	1.2	0.8	5.1	0.1	15.9	2.8	0.0	1.2	0.7	0.1	0.1	0.4	0.4	0.3	9.0	3.6	0.5	0.7	11.6	0.4	4.9	0.0	0.0	0.6	1.3	13.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	13.5	19.7	25.9	13.0	11.9	10.8	11.0	12.9	15.9	9.0	11.6	13.2	0.2	0.0	0.0	2.3	0.0	0.0	0.3	0.1	0.0	9.3	0.2	0.4	1.1	0.0	0.2	0.0	14.6	0.1	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.1	0.0	0.0	10.6	0.2	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	1.7	13.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.8	1.0	0.0	0.6	0.0	2.0	2.4	0.1	0.0	1.2	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.3	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.4	0.0	0.1
FOLR1	"FOLR, FR"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 396.3;fallopian tube: 188.8;lung: 195.2;salivary gland: 221.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 444.2;RPTEC TERT1: 476.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA	448000	140000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.1	1.8	4.3	0.2	1.8	0.1	28.6	12.4	5.7	124.5	396.3	0.5	0.3	1.9	7.6	3.5	188.8	2.4	0.4	14.9	12.1	154.4	0.2	195.2	0.0	4.8	9.0	0.8	0.7	7.2	17.7	8.2	36.5	3.4	1.5	0.4	0.5	221.4	15.4	0.1	2.1	0.4	0.2	3.4	0.2	33.3	0.2	6.8	0.2	46.4	0.0	0.4	0.1	0.1	2.5	0.2	0.2	0.0	0.2	0.0	0.0	64.7	0.1	0.1	0.1	0.1	44.5	46.0	0.0	45.5	0.8	0.0	0.9	2.4	2.1	0.2	0.1	1.4	1.0	444.2	1.3	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.5	0.1	0.1	2.2	0.7	0.0	0.5	15.1	0.0	476.5	0.0	0.1	3.0	1.4	7.1	0.1	38.5	65.7	0.5	0.0	0.0	8.4	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.8	12.4	5.7	14.9	12.1	4.8	9.0	0.8	3.4	3.4	6.8	2.5	1.0	496.8	213.3	0.0	1.3	0.9	7.9	80.3	0.0	0.0	211.3	62.9	0.2	34.3	276.3	318.2	0.0	462.2	1.1	0.0	133.1	14.3	0.1	33.6	2.3	3.4	1.8	0.0	0.0	1.4	110.9	4.3	9.7	33.7	5.1	0.0	0.0	0.0	29.5	0.0	0.0	0.1	87.5	0.0	0.4	0.0	0.6	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.3	0.0	366.0	149.1	0.1	0.0	0.1	6.3	0.0	0.5	3.2	0.1	259.0	2.2	0.3	0.3	10.4
FOLR3	"FR-G, FR"	ENSG00000110203	"Folate receptor gamma"	P41439	11	72114869-72139892	"Metabolic proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"bone marrow: 99.6;lymphoid tissue: 28.6"	"Group enriched"	"Detected in some"	10	"Distal tubular cells: 406.9;monocytes: 103.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 5.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	11	"classical monocyte: 330.8;neutrophil: 492.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 492.8;monocytes: 330.8"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 72.4;U-2197: 64.7"														"Secreted to blood"	NA	NA		12000000				"unprognostic (1.47e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.90e-2)"	"unprognostic (8.39e-2)"	"unprognostic (9.99e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.03e-6)"	"unprognostic (4.17e-1)"	5.8	0.4	0.3	10.7	0.4	99.6	0.2	0.2	1.3	0.2	1.3	0.1	0.4	0.0	0.0	1.0	1.0	0.3	0.5	0.2	0.5	5.0	0.8	5.9	0.1	0.3	0.4	0.2	0.0	0.2	0.0	0.1	0.7	0.4	0.2	0.1	0.0	0.6	0.1	0.1	0.5	0.5	0.6	0.3	28.6	0.4	0.9	0.5	1.3	1.7	0.5	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.3	10.4	13.1	3.7	9.2	0.0	0.0	0.0	1.3	2.0	0.2	1.1	0.0	6.9	8.4	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	8.8	5.4	72.4	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	0.3	64.7	0.0	0.1	0.0	0.0	2.7	0.0	0.0	15.1	330.8	30.9	0.5	26.1	1.8	0.3	0.1	0.2	36.2	0.1	0.1	0.0	492.8	0.5	1.4	6.3	0.4	294.4	0.3	0.4	0.2	1.3	0.2	0.5	0.3	0.4	0.2	0.4	0.3	0.5	0.3	0.1	0.0	7.9	0.0	1.1	0.3	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	1.9	23.9	0.0	0.1	1.3	0.0	406.9	0.1	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.8	0.0	1.1	0.0	1.6	0.0	0.0	0.0	0.0	22.4	1.7	10.9	0.0	17.4	0.0	0.0	103.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	18.1	1.5	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.1
FOXO6		ENSG00000204060	"Forkhead box O6"	A8MYZ6	1	41361922-41383590	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.9;Late spermatids: 6.0;Muller glia cells: 7.8;Skeletal myocytes: 6.4;Theca cells: 11.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 10.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.35e-2)"	"prognostic unfavorable (7.65e-6)"	"unprognostic (5.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.55e-9)"	"unprognostic (4.35e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.10e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.3	0.3	0.1	0.1	0.2	0.9	0.0	0.0	0.3	0.1	0.3	3.1	0.1	0.0	6.9	3.3	2.2	3.4	2.8	0.1	1.8	0.0	3.6	0.3	0.6	0.0	0.8	4.1	1.1	0.6	0.4	1.2	0.0	0.7	0.2	2.3	2.3	4.6	0.8	0.0	2.0	0.4	0.2	0.4	0.0	0.6	1.0	0.0	0.0	0.3	6.0	4.1	0.2	0.0	1.0	0.0	7.8	0.0	1.5	1.6	0.1	0.0	4.1	1.3	1.5	0.2	0.7	0.1	0.7	0.0	6.4	1.3	0.2	0.5	0.9	0.0	4.4	0.6	11.2	0.5	1.3
FXYD7		ENSG00000221946	"FXYD domain containing ion transport regulator 7"	P58549	19	35143250-35154302	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 275.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2;ovarian cancer: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 52.1"	"Group enriched"	"Detected in many"	23	"B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1"									HPA026916	Approved					NA	NA					"HPA026916: AB_1849217"	"unprognostic (1.25e-3)"	"unprognostic (8.73e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.95e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	1.9	0.4	97.1	1.7	118.1	0.6	1.1	24.2	275.3	4.0	19.7	2.1	0.6	1.9	0.0	0.4	0.9	0.4	0.6	135.5	72.8	0.4	1.1	1.1	2.8	92.2	60.8	115.4	1.0	0.2	0.0	2.1	0.1	96.0	1.0	0.3	1.6	0.5	0.3	2.7	1.2	2.0	0.2	45.4	2.8	1.0	1.3	88.8	0.2	0.5	0.1	1.6	0.8	3.1	169.6	0.6	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	1.8	0.0	0.2	0.3	0.1	0.2	0.6	0.0	0.1	0.0	5.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	2.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	15.0	0.0	9.5	19.0	23.7	17.2	0.1	14.6	7.5	13.8	0.6	52.1	0.1	1.3	7.5	4.9	97.1	118.1	24.2	275.3	135.5	72.8	92.2	60.8	115.4	96.0	45.4	88.8	169.6	1.1	0.0	1.3	7.2	8.0	2.0	0.1	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	1.8	0.0	0.0	14.0	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.4	42.0	0.2	0.1	1.1	0.0	0.0	1.3	0.1	0.7	0.2	0.1	1.7	12.9	0.0	0.0	0.0	4.4	0.2	1.2	0.7	3.6	9.4	0.2	1.5	0.0	3.5	6.2	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	6.6	0.7	1.1	3.1	5.0	0.1	1.1	0.3	19.2	0.0	0.0	0.0
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944362-86947506	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 106.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 127.1;Muller glia cells: 90.3;Skeletal myocytes: 213.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 30.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.2;ASC diff: 29.3;BJ hTERT+: 59.8;HSkMC: 41.1;RH-30: 91.1"	"Low region specificity"	"Detected in all"							"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"		NA	NA		27000	"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (1.96e-5)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (3.59e-2)"	52.2	6.4	4.0	16.7	4.4	0.2	38.6	3.8	4.4	26.2	13.7	21.0	2.2	106.3	15.3	5.9	61.3	10.5	20.5	3.4	3.3	12.3	2.2	7.9	6.9	4.0	4.0	3.1	45.5	11.2	1.9	8.5	22.3	4.2	22.8	2.3	3.4	13.2	9.7	12.3	21.6	9.4	43.8	3.7	3.7	16.4	1.8	4.0	7.2	16.1	9.3	3.1	22.7	27.4	7.1	0.0	0.0	7.5	44.2	29.3	10.9	0.8	8.8	59.8	2.9	2.6	0.0	0.1	0.0	0.5	15.8	0.3	0.6	0.0	0.3	1.2	5.2	17.8	0.0	25.0	0.0	14.9	0.1	0.7	41.1	6.3	1.0	5.3	0.0	0.0	0.9	0.0	0.0	12.6	0.0	0.0	0.4	9.5	0.3	0.1	9.6	91.1	0.0	0.4	0.0	1.0	4.0	12.9	0.0	14.1	4.8	0.1	0.2	0.1	13.0	3.6	0.9	3.0	0.0	0.0	0.0	0.4	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.4	3.8	4.4	3.4	3.3	4.0	4.0	3.1	4.2	3.7	4.0	7.1	15.8	0.0	0.6	2.0	0.4	25.9	7.5	10.9	10.2	8.3	3.9	28.3	5.5	0.0	3.1	14.7	10.4	21.5	7.8	0.1	9.8	0.5	0.1	2.4	36.6	5.6	0.0	0.4	1.2	0.4	3.7	127.1	1.1	2.0	0.0	2.1	22.9	0.3	5.8	5.0	2.6	0.3	0.0	1.0	15.4	0.9	32.3	2.2	17.8	1.9	0.2	90.3	7.2	8.5	4.4	0.2	0.0	12.4	2.1	4.5	0.0	2.6	0.7	3.2	39.5	213.7	15.4	0.3	1.3	1.0	12.5	4.5	2.1	0.8	0.2	0.4
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182928	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 29.2"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 839.8;Inhibitory neurons: 904.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.4;RPMI-8226: 1.8;U-138 MG: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA					"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.3	0.3	4.0	0.0	8.6	0.0	0.1	0.0	29.2	0.2	0.0	0.2	0.3	0.3	2.6	1.1	2.1	0.1	3.0	18.4	11.5	0.4	0.0	0.4	0.0	0.0	0.7	8.7	0.1	0.2	0.0	0.1	0.0	6.5	0.1	0.2	2.2	0.2	0.3	0.0	0.5	0.2	0.4	0.0	0.0	0.4	2.2	1.1	0.6	0.2	0.2	0.2	0.1	0.4	8.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.3	1.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	8.6	0.0	29.2	18.4	11.5	0.0	0.7	8.7	6.5	0.0	1.1	8.2	0.2	0.0	0.0	16.0	0.0	1.9	2.2	0.5	3.4	10.3	0.3	0.0	18.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2.1	17.2	0.3	0.1	0.5	0.0	0.0	839.8	0.2	0.0	2.7	0.0	0.7	0.0	3.3	0.0	0.3	0.1	1.7	904.7	0.0	0.0	0.3	0.4	15.1	0.9	0.1	0.0	15.9	0.0	15.6	0.0	27.6	65.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.9	0.0	0.0	5.4	8.2	10.0	0.2	0.4	0.0	0.0	0.0	0.1	0.3
H2AC18	"H2A.2, H2A/q, H2AFO, HIST2H2AA, HIST2H2AA3"	ENSG00000203812	"H2A clustered histone 18"	Q6FI13	1	149842188-149842736	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.5;Hofbauer cells: 1.0;Syncytiotrophoblasts: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 116.8;U-266/70: 472.4;U-266/84: 300.7"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.41e-2)"				"unprognostic (3.79e-1)"					"unprognostic (1.53e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.20e-1)"				46.4	38.1	5.7	16.7	7.7	177.3	47.6	7.0	18.7	89.2	40.6	40.0	11.5	14.0	7.8	80.2	50.9	14.7	52.1	6.3	37.3	73.4	75.3	154.0	12.8	16.0	11.4	4.9	55.1	24.2	0.1	31.7	22.0	11.1	202.2	3.5	0.0	47.3	6.6	43.0	89.4	32.0	5.6	12.9	128.6	60.3	118.4	11.5	15.3	31.3	3.8	2.3	43.1	137.0	9.6	14.7	0.0	1.1	0.0	11.1	7.8	0.0	29.8	12.3	17.3	14.5	0.3	7.3	7.5	20.5	11.7	0.7	4.6	1.6	5.5	2.0	15.3	0.0	3.7	31.7	8.8	11.4	0.0	7.9	55.0	9.9	4.2	4.8	0.0	4.5	0.0	43.6	116.8	6.0	21.6	0.0	28.9	0.0	30.1	31.4	6.1	0.0	47.8	7.4	11.8	2.7	1.2	50.4	10.1	1.6	0.0	41.2	12.8	10.1	7.8	58.3	1.5	2.6	472.4	300.7	11.5	26.3	59.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	7.7	7.0	18.7	6.3	37.3	16.0	11.4	4.9	11.1	12.9	11.5	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0
H2AC19	"H2A/r, HIST2H2AA4"	ENSG00000272196	"H2A clustered histone 19"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 26.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 1820.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 1820.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 98.8;U-266/70: 270.8;U-266/84: 249.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				40.5	28.0	41.6	10.2	33.1	21.1	40.5	56.9	31.6	101.1	39.2	36.2	10.9	10.1	0.0	67.3	45.6	6.9	29.0	29.0	49.8	52.3	58.8	141.7	3.8	53.1	29.4	17.5	53.7	13.8	3.0	27.5	4.8	32.2	157.6	1.0	6.2	41.5	0.0	30.5	81.2	32.2	0.0	45.0	125.6	64.9	110.8	41.6	9.7	29.3	2.6	1.4	47.8	125.3	114.2	14.9	41.0	4.2	9.4	0.0	0.0	12.9	31.6	0.0	0.0	0.0	26.4	13.9	0.0	36.4	0.0	10.0	23.0	0.0	0.0	0.0	20.4	53.9	5.4	35.5	15.5	0.0	5.2	27.4	0.0	0.0	0.0	0.0	9.7	0.0	18.7	32.9	61.2	0.0	85.0	18.5	5.6	15.7	75.7	31.8	14.3	6.4	20.1	0.0	5.9	37.8	16.1	98.8	21.2	9.1	5.3	38.5	8.9	0.0	6.9	71.4	14.1	4.5	270.8	249.5	20.8	0.0	26.9	11.6	314.7	206.9	388.5	34.8	121.2	35.8	72.9	30.4	32.6	135.6	93.1	22.8	21.6	1820.8	41.6	151.6	193.3	48.3	215.9	41.6	33.1	56.9	31.6	29.0	49.8	53.1	29.4	17.5	32.2	45.0	41.6	114.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0
H3C11	"H3.f, H3/f, H3FF, HIST1H3I"	ENSG00000275379	"H3 clustered histone 11"	P68431	6	27871845-27872346	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 1.3;brain: 5.0;choroid plexus: 3.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.1;MOLT-4: 4.0;NB-4: 2.8;REH: 4.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"		"unprognostic (1.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.48e-2)"		"unprognostic (2.39e-1)"		"unprognostic (1.18e-1)"				"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.29e-2)"	0.0	0.1	0.9	0.3	1.5	1.3	0.0	1.4	1.2	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	5.0	0.0	0.1	0.0	0.3	3.5	3.1	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.2	0.0	0.0	4.9	0.6	0.0	0.0	0.0	0.0	0.1	4.6	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.2	0.0	0.2	0.4	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.4	1.3	0.3	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.0	2.8	0.6	0.1	0.0	4.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.8	0.4	1.5	0.3	1.2	0.5	1.3	1.0	2.3	2.3	1.1	1.5	0.6	8.2	0.3	3.4	1.2	1.5	0.9	1.5	1.4	1.2	0.5	5.0	3.5	3.1	0.1	2.5	3.4	4.9	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H3C7	"H3/i, H3FI, HIST1H3F"	ENSG00000277775	"H3 clustered histone 7"	P68431	6	26250142-26250635	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.6;brain: 2.6;choroid plexus: 2.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 2.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"memory B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.3;U-266/84: 6.2"									"HPA042570, CAB070190"	Approved					NA	NA					"CAB070190: AB_10001790, HPA042570: AB_2678056"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.91e-6)"		"unprognostic (9.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"		"unprognostic (2.14e-1)"		"unprognostic (1.00e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-4)"	0.0	0.1	0.8	0.2	0.6	1.6	0.0	1.1	0.9	0.0	2.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.4	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.4	0.2	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	1.1	0.0	0.0	0.0	0.8	0.6	0.0	1.1	0.3	0.0	0.0	0.1	0.6	0.0	0.3	0.4	0.0	0.5	0.0	0.9	0.2	0.8	2.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.6	0.8	1.2	1.2	0.0	0.9	1.9	4.3	0.1	0.0	1.1	2.1	0.0	0.6	0.0	0.3	2.2	0.5	0.8	0.4	0.0	0.1	1.6	1.6	0.0	0.2	0.0	0.1	1.1	1.2	6.2	0.0	1.2	1.5	0.5	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.8	0.6	1.1	0.9	0.5	2.6	1.9	0.6	0.0	1.0	1.4	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
H4C3	"dJ221C16.1, H4/g, H4FG, HIST1H4C"	ENSG00000197061	"H4 clustered histone 3"	P62805	6	26103933-26104337	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"brain: 243.9"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 200.9;Cytotrophoblasts: 584.5;Extravillous trophoblasts: 700.1;Hofbauer cells: 264.1;Syncytiotrophoblasts: 220.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 243.9"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 39.5;PC-3: 21.4"									HPA042201	Supported					NA	Yes		25000000			"HPA042201: AB_2677898"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-4)"	"unprognostic (6.95e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (5.74e-6)"	"unprognostic (2.42e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.79e-3)"	0.2	0.2	27.5	0.9	55.1	5.0	0.2	243.9	34.5	0.4	1.6	1.0	0.3	0.6	0.0	0.7	0.5	0.1	0.1	22.5	39.6	0.6	0.6	0.2	2.1	30.7	41.5	18.0	0.4	0.4	0.1	0.2	0.4	43.1	0.2	1.1	0.5	1.8	0.3	0.1	0.3	0.5	0.0	26.0	1.0	0.4	0.6	39.1	3.7	1.2	0.0	1.7	0.8	0.1	41.1	2.3	2.1	0.8	3.3	0.0	0.4	0.0	1.3	1.0	0.7	1.6	3.3	0.6	0.8	1.0	0.4	0.9	1.2	2.5	0.7	0.6	1.9	39.5	1.5	4.5	5.0	1.0	1.8	1.3	1.7	0.0	0.5	0.0	0.0	0.9	0.6	2.3	1.6	0.6	1.1	8.9	4.4	2.1	1.5	21.4	2.5	1.2	3.7	1.4	0.2	2.2	1.4	1.1	1.5	0.9	0.9	1.0	5.4	0.6	2.3	2.4	1.1	1.9	3.1	3.2	4.4	1.4	3.3	1.2	605.5	279.8	218.0	343.5	117.8	331.0	645.7	432.0	285.4	218.9	559.1	496.9	378.6	509.7	325.0	128.7	317.6	322.8	2335.9	27.5	55.1	243.9	34.5	22.5	39.6	30.7	41.5	18.0	43.1	26.0	39.1	41.1	25.3	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	200.9	0.0	0.0	0.0	0.0	584.5	76.4	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	700.1	54.9	0.0	0.0	0.0	0.0	0.0	0.0	264.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	220.3	13.0	0.0	0.0	0.0
H4C6	"H4, H4/c, H4FC, HIST1H4F"	ENSG00000274618	"H4 clustered histone 6"	P62805	6	26240393-26240793	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 6.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 6.4;pons: 2.8;white matter: 4.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.5;REH: 1.9"									HPA042201	Supported					NA	NA		25000000			"HPA042201: AB_2677898"										"unprognostic (1.47e-1)"				"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"			0.0	0.0	0.4	0.0	0.4	0.9	0.0	0.4	6.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	1.1	0.7	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	4.5	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.5	3.0	2.4	2.3	5.5	3.9	4.0	3.8	6.9	3.2	2.3	10.7	2.1	2.0	6.4	1.1	1.5	0.4	0.4	0.4	6.4	0.7	0.2	0.7	0.8	0.0	2.8	1.0	1.1	4.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 9.1;Endometrial ciliated cells: 12.3;Granulosa cells: 10.5;Sertoli cells: 6.6;Squamous epithelial cells: 8.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.8;HDLM-2: 31.2;HEK 293: 33.0;SH-SY5Y: 27.3"	"Region enriched"	"Detected in single"	24	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	49	"medulla oblongata: 4.9;pons: 3.7;spinal cord: 6.0"	HPA053910			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053910: AB_2682305"	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	6.3	4.5	0.4	2.1	1.9	0.1	5.2	0.2	3.0	0.7	0.1	1.9	1.1	4.7	7.3	8.2	27.3	0.4	0.3	0.2	1.0	13.6	0.1	0.8	3.6	13.4	4.1	0.0	11.2	0.3	0.1	0.1	6.3	15.6	1.6	0.2	0.0	0.3	0.9	9.2	6.1	6.8	4.8	6.4	1.8	5.2	3.3	1.9	0.4	1.0	0.0	1.9	0.8	0.8	7.6	5.3	5.1	0.0	23.8	9.4	4.9	0.0	2.4	2.5	2.4	1.7	0.2	4.3	20.5	0.2	18.5	0.1	4.7	0.4	0.6	1.5	31.2	33.0	0.2	2.9	0.0	1.1	2.5	0.7	12.5	2.3	13.7	2.4	0.0	0.3	6.7	1.1	0.0	8.9	0.3	2.8	0.5	0.1	0.9	0.1	6.7	7.2	0.0	10.2	0.0	0.0	27.3	3.8	1.2	13.7	1.1	18.0	1.2	0.0	12.0	6.9	1.0	12.8	5.3	6.0	10.6	0.7	2.3	12.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.2	3.0	0.2	1.0	13.4	4.1	0.0	15.6	6.4	1.9	7.6	1.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	9.1	0.0	1.4	3.4	0.5	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.9	0.0	4.1	12.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.6	0.1	0.0	10.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.0	2.9	3.1	0.2	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.1	0.0	1.5	3.7	0.0	0.1	2.9	0.0	0.0	6.6	3.9	3.6	2.7	0.5	8.2	0.0	0.3	1.6	2.7	0.1	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54033050-54035361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5;fallopian tube: 4.2"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.6"	"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.5;spinal cord: 2.1"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.0	0.9	0.0	0.1	0.3	0.0	1.0	0.0	0.5	0.0	0.0	0.2	0.2	0.3	2.8	0.9	4.2	0.1	0.0	0.0	0.1	0.7	0.0	0.1	0.2	2.8	0.6	0.0	2.6	0.0	0.0	0.0	0.8	3.5	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.7	1.5	1.9	0.0	2.1	1.4	0.4	0.0	0.2	0.0	0.0	0.1	0.1	1.3	0.8	1.9	0.0	7.1	4.0	4.8	0.0	0.4	0.3	0.8	0.6	3.0	0.4	0.0	0.5	2.1	0.0	1.1	0.1	0.0	0.3	2.4	2.4	0.0	1.0	0.1	0.1	0.0	0.1	4.5	0.4	3.3	0.4	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	7.6	0.5	0.2	3.9	0.9	1.4	0.0	0.0	1.2	0.7	2.6	0.2	0.0	0.0	0.0	0.1	0.1	2.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.1	2.8	0.6	0.0	3.5	1.9	0.4	1.3	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.2	0.0	0.3	0.9	0.1	0.0	0.0	1.8	0.0	0.1	0.8	0.0	1.9	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	2.5	3.2	1.0	2.2	0.9	0.3	0.1	1.0	0.1	0.0
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 42.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.6;Collecting duct cells: 9.2;Distal tubular cells: 15.6;Early spermatids: 14.4;Endothelial cells: 6.5;Theca cells: 4.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HSkMC: 11.2;RPTEC TERT1: 12.0;SCLC-21H: 14.5;SH-SY5Y: 10.1"	"Region enriched"	"Detected in single"	35	"pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 4.1;pons: 1.1;spinal cord: 3.0"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	3.2	2.3	1.6	0.8	1.5	0.0	2.8	0.3	1.0	3.1	0.1	0.9	0.3	6.9	42.5	0.7	6.9	0.6	0.1	0.2	0.7	8.0	0.0	0.2	0.8	8.2	1.7	0.1	5.5	0.2	0.1	0.0	0.1	5.9	1.8	0.6	0.0	0.5	7.1	0.7	0.9	0.8	4.1	4.9	0.7	0.3	1.7	2.3	0.2	0.4	0.0	0.2	1.0	2.0	5.2	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.7	0.2	0.0	0.4	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.9	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	12.0	0.9	14.5	10.1	0.2	0.1	4.6	0.2	0.0	0.0	1.0	0.2	0.2	1.5	0.8	0.0	0.2	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.3	1.0	0.2	0.7	8.2	1.7	0.1	5.9	4.9	2.3	5.2	6.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.3	15.6	0.0	14.4	0.1	2.1	6.5	1.2	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	3.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.3	4.5	0.0	0.1	0.3	2.9	0.0	0.0	0.0	1.3	1.1	0.8	0.5	0.0	1.3	0.0	0.1	4.7	0.6	0.1
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151550-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 24.6;epididymis: 28.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Collecting duct cells: 16.5;Early spermatids: 3.7;Endothelial cells: 3.6;Leydig cells: 4.7;Proximal tubular cells: 6.5;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Group enriched"	"Detected in many"	4	"medulla oblongata: 9.9;pons: 5.6;spinal cord: 7.9;white matter: 7.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;HEK 293: 39.7;RPTEC TERT1: 29.6;SK-MEL-30: 11.0"	"Region enriched"	"Detected in single"	46	"pons and medulla: 4.5"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 6.0;spinal cord: 7.8"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	6.9	8.4	1.2	1.6	1.6	0.0	7.4	0.0	0.7	6.0	0.0	6.1	1.0	24.6	28.2	1.1	14.4	1.5	0.4	0.0	0.3	16.2	0.0	0.4	1.7	9.9	1.0	0.0	15.2	0.6	0.1	0.0	0.4	5.6	2.9	2.0	0.0	0.7	11.2	2.8	2.5	6.3	9.8	7.9	7.3	1.0	3.0	1.8	0.2	1.2	0.5	0.4	2.7	4.1	7.4	0.5	0.3	0.0	0.0	2.0	3.0	0.0	0.2	0.9	0.1	1.1	0.9	0.0	0.0	16.6	3.4	0.7	0.2	2.6	0.0	0.4	0.0	39.7	0.5	0.0	0.0	0.5	0.0	0.1	9.3	2.6	0.0	0.5	0.2	6.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	29.6	4.1	2.5	4.2	0.6	0.0	11.0	0.6	0.0	0.0	5.0	0.5	0.2	2.9	2.1	0.0	0.1	0.0	2.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.0	0.7	0.0	0.3	9.9	1.0	0.0	5.6	7.9	1.8	7.4	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	3.7	0.1	1.1	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	2.6	4.7	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	3.0	0.0	0.1	0.3	6.5	0.0	0.0	6.6	0.6	0.9	0.3	0.4	0.0	0.6	0.0	0.1	3.0	1.3	0.0
IGKV2D-40		ENSG00000251039	"Immunoglobulin kappa variable 2D-40"	P01614	2	89851791-89852497	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.3"	"Cell type enriched"	"Detected in some"	489	"Plasma cells: 1517.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 30.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	494	"memory B-cell: 134.9;naive B-cell: 96.8"	"Lineage enriched"	"Detected in single"	575	"B-cells: 134.9"	"Cell line enhanced"	"Detected in single"		"Daudi: 3.7"														"Immunoglobulin genes"	NA	NA		1900000000				"prognostic favorable (5.01e-4)"	"unprognostic (1.16e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.04e-2)"		"prognostic favorable (9.78e-7)"		"unprognostic (1.87e-1)"		"unprognostic (2.29e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.25e-1)"	1.7	1.5	0.0	21.2	0.0	14.9	13.6	0.0	0.1	10.1	0.0	16.8	7.0	3.1	0.0	35.9	14.5	7.8	2.0	0.0	0.0	1.0	2.9	19.7	66.3	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	22.0	0.0	32.6	21.9	0.0	0.0	31.4	1.6	0.0	45.2	38.9	0.4	0.0	26.6	5.7	0.0	124.3	34.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	134.9	0.0	0.0	0.0	96.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1517.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGLV3-22		ENSG00000211661	"Immunoglobulin lambda variable 3-22"	A0A075B6J6	22	22704265-22704822	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 2.6;lymphoid tissue: 9.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	72	"memory B-cell: 6.6;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	78	"B-cells: 7.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		1100000000											"unprognostic (2.00e-1)"						"unprognostic (9.93e-3)"	"unprognostic (3.73e-1)"			0.0	0.7	0.0	1.0	0.0	1.5	2.6	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.8	0.3	0.0	0.0	1.5	0.0	0.0	1.4	0.8	0.3	0.0	9.5	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL4I1	FIG1	ENSG00000104951	"Interleukin 4 induced 1"	Q96RQ9	19	49889654-49929539	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 18.5;testis: 27.0"	"Group enriched"	"Detected in many"	5	"Langerhans cells: 295.1;monocytes: 682.5"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 35.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 103.4"	"Group enriched"	"Detected in many"	6	"monocytes: 36.8;T-cells: 103.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;HDLM-2: 62.4;Karpas-707: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045598	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Nucleoplasm, Cytosol"		"HPA045598: AB_10969138"	"unprognostic (6.23e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.23e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-3)"	1.6	0.6	2.3	18.5	0.5	4.2	0.9	0.8	0.8	1.1	0.7	1.7	4.1	1.6	0.2	0.6	4.0	2.0	0.5	0.5	1.1	3.7	1.2	2.4	9.4	1.8	0.6	0.3	0.5	0.7	0.2	0.6	2.0	1.7	0.8	1.4	0.1	0.9	0.5	0.3	1.3	2.7	1.5	2.1	4.1	3.1	27.0	1.4	3.4	0.5	0.2	6.8	4.6	0.5	2.5	1.0	1.2	0.8	0.7	0.0	0.8	0.3	0.5	2.0	1.4	2.1	0.7	1.9	3.5	34.3	0.4	2.9	0.5	0.4	0.0	0.2	62.4	0.2	1.6	0.1	0.5	0.1	1.2	12.3	1.0	0.4	0.6	0.1	0.4	2.6	0.4	0.4	47.3	0.1	0.4	0.7	2.1	0.4	0.9	0.1	1.0	0.9	3.6	2.5	3.2	0.7	0.8	0.5	0.9	0.5	0.2	0.4	2.8	2.9	7.1	1.0	0.1	1.0	4.1	9.7	2.0	1.0	0.5	0.7	0.3	22.0	0.3	6.4	36.8	103.4	0.4	13.2	11.5	11.6	0.2	0.3	0.1	0.5	1.3	5.3	1.3	0.7	8.8	2.3	0.5	0.8	0.8	0.5	1.1	1.8	0.6	0.3	1.7	2.1	1.4	2.5	0.8	0.0	0.0	0.0	3.6	9.7	0.6	9.8	0.0	0.1	1.2	1.3	0.5	0.0	5.5	3.7	0.0	0.4	1.0	0.2	0.0	3.5	75.4	2.9	0.6	6.7	0.0	0.0	0.4	4.0	0.7	1.3	0.5	2.1	1.3	0.1	1.1	0.2	97.4	0.0	0.4	0.3	6.1	3.0	295.1	18.4	0.3	38.8	3.6	1.9	682.5	0.1	1.0	0.0	0.4	0.5	0.1	0.4	0.7	1.4	0.3	2.7	1.6	0.2	0.0	0.2	2.5	45.2	3.6	0.4	8.2	0.8	6.3	0.0	0.2	2.1
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain ArfGEF 3"	Q9UPP2	12	66767-178455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 39.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.8;Excitatory neurons: 81.6;Horizontal cells: 114.4;Inhibitory neurons: 76.2;Spermatocytes: 48.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 7.1;U-266/70: 9.1;U-266/84: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039025			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	4.1	0.9	4.2	0.5	7.7	0.7	1.4	17.2	39.5	2.1	0.0	0.5	0.4	2.5	0.3	0.3	3.3	1.5	1.3	10.7	4.7	2.0	0.2	2.0	0.4	4.9	2.9	5.5	1.6	0.8	0.0	8.7	0.9	9.5	1.2	0.2	7.5	0.3	2.9	1.0	0.2	0.5	1.2	1.4	0.4	0.5	1.4	8.0	3.2	0.4	0.4	0.1	1.0	1.6	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	2.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.2	7.7	17.2	39.5	10.7	4.7	4.9	2.9	5.5	9.5	1.4	8.0	16.0	9.9	3.2	0.0	1.6	0.0	0.3	0.0	0.0	0.6	50.8	0.1	0.1	2.2	0.0	0.0	0.0	8.4	0.0	2.1	0.1	0.0	0.0	0.8	0.1	0.9	3.3	0.0	0.0	81.6	0.0	0.0	1.3	0.0	0.2	2.5	0.1	2.2	0.4	1.6	114.4	76.2	0.0	0.0	0.8	0.6	4.3	0.6	1.4	0.0	7.5	0.1	6.6	1.0	4.5	1.4	0.2	0.0	0.0	0.0	0.1	0.7	5.2	0.0	16.1	0.0	0.5	1.1	48.6	21.8	0.1	0.1	0.0	0.5	0.1	0.2	0.1
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 36.0;lymphoid tissue: 15.9;skeletal muscle: 13.5"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 60.1;Inhibitory neurons: 55.0;Theca cells: 21.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 36.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.5;RPMI-8226: 1.8;SCLC-21H: 3.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.8"	HPA059880	Uncertain					NA	NA					"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	0.4	0.1	2.0	0.1	6.7	0.1	0.3	1.7	36.0	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.6	0.2	0.7	4.3	0.7	0.0	0.1	0.3	0.0	4.7	0.4	5.7	5.0	0.1	0.0	8.7	0.3	5.9	0.1	0.0	0.4	0.2	0.0	13.5	0.1	0.2	0.0	0.0	15.9	0.5	0.9	0.6	0.0	0.1	8.3	0.0	0.2	0.2	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	1.8	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.7	1.7	36.0	4.3	0.7	4.7	0.4	5.7	5.9	0.0	0.6	12.0	0.0	0.0	0.0	3.6	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	60.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.3	0.0	3.5	2.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.1	1.1	0.3	1.0	0.0	0.0	0.0	0.1	21.2	0.0	0.0
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 259.4;esophagus: 95.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 575.5;CAPAN-2: 1346.5"	"Region enhanced"	"Detected in all"		"pons and medulla: 167.8"	"Region enhanced"	"Detected in many"		"spinal cord: 371.7"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		10000000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.1	0.0	91.6	0.0	135.3	0.0	7.3	172.1	120.8	25.4	59.3	0.1	0.2	1.5	0.4	95.0	29.1	3.5	0.0	82.8	115.3	19.8	0.0	0.0	0.0	188.9	143.3	69.9	0.9	0.0	0.0	0.7	0.0	173.7	0.1	0.0	0.0	15.9	2.2	0.0	7.2	0.0	0.0	167.0	5.8	0.1	0.9	130.7	1.5	0.0	0.0	36.8	0.0	27.6	259.4	575.5	0.0	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.7	1346.5	0.0	8.1	0.0	0.6	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	131.0	2.2	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	5.6	18.2	1.0	1.9	0.0	1.1	46.3	0.0	1.3	0.0	0.4	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.6	135.3	172.1	120.8	82.8	115.3	188.9	143.3	69.9	173.7	167.0	130.7	259.4	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	0.0	23.9	16.1	0.3	0.0	1.7	11.0	0.0	0.1	0.4	0.0	0.0	0.1	2.3	0.6	7.5	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	87.9	7.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	1.6	0.0	0.3	0.1	0.0	0.0	2.4
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976468-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 95.4;skin 1: 190.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		3700000	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	3.4	0.1	8.9	0.1	7.3	0.3	11.4	1.3	7.5	9.5	1.4	0.1	0.5	0.7	0.2	95.4	16.4	1.3	0.2	6.4	2.0	11.7	0.1	3.2	0.0	5.4	2.5	5.7	0.1	0.1	0.3	0.7	0.0	4.7	0.1	0.0	0.1	21.8	0.2	1.0	190.7	0.0	0.2	2.4	0.8	0.3	0.4	6.2	0.9	0.2	0.0	11.0	0.0	31.2	4.9	5.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	8.0	0.0	1.1	0.0	0.1	31.7	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	8.9	7.3	1.3	7.5	6.4	2.0	5.4	2.5	5.7	4.7	2.4	6.2	4.9	0.0	6.4	1.1	0.0	0.0	5.0	0.1	0.5	4.6	0.0	9.4	10.4	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	5.9	10.7	0.0	0.1	0.0	0.1	2.7
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 118.9;skin 1: 85.7;vagina: 47.6"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 66.0;Suprabasal keratinocytes: 180.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 88.3;CAPAN-2: 112.2;HaCaT: 83.5"	"Region enriched"	"Detected in all"	5	"hippocampal formation: 36.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		3200000	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	2.7	0.0	0.1	0.0	0.1	0.0	8.5	0.8	0.7	12.1	0.2	0.0	0.0	0.9	0.4	118.9	13.3	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	17.3	0.1	0.7	85.7	0.0	0.2	0.1	0.2	0.1	1.3	0.1	1.1	0.5	0.0	9.6	0.0	47.6	0.5	88.3	0.0	0.0	0.6	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.7	112.2	0.0	2.2	0.0	0.1	83.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	10.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.7	0.1	0.3	0.5	0.1	0.0	0.4	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.3	66.0	0.0	0.4	14.8	0.0	13.0	15.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.7	11.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	5.0	1.8	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	2.8	6.2	21.1	180.1	0.0	0.2	0.0	0.2	0.1
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526540	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 12.9;seminal vesicle: 8.0"	"Cell type enriched"	"Detected in some"	8	"Basal prostatic cells: 8.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		3800000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.0	0.0	0.0	12.9	1.9	0.0	0.5	0.9	0.3	0.0	0.0	0.1	0.0	0.3	0.3	0.3	0.0	0.1	0.0	1.9	0.2	0.3	0.0	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.9	0.9	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205455954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 14.9;testis: 55.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4203.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 39.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.9"	HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.0	0.3	0.3	0.0	0.2	0.0	0.3	2.6	0.6	0.2	0.0	0.0	0.7	0.3	14.9	0.8	1.6	0.1	0.0	0.1	0.4	1.0	0.0	0.4	0.0	1.9	1.3	0.1	0.6	0.0	0.0	0.5	0.1	2.7	0.2	0.0	1.4	1.9	0.4	0.0	0.3	0.2	0.1	0.2	0.0	0.9	55.5	2.7	0.0	0.6	0.0	0.8	0.1	0.6	1.4	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	39.6	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	2.6	0.6	0.1	0.4	1.9	1.3	0.1	2.7	0.2	2.7	1.4	0.0	0.0	2.6	1.0	0.0	0.0	1.2	8.4	4.6	12.1	1.6	0.9	0.0	0.0	6.4	0.0	4.2	0.1	0.0	0.0	0.0	1.9	968.7	0.8	0.1	0.7	0.0	0.0	1.4	0.7	0.1	0.2	0.0	1.1	0.0	0.6	1.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	4203.7	12.8	1.1	0.0	0.0	0.0	1.3	0.0	1.0	0.5	6.8	0.1	13.9	0.0	8.5	0.3	4.3	1.6	0.7	6.6	0.0	0.4	15.6	9.7	0.7	0.0	0.4	0.1	0.1	0.3	4.4
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193799-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;pituitary gland: 17.7"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 9.0;Cardiomyocytes: 10.5;dendritic cells: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"gdT-cell: 15.4;memory CD8 T-cell: 9.1;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"T-cells: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;CAPAN-2: 15.4;HaCaT: 8.3;HeLa: 3.9"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 24.4"	"Low region specificity"	"Detected in many"			HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.0	0.2	2.2	0.4	4.7	1.5	5.1	9.4	3.5	3.0	0.4	1.4	0.1	1.2	2.2	5.1	8.9	6.3	8.3	0.9	29.6	0.8	2.1	3.4	0.8	12.5	6.7	0.2	1.8	0.2	0.0	17.7	0.3	11.0	5.9	0.7	0.0	5.4	1.4	0.3	4.0	1.3	0.3	5.1	6.8	0.6	7.2	9.6	0.3	5.1	0.5	0.3	2.9	3.8	5.5	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.0	0.0	1.7	9.1	0.0	0.0	0.7	4.8	0.0	0.4	0.0	0.0	0.5	3.4	2.2	4.7	9.4	3.5	0.9	29.6	12.5	6.7	0.2	11.0	5.1	9.6	5.5	0.1	0.0	0.0	2.6	0.2	1.3	3.6	0.5	23.3	0.0	1.5	9.0	10.5	0.0	0.6	0.0	0.0	0.9	6.0	0.8	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.4	1.0	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.8	1.6	0.0	0.6	0.3	4.1	0.0	0.2	0.0	1.9	0.0	0.0	4.1	0.0	0.2	0.0	0.7	0.0	2.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	5.6	5.5	3.3	0.3	0.1	0.8	4.3	0.0	2.7	0.9
LPAR3	"Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3"	ENSG00000171517	"Lysophosphatidic acid receptor 3"	Q9UBY5	1	84811602-84893206	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 15.6;Cardiomyocytes: 31.2;Endometrial ciliated cells: 36.9;Glandular and luminal cells: 51.6;Respiratory ciliated cells: 18.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 19.0;HBEC3-KT: 22.2;hTCEpi: 25.0;NTERA-2: 20.3;PC-3: 19.0;SK-MEL-30: 24.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA013421			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA013421: AB_1847990"	"unprognostic (2.85e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.31e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.13e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	0.0	1.4	2.3	0.2	3.1	0.3	0.9	2.0	5.1	10.5	1.9	0.5	0.1	2.9	6.0	7.1	36.7	0.6	9.5	3.4	2.3	0.0	0.1	1.5	0.2	8.1	2.7	2.5	1.5	10.5	0.1	0.1	1.4	2.3	13.5	0.6	0.1	5.7	1.0	0.4	4.0	0.1	0.1	1.8	0.1	0.3	10.5	3.5	2.3	0.2	0.0	1.0	5.1	5.3	3.1	0.7	0.1	0.0	0.1	0.0	0.0	0.7	0.3	1.7	1.4	1.1	0.0	0.0	0.1	0.3	0.0	0.0	0.4	19.0	22.2	1.4	0.2	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	25.0	4.8	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	20.3	0.0	19.0	0.0	0.0	0.0	0.0	5.8	1.3	1.1	0.0	0.5	24.1	1.4	0.0	2.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.3	3.1	2.0	5.1	3.4	2.3	8.1	2.7	2.5	2.3	1.8	3.5	3.1	0.0	0.0	0.5	12.7	0.0	3.4	15.6	5.6	7.4	0.0	1.8	3.7	31.2	0.0	6.5	0.0	0.0	0.5	0.1	0.3	0.0	0.0	2.9	36.9	3.6	0.5	0.0	0.0	0.2	1.3	0.0	1.2	0.0	51.6	0.0	0.5	0.4	0.0	0.4	0.0	0.1	0.2	2.0	0.0	1.5	2.4	0.6	0.7	1.8	1.9	0.0	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	13.1	0.0	0.0	18.7	0.0	0.0	0.0	1.2	0.7	3.4	7.7	9.1	0.1	1.5	0.6	0.4	13.5
LYG2	LYGH	ENSG00000185674	"Lysozyme g2"	Q86SG7	2	99242246-99255282	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.9;retina: 3.5;skin 1: 5.7;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.7;Cone photoreceptor cells: 14.6;Excitatory neurons: 19.6;Horizontal cells: 15.2;Inhibitory neurons: 17.5;Rod photoreceptor cells: 29.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enhanced"	"Detected in some"		"cerebellum: 4.9"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.7;U-937: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039179	Uncertain				"Secreted in other tissues"	NA	NA					"HPA039179: AB_10794633"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-5)"	"unprognostic (1.40e-3)"	"unprognostic (1.08e-13)"	"unprognostic (9.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.24e-3)"	0.1	0.1	0.2	0.1	0.4	0.5	0.0	4.9	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.3	0.0	1.8	0.1	0.0	3.5	0.3	0.0	0.3	5.7	0.1	0.0	0.0	0.2	0.2	1.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.4	0.4	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.3	0.9	0.2	0.0	1.0	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	1.0	0.2	0.6	0.3	0.0	1.2	0.2	0.6	0.4	1.1	0.3	0.5	0.1	0.0	0.0	0.0	0.4	0.3	1.7	0.6	0.6	0.4	0.1	0.4	0.2	0.8	0.1	0.3	2.5	0.4	0.0	0.2	0.1	0.3	0.0	0.2	0.6	0.8	0.4	0.0	1.1	0.3	0.3	0.1	0.2	0.0	0.9	0.1	0.0	0.2	0.4	4.9	0.9	0.6	0.2	0.3	0.3	0.1	1.8	0.0	0.2	0.8	0.9	0.0	0.0	5.5	1.2	0.6	0.5	0.3	0.0	13.7	0.8	0.9	0.3	5.7	0.1	0.0	14.6	0.9	1.6	0.1	0.0	0.1	6.1	0.6	0.9	0.7	0.0	0.0	19.6	0.0	0.2	0.8	0.0	0.3	0.0	0.5	1.1	0.0	0.2	15.2	17.5	0.0	0.0	0.9	0.3	2.2	0.0	0.2	1.8	0.0	0.2	6.9	4.1	7.5	8.9	0.1	0.0	0.7	0.0	0.7	0.3	0.3	0.0	29.9	0.0	2.0	0.9	1.8	1.6	0.0	0.4	0.3	0.9	0.2	0.4	0.1
LYPD1	"LYPDC1, MGC29643"	ENSG00000150551	"LY6/PLAUR domain containing 1"	Q8N2G4	2	132643286-132671579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3;fallopian tube: 54.0;pituitary gland: 34.0"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 73.8;Exocrine glandular cells: 74.5;monocytes: 62.0;Oligodendrocyte precursor cells: 28.1;Pancreatic endocrine cells: 43.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 57.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 41.6;HUVEC TERT2: 32.7;SK-MEL-30: 36.5;U-251 MG: 65.9;WM-115: 140.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068333			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA068333: "	"unprognostic (9.25e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.60e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	0.5	0.8	25.9	0.3	25.1	0.4	0.8	18.4	25.6	0.2	13.2	6.1	0.1	0.9	0.2	1.5	54.0	1.3	0.5	21.9	26.8	5.9	1.0	1.0	0.6	25.1	24.7	18.1	1.3	5.2	0.3	34.0	0.0	23.1	0.7	0.2	1.6	5.5	0.1	0.3	0.3	1.6	0.6	26.7	0.3	0.9	0.7	26.6	2.3	0.9	0.1	1.0	0.8	0.6	31.3	0.4	8.6	11.6	0.2	0.0	0.0	0.0	1.9	1.5	6.3	1.4	0.6	1.1	0.0	18.3	5.1	3.0	7.2	0.0	0.0	2.9	0.1	1.8	0.0	4.0	0.0	0.0	0.0	0.2	0.0	0.1	41.6	0.0	1.7	32.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	11.1	0.2	3.3	0.0	0.0	0.0	15.1	0.2	1.1	2.3	1.8	0.2	36.5	26.8	0.1	0.3	1.5	0.7	17.4	5.9	65.9	0.1	0.0	0.1	10.0	0.0	140.5	0.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	25.1	18.4	25.6	21.9	26.8	25.1	24.7	18.1	23.1	26.7	26.6	31.3	0.7	0.0	0.0	8.1	0.2	0.1	0.1	0.4	0.0	1.6	2.0	0.9	0.2	2.8	0.2	5.5	0.0	0.0	0.0	0.5	1.9	73.8	5.6	1.4	0.1	0.2	1.8	0.0	0.8	74.5	0.0	2.2	0.0	0.9	0.0	0.1	0.4	0.0	0.1	15.2	4.7	0.0	0.0	0.8	0.7	9.3	4.1	0.1	0.0	0.0	62.0	1.4	0.0	28.1	4.4	43.4	0.0	0.0	0.0	0.1	0.1	4.8	0.3	0.8	0.0	0.2	3.9	2.6	2.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752532	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"esophagus: 350.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 97.0;Club cells: 378.7;Ionocytes: 71.2;Respiratory ciliated cells: 77.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9;ovarian cancer: 46.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	13	"non-classical monocyte: 440.1"	"Lineage enriched"	"Detected in many"	22	"monocytes: 440.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HaCaT: 2.8;OE19: 1.9"	"Low region specificity"	"Detected in many"							HPA028599	Uncertain				"Intracellular and membrane"	NA	NA					"HPA028599: AB_10603777"		"prognostic favorable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favorable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.3	7.2	0.0	0.0	0.0	0.0	0.0	350.6	0.3	0.2	2.5	0.1	0.0	0.0	1.3	1.6	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.0	0.0	27.2	0.0	0.1	28.1	0.1	0.0	0.0	0.2	23.4	0.0	0.1	2.5	0.0	0.0	26.5	0.0	48.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	33.7	0.4	2.0	0.1	0.2	20.1	0.0	0.2	0.1	0.0	0.0	440.1	1.6	0.1	10.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	97.0	0.0	0.0	0.1	0.0	0.0	0.0	378.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	5.7	0.4	0.4	0.0	0.0	0.0	71.2	1.3	0.0	0.1	0.0	25.3	0.0	0.0	11.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.0	0.0	0.0	22.3	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.2
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 87.0;stomach 1: 41.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7;Gastric mucus-secreting cells: 87.7;Inhibitory neurons: 77.8;Late spermatids: 118.5;Suprabasal keratinocytes: 69.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 64.8;LHCN-M2: 102.3;NB-4: 34.7;RT4: 54.7;SK-BR-3: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049239	Uncertain				"Intracellular and membrane"	NA	NA					"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.2	0.3	3.4	0.4	2.6	0.2	16.5	1.6	5.5	2.9	1.7	1.7	2.7	0.9	1.2	4.1	23.6	37.6	0.0	4.4	3.3	7.5	0.9	1.7	0.4	2.4	4.5	2.4	0.4	12.4	16.2	0.4	0.9	2.4	11.2	3.4	1.0	5.9	15.3	0.2	87.0	1.2	0.3	1.9	2.8	41.6	34.4	6.1	0.3	0.2	0.0	1.9	14.4	6.3	2.3	1.4	0.0	0.0	1.5	0.0	0.1	0.1	8.0	1.5	6.6	2.5	1.0	0.0	0.0	0.0	64.8	0.0	14.0	1.5	1.3	20.6	0.0	7.4	0.0	1.9	0.0	0.2	0.0	0.1	0.6	21.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	102.3	24.3	0.0	34.7	2.0	14.6	0.3	0.0	0.4	4.3	3.2	54.7	3.9	0.1	0.4	32.1	0.0	6.3	4.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	13.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	2.6	1.6	5.5	4.4	3.3	2.4	4.5	2.4	2.4	1.9	6.1	2.3	0.5	0.0	2.0	2.3	5.5	29.8	21.0	30.6	6.2	0.0	23.4	17.1	1.4	42.9	23.9	46.0	0.0	0.1	0.1	4.0	7.9	12.4	245.7	5.2	0.3	1.0	2.4	2.7	4.6	19.1	0.7	0.8	87.7	5.7	0.0	0.4	0.0	0.1	0.1	0.0	77.8	3.9	8.2	0.0	2.8	118.5	2.1	0.4	5.4	0.0	0.6	0.0	0.0	0.0	0.4	30.9	6.0	0.0	4.5	40.6	5.7	0.2	21.4	0.0	0.0	0.0	1.3	4.2	1.7	3.5	69.0	0.3	1.1	0.0	3.5	53.7
MAMSTR	"FLJ36070, MASTR"	ENSG00000176909	"MEF2 activating motif and SAP domain containing transcriptional regulator"	Q6ZN01	19	48712725-48719725	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 32.7;skeletal muscle: 89.8;tongue: 22.8"	"Cell type enhanced"	"Detected in many"		"Theca cells: 10.1"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.2;RH-30: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049765			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049765: AB_2680870"	"unprognostic (6.00e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.50e-3)"	"unprognostic (4.34e-4)"	"unprognostic (2.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.39e-2)"	2.9	32.7	1.6	0.8	1.5	0.3	1.8	7.3	3.7	5.6	0.0	2.0	0.6	8.1	1.5	3.6	8.0	1.0	3.9	2.0	0.2	1.5	0.4	1.5	0.6	0.8	0.7	1.8	8.8	1.9	3.0	3.9	1.6	3.2	2.4	0.8	0.5	2.9	1.9	89.8	2.1	1.3	4.7	0.1	6.2	1.6	9.3	0.6	0.5	1.2	22.8	0.6	2.1	4.6	1.1	0.5	1.3	1.4	3.5	2.7	4.5	1.3	4.8	3.8	2.3	3.6	1.4	0.9	0.7	0.2	4.4	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	0.6	7.2	1.4	0.1	0.9	2.8	0.9	3.2	0.4	3.1	0.8	1.3	0.3	0.9	1.5	0.6	1.1	0.5	0.1	1.1	1.0	1.3	16.6	0.4	0.2	0.3	1.5	2.8	0.7	0.3	0.3	0.3	0.5	0.0	0.3	4.7	0.8	3.8	0.6	1.0	0.6	0.5	1.7	0.5	0.9	0.0	0.2	0.5	1.6	0.4	1.0	1.3	1.7	1.6	0.4	2.1	1.6	1.5	0.2	0.3	0.4	1.3	0.8	0.3	1.6	1.5	7.3	3.7	2.0	0.2	0.8	0.7	1.8	3.2	0.1	0.6	1.1	2.4	0.0	0.0	2.6	1.3	0.9	1.8	1.5	4.6	1.8	1.4	2.2	2.9	0.0	2.3	1.8	2.1	0.8	0.5	0.6	5.9	1.7	0.8	0.8	3.5	3.8	0.0	1.3	2.9	1.0	2.9	4.9	1.1	1.6	0.0	6.1	4.6	0.3	1.1	0.0	2.0	0.7	2.0	0.3	2.2	1.7	5.6	1.6	7.2	0.0	1.2	5.3	2.1	1.5	1.2	0.5	0.0	6.0	1.5	0.6	1.1	0.6	0.4	2.9	0.0	5.1	4.7	0.7	1.6	2.4	0.9	1.0	1.8	10.1	0.8	1.6
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716340-143722458	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 46.1;fallopian tube: 47.1"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 62.5;Respiratory ciliated cells: 107.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.6;HeLa: 20.7;MCF7: 14.3;T-47d: 14.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.8	0.1	7.8	0.2	5.4	0.0	1.9	3.8	8.2	4.2	46.1	0.9	0.3	2.5	2.4	1.1	47.1	0.2	0.4	5.3	6.9	6.9	0.3	12.2	0.4	9.0	10.1	3.4	0.9	4.4	9.5	7.0	0.3	7.3	2.2	0.2	0.0	2.2	1.7	0.1	4.0	0.8	0.4	7.9	0.7	0.8	11.5	4.3	1.1	16.3	0.0	0.2	0.5	2.1	2.9	0.4	0.6	1.9	0.0	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.5	9.6	0.0	1.6	0.0	0.0	5.5	0.1	0.2	0.0	1.0	2.0	0.0	20.7	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.2	3.4	0.0	0.0	14.3	0.0	0.0	2.5	1.2	1.2	0.0	3.7	0.5	1.0	1.6	3.6	5.1	0.0	3.3	0.0	0.2	14.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	5.4	3.8	8.2	5.3	6.9	9.0	10.1	3.4	7.3	7.9	4.3	2.9	0.1	0.0	6.4	0.0	0.1	0.4	0.3	5.7	0.0	0.0	1.0	1.3	0.7	0.0	11.8	0.0	0.0	0.0	0.0	0.1	0.0	1.1	13.8	62.5	0.5	0.3	0.0	0.0	0.2	0.0	0.7	0.8	0.0	1.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.6	16.2	0.0	0.0	11.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	1.4	107.9	0.0	0.0	0.4	2.2	2.3	0.9	0.0	0.3	0.1	0.2	0.1	0.3	0.1
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371062-60372775	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 3.2;fallopian tube: 3.1;retina: 3.9"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 7.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	70	"fHDF/TERT166: 94.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 10.2"	HPA016719	Uncertain					NA	NA					"HPA016719: AB_1853617"	"unprognostic (2.29e-1)"			"unprognostic (5.31e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.41e-1)"		"unprognostic (1.35e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.59e-1)"		0.0	0.2	1.9	0.0	2.7	0.0	0.2	0.4	1.6	0.0	0.4	0.0	0.1	0.0	0.3	0.0	3.1	0.0	0.0	1.9	3.2	0.0	0.0	0.0	0.0	1.3	1.5	2.3	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	2.5	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.7	0.4	1.6	1.9	3.2	1.3	1.5	2.3	1.0	0.7	2.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEIS1		ENSG00000143995	"Meis homeobox 1"	O00470	2	66433452-66573869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	Transcription	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Endometrial stromal cells: 117.2;Horizontal cells: 82.4;Oligodendrocytes: 227.5;Rod photoreceptor cells: 121.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;HeLa: 29.3;HHSteC: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011521, HPA056000, HPA058641"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011521: AB_776272, HPA056000: AB_2683004, HPA058641: AB_2683784"	"unprognostic (6.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-2)"	12.5	52.4	7.5	12.1	10.3	2.5	13.2	32.1	8.5	81.6	4.1	53.3	5.7	84.7	23.2	23.2	83.4	15.8	12.9	4.6	9.2	9.5	3.9	34.4	2.3	15.2	12.4	5.0	43.9	45.4	7.0	1.6	15.4	16.0	34.1	12.4	43.4	39.4	35.7	5.7	9.9	19.9	50.4	9.8	18.5	32.0	2.9	9.7	4.7	5.8	3.4	6.9	39.5	56.4	19.4	0.3	1.6	12.4	2.7	16.3	10.9	1.6	17.0	43.5	14.4	15.2	1.5	12.3	0.0	4.2	13.5	0.8	2.0	7.7	7.5	14.1	0.0	6.9	20.3	29.3	3.1	31.3	0.0	5.8	9.6	8.8	6.0	2.4	11.5	6.7	3.3	1.8	0.0	0.6	0.7	1.8	0.4	0.3	1.6	1.8	0.0	3.3	3.6	1.2	4.0	3.8	26.2	3.0	1.0	1.3	9.4	1.3	2.5	2.1	3.1	4.8	2.3	4.8	3.4	1.1	0.1	2.3	18.2	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	1.3	0.1	2.1	7.5	10.3	32.1	8.5	4.6	9.2	15.2	12.4	5.0	16.0	9.8	9.7	19.4	0.6	0.0	0.5	55.5	0.2	3.2	11.9	10.1	15.4	19.8	2.5	1.4	18.7	1.5	8.3	0.0	110.5	5.7	0.4	2.1	0.0	21.6	10.3	36.8	117.2	4.4	1.2	5.9	6.5	17.5	1.6	19.4	7.1	27.9	0.0	0.2	16.1	1.8	2.2	82.4	5.8	0.7	10.2	1.4	1.9	14.1	34.5	10.3	3.6	15.9	0.5	21.4	1.0	54.3	227.5	20.1	67.3	28.2	0.0	2.4	0.6	3.2	6.8	121.0	19.7	6.7	12.5	2.7	2.0	17.9	2.3	1.9	2.0	6.3	1.2	18.8
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.7;breast: 26.3"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	29.7	0.5	0.0	4.7	0.0	0.0	26.3	0.0	0.1	6.8	0.0	4.4	1.6	5.6	1.1	3.8	9.1	5.7	22.4	0.0	0.0	0.1	0.1	1.4	6.6	0.0	0.0	0.0	1.0	1.5	1.2	0.5	0.2	0.0	2.6	2.5	0.0	4.9	1.9	8.4	6.1	5.2	10.7	0.0	10.9	3.1	1.1	0.0	3.0	2.0	17.2	5.3	7.8	7.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632163-1635263	"Enzymes, Predicted intracellular proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 30.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 90.5;Leydig cells: 98.2;NK-cells: 64.9;Peritubular cells: 177.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 11.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.4;NTERA-2: 2.7;PC-3: 1.9;U-266/70: 3.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 7.8"	"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	4.9	2.8	0.7	0.3	0.5	1.3	4.1	0.3	1.0	13.6	0.0	4.4	1.9	15.5	0.0	2.8	11.1	2.9	14.0	0.5	0.0	3.2	3.3	14.4	1.1	0.7	0.1	0.1	30.1	1.6	0.0	5.7	2.9	0.7	11.9	0.1	0.1	1.0	1.1	0.5	3.1	3.4	1.2	0.3	3.0	4.4	5.2	0.7	0.0	2.4	0.0	0.1	12.0	11.0	0.6	0.6	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.2	1.2	4.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.4	0.0	0.2	2.7	0.0	1.9	0.9	0.0	1.1	0.0	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.3	0.0	3.9	0.2	1.1	0.0	0.2	0.1	0.0	0.2	0.0	1.5	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.0	0.7	0.1	2.2	0.1	11.3	0.3	1.7	0.7	0.5	0.3	1.0	0.5	0.0	0.7	0.1	0.1	0.7	0.3	0.7	0.6	2.2	0.0	0.5	1.0	1.1	13.4	0.8	0.7	0.6	1.3	1.7	1.5	9.6	1.5	0.4	1.8	0.0	4.0	27.4	3.0	0.0	1.2	1.0	4.0	3.5	2.2	3.0	2.7	0.3	0.5	2.2	90.5	4.6	1.0	0.0	1.4	12.1	1.0	5.7	3.3	0.6	1.9	4.1	1.0	18.5	6.2	98.2	1.3	19.6	0.0	1.2	0.5	64.9	0.0	0.2	4.3	0.9	177.9	4.3	0.5	2.7	1.0	0.5	7.7	0.0	0.7	5.3	2.1	10.5	0.7	15.8	10.3	8.1	2.1	1.7	0.9
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760734-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 280.6;lung: 72.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	39	"dendritic cells: 5.9;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"spinal cord: 1.7"	"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	42.4	0.2	0.7	1.1	0.9	3.2	0.5	0.5	1.2	16.0	0.3	9.0	7.1	6.3	24.3	7.2	280.6	16.5	4.5	0.6	1.2	6.4	0.2	72.4	0.2	1.8	0.9	0.7	3.7	0.9	0.1	0.7	2.7	1.3	3.8	4.0	0.7	39.6	9.9	0.0	1.3	2.9	3.4	0.8	0.4	13.1	1.1	0.9	0.8	0.2	0.0	27.5	3.0	2.9	1.5	0.4	2.1	0.0	1.0	0.0	0.0	2.3	0.3	7.7	8.7	2.0	7.4	513.4	0.0	77.4	0.7	0.1	1.3	0.0	0.7	0.7	0.2	0.3	0.0	173.4	5.9	4.4	0.2	0.1	0.0	111.5	0.0	2.0	7.8	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.6	96.4	0.8	0.2	0.2	0.6	2.4	0.1	0.1	0.0	29.7	0.1	0.0	0.1	0.7	0.0	0.0	0.4	12.1	0.1	0.0	0.3	0.3	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.3	0.7	0.9	0.5	1.2	0.6	1.2	1.8	0.9	0.7	1.3	0.8	0.9	1.5	0.0	189.1	85.6	0.0	0.0	0.3	3.0	49.0	0.0	1.4	0.3	0.3	1.6	52.9	121.9	25.8	0.0	0.2	0.0	4.1	0.0	9.3	1.6	35.8	3.3	0.7	3.0	0.0	0.0	0.9	0.0	4.6	0.0	57.1	0.0	0.0	0.4	0.1	2.9	0.0	0.0	1.6	22.4	1.0	1.9	7.4	4.7	3.7	1.8	1.0	4.4	0.0	0.0	0.0	0.0	33.0	214.4	0.0	1.4	3.3	1.7	0.1	54.2	0.6	0.0	0.0	2.8	0.6	0.7	0.5	0.1	0.1	1.3	0.0	3.1	50.8
MSLNL	"C16orf37, MPFL"	ENSG00000162006	"Mesothelin like"	Q96KJ4	16	769428-783370	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CAPAN-2: 11.2;HeLa: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (5.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (4.49e-2)"		"unprognostic (2.38e-2)"		"unprognostic (1.54e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.50e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.16e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719571-17722136	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 36.4"	"Group enriched"	"Detected in some"	9	"Skeletal myocytes: 10.0;Spermatogonia: 3.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 461.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA055436, HPA078647"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	461.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPFFR1	"GPR147, NPFF1R1, OT7T022"	ENSG00000148734	"Neuropeptide FF receptor 1"	Q9GZQ6	10	70247329-70284004	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.7;retina: 3.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.5;Muller glia cells: 10.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 15.7;hypothalamus: 6.3"	"Low region specificity"	"Detected in single"			HPA037521	Uncertain					NA	NA					"HPA037521: AB_2675520"	"unprognostic (1.73e-3)"	"unprognostic (7.29e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.51e-1)"	"unprognostic (9.62e-2)"	"unprognostic (6.78e-2)"	"unprognostic (5.84e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	0.1	0.0	1.7	0.4	2.6	0.3	0.1	8.7	1.7	0.1	0.8	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.0	1.5	2.5	0.0	0.0	0.2	0.6	2.3	2.8	0.9	0.1	0.0	0.0	0.1	0.0	4.5	0.1	0.1	3.1	0.0	0.2	0.2	0.1	0.1	0.0	1.5	0.2	0.2	1.0	2.9	0.0	0.0	0.1	0.3	0.1	0.2	2.8	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.7	1.7	2.6	8.7	1.7	1.5	2.5	2.3	2.8	0.9	4.5	1.5	2.9	2.8	0.2	0.0	2.0	6.5	0.2	1.7	1.8	0.3	0.0	0.7	0.1	0.3	1.0	1.5	0.0	1.8	0.0	0.2	1.5	0.4	0.0	0.0	0.3	0.6	0.2	0.5	0.0	0.0	0.2	0.2	0.2	0.8	0.0	0.8	2.5	0.1	0.4	0.2	0.1	0.0	1.4	0.1	0.0	0.3	2.8	1.6	0.6	0.8	0.0	0.0	0.4	10.4	1.0	1.0	1.0	0.1	0.1	0.4	0.0	1.1	0.0	0.1	0.1	1.6	0.0	1.7	0.6	0.6	1.2	0.0	2.0	1.1	0.3	0.0	0.2	0.9
NPW	PPL8	ENSG00000183971	"Neuropeptide W"	Q8N729	16	2009926-2020755	"Predicted intracellular proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 10.6"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 188.1;Enteroendocrine cells: 158.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"NB-4: 43.5;PC-3: 35.6;RPMI-8226: 74.7;SCLC-21H: 118.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.2"	HPA064874	Approved				"Secreted to blood"	NA	NA					"HPA064874: AB_2685378"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.81e-5)"	"unprognostic (6.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.41e-1)"	"unprognostic (3.43e-2)"	0.3	0.1	1.3	0.4	0.5	1.3	0.1	0.5	2.7	0.8	0.8	0.5	0.6	1.1	1.3	0.4	0.6	0.0	0.1	0.8	1.4	0.4	10.6	0.1	0.2	0.9	0.8	0.4	0.4	0.4	0.0	2.7	0.1	1.4	0.3	0.1	0.0	0.2	0.2	0.0	1.6	0.2	0.2	0.7	0.7	2.4	1.2	1.7	0.0	0.2	0.0	0.4	0.2	0.6	3.4	0.4	1.7	0.2	2.5	0.4	0.0	0.7	0.9	0.2	0.5	1.0	3.8	1.5	0.4	0.1	0.8	0.6	0.8	1.1	0.3	0.5	1.8	2.9	0.1	3.0	1.7	2.3	0.4	0.1	1.0	1.3	0.9	1.9	0.1	0.0	2.5	10.8	1.7	0.1	0.9	0.4	43.5	1.9	1.5	35.6	10.5	0.0	74.7	0.4	0.0	118.8	9.9	1.3	2.2	0.3	0.6	5.6	4.4	1.7	0.3	0.6	0.5	0.1	3.6	1.1	1.1	0.6	0.9	0.4	1.2	0.7	0.7	0.2	0.4	0.6	0.4	0.1	0.0	0.7	0.4	0.2	0.1	1.5	0.6	0.2	0.4	0.4	0.2	1.3	0.5	0.5	2.7	0.8	1.4	0.9	0.8	0.4	1.4	0.7	1.7	3.4	2.5	0.0	0.0	0.0	2.9	2.0	3.2	1.9	4.0	1.5	2.7	7.1	0.3	0.0	2.0	0.0	0.0	1.2	0.1	6.0	0.0	0.5	0.9	9.9	188.1	4.4	158.5	12.2	0.4	0.2	0.9	14.0	15.8	8.5	8.9	0.5	0.7	35.9	2.3	0.0	0.7	35.8	0.0	0.3	0.3	2.1	2.1	1.6	3.6	0.0	0.1	0.0	0.0	0.0	0.1	2.1	12.4	2.2	1.5	11.9	3.2	0.8	0.3	0.3	0.0	0.5	2.7	8.8	35.4	4.1	2.3	1.6	2.3	1.6	3.9	4.6
NTF3	NGF2	ENSG00000185652	"Neurotrophin 3"	P20783	12	5432108-5521536	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 11.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.5;Basal prostatic cells: 36.6;Basal squamous epithelial cells: 89.4;Prostatic glandular cells: 20.5;Sertoli cells: 32.9;Smooth muscle cells: 24.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Region enhanced"	"Detected in some"		"cerebellum: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.4;BJ hTERT+ SV40 Large T+: 14.8;BJ hTERT+ SV40 Large T+ RasG12V: 19.7;HBF TERT88: 18.0;RT4: 8.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 4.7;cerebral cortex: 2.0;hippocampal formation: 2.2"	HPA032001	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA032001: AB_2674106"	"unprognostic (3.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.33e-3)"	"unprognostic (4.66e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.77e-4)"	"unprognostic (4.02e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.06e-3)"	"unprognostic (4.51e-3)"	3.5	1.8	0.1	0.8	0.3	0.0	2.7	3.4	1.3	5.8	0.3	1.6	1.9	1.9	2.0	3.4	3.0	1.8	2.7	1.2	0.2	2.6	7.7	1.6	0.3	0.3	0.8	0.1	11.2	0.2	0.1	1.1	1.9	0.6	3.6	1.0	0.1	3.2	2.4	1.8	2.7	2.5	0.9	0.2	4.6	2.5	0.8	0.1	0.4	0.9	1.0	0.4	4.7	7.1	0.2	1.9	0.0	6.7	0.0	0.0	0.0	0.0	4.5	11.4	14.8	19.7	0.1	0.2	0.0	6.7	7.3	0.0	2.4	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	4.5	4.7	8.5	0.3	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.2	0.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	3.4	1.3	1.2	0.2	0.3	0.8	0.1	0.6	0.2	0.1	0.2	1.0	0.0	0.0	0.0	0.0	18.5	36.6	0.7	89.4	0.0	0.2	10.3	0.9	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.2	0.2	1.4	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.1	0.0	0.0	5.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	2.1	0.1	8.4	0.3	7.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.9	0.0	20.5	0.2	0.0	0.8	0.0	32.9	6.8	24.0	0.5	0.8	5.0	3.3	0.1	0.5	0.5	0.2	6.9
NUPR2	NUPR1L	ENSG00000185290	"Nuclear protein 2, transcriptional regulator"	A6NF83	7	56114681-56116417	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"testis: 357.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 15101.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 13.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.0;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 11.9"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.81e-2)"	"unprognostic (2.01e-1)"		"unprognostic (1.10e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.25e-2)"		"unprognostic (2.46e-1)"		"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.53e-5)"	"unprognostic (1.66e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.44e-2)"	2.2	3.3	7.1	0.3	7.5	1.0	2.7	8.4	9.3	1.8	5.4	0.9	1.2	0.7	3.0	0.7	1.6	0.4	1.3	7.4	7.9	17.6	2.3	1.0	0.7	7.1	7.0	7.7	1.3	4.0	3.3	12.8	0.7	7.1	6.5	0.7	2.6	7.8	5.7	1.5	1.3	0.7	0.6	6.3	0.7	6.0	357.6	7.9	1.4	15.6	1.0	0.6	0.6	0.8	7.5	1.0	3.1	1.4	4.0	3.6	1.5	0.5	0.2	1.4	0.7	0.4	0.4	2.2	0.4	4.7	0.1	1.5	0.3	1.9	0.5	0.9	0.7	6.0	2.4	1.4	2.7	1.9	0.8	0.3	2.8	2.0	1.0	4.4	1.7	1.3	3.1	3.0	2.5	1.4	3.3	1.3	3.1	1.3	1.2	3.3	1.1	1.6	11.9	2.3	0.5	3.9	3.6	1.9	0.5	5.4	4.6	1.2	0.7	1.0	0.6	1.7	0.9	0.7	3.8	4.8	4.6	2.4	3.0	1.1	2.0	0.3	0.6	0.3	0.0	0.5	0.4	1.8	0.5	0.4	0.5	5.1	1.4	0.1	0.4	0.5	0.8	0.5	0.8	7.1	7.5	8.4	9.3	7.4	7.9	7.1	7.0	7.7	7.1	6.3	7.9	7.5	0.2	0.0	1.5	0.0	0.2	0.0	21.3	0.0	2.2	1.4	39.6	41.3	0.0	0.0	1.8	90.1	0.0	9.6	0.5	1.4	422.6	3.6	3765.4	3.9	0.1	6.7	14.6	0.0	0.0	1.8	1.7	0.9	9.7	2.4	1.3	0.1	0.0	0.0	0.6	16.8	0.0	3.0	0.0	0.0	0.0	15101.8	94.1	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.5	68.4	0.0	24.8	0.1	3.2	2.9	0.8	85.5	0.0	1.5	112.8	53.3	2.7	0.0	2.9	0.6	0.0	2.0	20.4
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88534033-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 7.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	6.6	0.7	4.5	1.2	3.6	4.2	2.9	6.1	5.6	4.0	1.4	0.5	0.9	2.0	1.4	0.4	4.3	1.0	0.7	3.6	1.8	2.3	4.5	0.7	0.9	1.7	0.8	2.7	1.2	0.4	0.3	0.1	0.6	3.0	0.9	0.4	4.9	1.6	0.7	1.4	1.5	0.9	0.5	0.1	1.1	0.8	1.3	2.5	0.5	1.3	0.1	0.5	0.4	0.3	6.9	1.5	2.6	1.0	1.0	0.1	0.7	0.7	2.6	0.7	0.3	0.5	0.6	1.0	0.6	1.1	0.3	0.7	1.3	0.4	0.1	0.9	0.4	0.8	1.3	4.0	1.0	0.4	0.7	1.1	0.5	0.2	0.3	0.2	0.4	0.0	0.9	0.9	2.7	0.7	0.7	0.7	1.2	1.4	0.5	0.7	0.5	0.5	0.9	10.4	0.8	0.6	0.4	1.6	0.8	0.5	0.7	1.2	0.6	0.9	0.9	1.9	1.5	0.6	0.9	0.8	0.7	0.7	0.9	0.7	2.1	0.3	0.8	0.6	0.1	0.6	0.2	0.3	0.7	0.0	0.3	0.6	0.7	0.8	0.5	0.1	0.3	0.6	0.3	4.5	3.6	6.1	5.6	3.6	1.8	1.7	0.8	2.7	3.0	0.1	2.5	6.9	0.2	0.0	0.0	1.3	0.1	0.0	1.9	0.7	1.2	0.2	7.5	3.2	0.3	4.3	0.1	1.8	0.0	0.2	0.0	0.0	1.9	0.8	11.4	39.1	4.3	0.8	0.0	0.0	1.2	0.2	1.3	0.8	0.0	13.9	0.0	13.2	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	4.4	0.9	0.2	0.0	0.0	0.0	0.5	0.0	1.0	0.7	0.2	0.0	2.2	0.1	0.4	0.0	18.6	0.2	0.8	0.0	0.3	1.3	0.4	1.6	0.0	0.1	1.1	0.3	12.7	0.0	2.2
OLFM3	NOE3	ENSG00000118733	"Olfactomedin 3"	Q96PB7	1	101802560-101996926	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 12.5;retina: 7.4"	"Group enriched"	"Detected in some"	17	"Excitatory neurons: 653.3;Inhibitory neurons: 174.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AF22: 5.7;HAP1: 3.9;HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 2.2"	"Region enhanced"	"Detected in all"		"cerebellum: 177.3"	"Low region specificity"	"Detected in all"			HPA050297			Uncertain	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA050297: "			"unprognostic (4.19e-1)"	"unprognostic (4.19e-4)"	"unprognostic (1.26e-1)"				"unprognostic (4.61e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.47e-2)"			"unprognostic (3.58e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.68e-2)"		0.0	1.4	3.9	0.4	6.0	0.0	0.0	8.2	12.5	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.0	0.0	0.0	6.5	8.4	0.4	0.0	0.0	0.0	2.0	3.1	8.0	0.0	0.0	0.0	1.2	0.0	2.1	0.0	0.5	7.4	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.2	0.1	5.8	0.0	0.3	0.0	0.0	0.0	0.0	12.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.0	8.2	12.5	6.5	8.4	2.0	3.1	8.0	2.1	0.0	5.8	12.3	0.1	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	23.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	653.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	174.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.7	0.0	8.5	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	6.5	0.0	0.0
OXTR		ENSG00000180914	"Oxytocin receptor"	P30559	3	8750381-8769628	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 14.8;breast: 54.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 122.6;Excitatory neurons: 25.8;Oligodendrocyte precursor cells: 21.1;Respiratory ciliated cells: 57.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 421.2;BJ hTERT+: 127.9;BJ hTERT+ SV40 Large T+: 119.4;fHDF/TERT166: 424.5;HBF TERT88: 92.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.18e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.24e-4)"	"unprognostic (8.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-1)"	0.4	0.2	4.3	0.1	7.8	0.6	54.7	3.4	7.3	0.3	1.5	0.2	0.1	3.6	0.3	1.6	3.0	0.3	0.4	3.2	10.6	0.5	0.2	0.9	0.2	14.8	11.3	3.6	3.1	0.1	0.1	0.3	0.5	8.4	0.8	0.1	2.7	0.2	0.8	0.2	0.2	0.2	0.5	5.1	0.3	0.2	0.3	9.8	0.3	0.3	0.1	0.1	0.8	0.2	13.5	1.1	4.6	2.5	0.5	0.5	1.2	0.8	421.2	127.9	119.4	63.4	0.6	11.3	0.3	0.9	424.5	1.7	0.9	2.0	0.9	92.4	3.9	2.1	1.1	1.9	0.7	2.2	1.0	1.0	0.7	0.5	1.7	0.9	36.1	0.2	1.3	0.2	0.8	67.5	0.3	0.9	3.3	2.7	1.4	18.7	0.9	1.6	25.5	4.5	0.4	0.7	0.8	0.7	0.9	0.2	8.1	0.3	0.6	0.6	5.9	1.5	1.2	1.2	0.7	1.2	0.2	0.6	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.3	7.8	3.4	7.3	3.2	10.6	14.8	11.3	3.6	8.4	5.1	9.8	13.5	1.3	9.6	1.1	3.3	0.3	0.4	0.6	1.0	0.0	0.8	2.3	122.6	1.5	1.5	6.5	0.0	0.0	0.2	0.4	0.3	0.0	2.7	1.4	4.7	0.6	0.7	0.0	0.0	25.8	0.0	0.1	2.0	0.0	0.9	0.0	4.3	1.4	0.0	0.2	0.0	14.0	0.0	2.0	0.0	0.0	2.0	0.0	3.1	0.0	5.6	0.1	7.9	0.0	21.1	15.4	1.2	0.1	0.4	0.2	2.2	0.0	0.1	57.1	0.2	0.0	2.0	16.9	1.0	1.8	0.0	0.1	0.0	0.3	3.1	0.1	0.3
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 14.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.9;Excitatory neurons: 24.5;Inhibitory neurons: 51.8;Oligodendrocyte precursor cells: 40.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6;ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol		NA	NA		83000	Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	1.7	0.1	7.1	0.2	8.5	0.0	1.7	0.0	11.1	1.6	0.0	1.3	0.2	1.1	0.2	0.8	0.6	0.4	0.3	11.0	11.7	0.2	0.0	0.1	0.2	1.1	3.1	6.9	1.0	0.1	0.1	0.7	0.1	2.6	0.2	1.7	1.8	0.6	0.3	0.4	1.0	0.4	0.9	0.0	0.0	0.5	0.6	14.5	0.8	0.2	0.9	0.0	0.8	0.6	2.3	0.0	0.0	18.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	3.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	8.5	0.0	11.1	11.0	11.7	1.1	3.1	6.9	2.6	0.0	14.5	2.3	29.9	0.0	0.5	13.4	0.0	3.1	0.1	0.9	4.6	12.9	0.5	0.8	1.8	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.4	6.2	11.3	1.8	0.0	24.5	0.0	0.1	2.9	0.0	1.4	0.0	2.5	1.1	0.0	0.1	0.0	51.8	0.1	0.0	0.3	3.4	2.2	3.4	0.1	0.0	7.5	0.0	1.9	0.0	40.7	2.2	0.1	0.1	0.4	0.0	0.4	0.0	0.2	1.3	1.9	0.0	5.9	7.8	0.1	1.5	1.0	1.6	0.0	0.2	0.7	0.0	0.1
PDCL2	GCPHLP	ENSG00000163440	"Phosducin like 2"	Q8N4E4	4	55556519-55592245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 65.6"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1285.9;Late spermatids: 634.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0;testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;HaCaT: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048260, HPA072384"	Enhanced		Approved	Microtubules,Centrosome		NA	NA			Microtubules	Centrosome	"HPA048260: AB_2680333, HPA072384: "		"unprognostic (5.93e-3)"		"unprognostic (1.19e-7)"		"unprognostic (1.04e-1)"				"unprognostic (3.01e-3)"				"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.41e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	65.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1285.9	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	634.7	7.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	13.1	0.0	0.1	40.4	50.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase 1"	Q8TCT1	17	49223366-49230787	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 103.8"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1499.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	160	"eosinophil: 171.1;neutrophil: 426.7"	"Lineage enriched"	"Detected in many"	228	"granulocytes: 426.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;EFO-21: 3.2;HDLM-2: 4.1;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	2.3	3.4	3.1	19.1	0.5	6.4	4.3	0.4	1.1	0.7	2.9	0.7	0.2	1.0	1.3	2.2	1.4	2.1	6.1	1.3	1.0	2.3	1.6	9.1	5.6	0.4	0.3	1.2	0.2	0.6	6.4	8.9	0.8	0.0	0.7	1.2	0.3	3.4	1.3	3.0	0.4	5.4	14.3	0.9	103.8	4.9	0.3	0.7	3.3	0.2	0.9	0.5	10.0	0.0	1.0	0.0	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.1	1.5	0.0	5.7	3.2	0.0	2.1	0.0	0.9	0.3	0.1	4.1	0.1	0.7	0.7	0.2	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.7	1.2	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.1	0.1	2.2	0.3	1.7	1.1	0.0	0.1	0.2	0.3	1.5	2.0	0.1	0.2	0.6	171.1	0.4	1.5	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.2	426.7	0.5	1.8	0.0	0.1	1.1	2.3	3.1	6.4	4.3	2.1	6.1	9.1	5.6	0.4	8.9	5.4	4.9	10.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	205.8	0.0	0.0	1.4	0.0	8.6	0.7	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	1.4	0.0	0.0	0.3	0.0	1499.6	7.8	0.6	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	11.2	4.5	0.0	0.0	237.6	0.1	0.0	0.1	0.1
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 48.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.1	0.1	0.2	0.1	0.1	0.2	2.0	0.3	0.4	0.4	0.0	0.7	0.9	0.0	1.8	1.3	0.5	0.7	0.1	0.2	0.1	0.3	0.1	1.0	0.2	0.1	0.1	0.2	0.1	0.2	6.3	0.4	0.3	0.2	0.6	0.2	0.1	1.1	2.1	0.2	48.4	0.7	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.7	0.0	0.5	0.4	2.1	0.4	1.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	3.6	0.1	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	2.5	0.0	0.3	3.9	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.2	0.0	8.2	0.3	0.0	20.9	10.6	5.0	1.8	0.0	3.0	1.5	0.8	0.0	3.9	11.0	0.0	1.5	0.1	0.9	0.0	5.3	2.2	1.3	0.7	0.3	3.0	0.0	0.4	1.3	0.4	0.6	10.2	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.2	8.2	0.0	2.2	5.5	0.0	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.5	20.8	1.1	0.0	0.0	5.0	0.4	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.1	7.0	37.6	7.9	0.5	0.2	0.6	14.2
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788485	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.6"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 35.5;Oligodendrocytes: 54.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: AB_2679744, HPA060047: AB_2684194"	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	4.0	3.0	7.7	3.0	10.2	0.0	3.8	10.5	9.5	17.5	2.9	40.6	2.1	14.0	2.1	8.1	18.4	1.6	7.1	5.1	10.7	1.1	0.8	1.0	0.1	16.0	12.9	4.0	5.4	1.4	0.0	0.7	1.0	13.8	15.7	3.7	5.7	5.1	5.0	0.9	3.3	21.8	8.2	13.8	0.2	20.2	1.7	8.9	0.2	1.7	1.4	2.3	11.1	14.5	18.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.3	8.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	10.2	10.5	9.5	5.1	10.7	16.0	12.9	4.0	13.8	13.8	8.9	18.3	0.2	0.0	0.0	1.3	0.0	0.5	1.0	0.3	0.6	2.6	0.4	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	3.4	2.6	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.2	2.8	0.1	0.0	0.0	0.0	35.5	0.0	2.0	54.7	0.1	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.3	0.0	4.9	0.3	0.7	1.4	0.6	0.3	0.0	0.0	0.0	0.0	0.1
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771655-71785206	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Biological rhythms"	Neuropeptide	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 65.0;lymphoid tissue: 22.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 5.9;Kupffer cells: 8.0;Macrophages: 11.3;monocytes: 6.9;Spermatocytes: 23.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Region enriched"	"Detected in some"	6	"cerebral cortex: 11.4"	"Immune cell enriched"	"Detected in many"	50	"neutrophil: 414.4"	"Lineage enriched"	"Detected in many"	50	"granulocytes: 414.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.2;NB-4: 8.9;NTERA-2: 5.5;U-266/70: 12.0;U-266/84: 20.8;U-937: 8.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.1;olfactory bulb: 3.5"	"Low region specificity"	"Detected in all"			HPA041408	Approved				"Secreted to blood"	NA	NA					"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	7.3	0.3	0.6	17.8	0.6	65.0	0.3	0.2	11.4	0.4	1.1	0.4	0.3	0.2	0.0	0.4	2.7	1.2	1.0	0.2	1.3	0.6	2.6	13.2	0.2	0.5	0.9	0.3	0.2	1.1	0.0	0.4	3.1	1.3	0.2	0.2	0.1	0.3	0.0	0.5	0.1	0.5	1.5	0.3	22.6	0.6	11.5	2.0	1.1	0.5	4.3	0.5	6.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.6	0.0	0.0	0.0	0.3	8.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	20.8	0.0	0.0	8.3	0.0	0.0	8.2	3.5	3.4	0.7	0.0	0.0	2.7	2.9	0.7	0.0	0.9	5.0	414.4	0.0	0.2	0.3	1.7	3.1	0.6	0.6	0.2	11.4	0.2	1.3	0.5	0.9	0.3	1.3	0.3	2.0	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	1.8	0.0	0.0	2.5	0.0	0.0	0.0	1.6	0.1	0.1	0.1	0.0	5.9	0.0	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	8.0	0.3	2.8	0.3	11.3	1.8	0.0	6.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	23.8	2.9	0.0	0.0	0.0	3.5	0.1	0.0	0.0
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 85.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 84.1;Early spermatids: 111.0;Late spermatids: 349.7;Spermatocytes: 453.2;Spermatogonia: 270.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 16.1;eosinophil: 33.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 33.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.0;HEL: 28.5;HeLa: 71.0;K-562: 34.3;U-698: 104.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	38	"basal ganglia: 8.9"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.1	0.0	0.1	0.5	0.1	7.9	1.4	0.0	0.1	1.6	0.0	0.6	0.5	0.2	0.0	1.5	2.7	1.8	0.0	0.1	0.1	0.1	0.1	2.5	1.2	0.1	0.1	0.1	0.1	2.0	1.5	0.1	0.0	0.1	3.8	0.5	0.0	20.6	0.3	0.0	0.8	0.8	0.1	0.0	1.7	0.8	85.3	0.1	1.1	0.0	0.0	1.2	0.4	1.4	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	25.0	0.0	0.1	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	28.5	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	13.8	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	16.1	3.5	33.0	3.1	2.6	4.8	1.2	1.5	2.6	0.9	0.8	2.2	3.2	0.3	1.8	0.5	2.2	1.0	2.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	4.6	1.1	37.9	9.4	13.1	0.0	6.1	8.4	84.1	0.0	2.7	0.0	0.0	0.3	2.1	1.4	0.0	1.1	111.0	0.3	2.6	1.6	0.0	9.7	0.0	0.4	9.0	0.7	0.0	0.4	0.0	0.4	0.0	0.0	11.1	0.0	0.0	1.5	4.1	0.6	0.7	349.7	6.5	5.7	0.0	0.0	1.1	0.0	4.1	0.0	0.1	0.7	0.6	3.8	20.4	32.7	0.1	0.1	0.5	0.0	46.0	0.0	1.0	453.2	270.2	2.8	0.6	0.1	3.4	0.0	2.4	14.5
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 4.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Melanocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	65	"eosinophil: 1296.1"	"Lineage enriched"	"Detected in many"	391	"granulocytes: 1296.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;hTERT-RPE1: 5.0;SK-MEL-30: 5.9;U-2 OS: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.0	0.0	4.7	0.4	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.9	0.4	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.4	1296.1	0.2	0.4	0.2	0.1	0.1	0.0	0.2	0.2	0.1	0.3	2.1	3.3	0.3	0.1	0.1	1.0	0.0	0.1	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PTF1A	"bHLHa29, p48, PTF1-p48"	ENSG00000168267	"Pancreas associated transcription factor 1a"	Q7RTS3	10	23192312-23194245	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"pancreas: 105.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.1;Exocrine glandular cells: 4.8;Spermatocytes: 3.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.6;pancreatic cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022612			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB022612: "										"unprognostic (2.02e-1)"	"unprognostic (1.85e-1)"			"unprognostic (4.49e-1)"	"unprognostic (1.80e-1)"			0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.9	1.6	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.9	0.9	0.0	0.0	0.0	0.0	1.1	0.8	0.7	0.1	105.0	0.0	0.2	0.0	1.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.9	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.9	1.6	0.9	0.9	1.1	0.8	0.7	1.1	0.8	0.7	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475354	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"kidney: 11.6;lymphoid tissue: 6.6"	"Cell type enriched"	"Detected in some"	70	"Collecting duct cells: 198.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.4;NB-4: 1.3;PC-3: 3.2;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.6	1.4	0.6	0.5	0.6	0.0	0.4	0.3	2.0	0.8	0.7	0.4	0.3	0.5	0.0	0.8	1.0	0.0	0.1	0.3	0.8	11.6	0.3	2.4	0.0	0.7	0.3	0.2	0.1	0.3	0.1	1.4	0.0	0.8	0.7	0.0	0.0	0.3	0.0	0.1	0.1	1.4	0.4	0.2	6.6	3.0	0.2	0.4	0.0	0.5	0.0	0.0	1.1	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.0	3.2	0.3	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.6	0.3	2.0	0.3	0.8	0.7	0.3	0.2	0.8	0.2	0.4	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.3	0.9	2.8	0.0	198.6	0.0	0.1	1.3	0.3	0.0	0.1	0.1	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.2	2.5	1.1	1.4	0.0	0.4	0.4	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.8	0.0	0.8	0.1	0.1	0.0	0.4	2.5	0.3	0.9	0.3	0.0	0.0	0.6	0.8	0.2	0.4
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 153.7;urinary bladder: 176.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 28.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2100000	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	8.1	3.0	2.4	10.6	2.8	9.1	6.8	3.9	6.0	4.1	9.6	72.7	10.9	6.2	2.3	67.9	43.6	9.7	9.0	6.8	4.2	9.4	3.0	11.4	4.6	5.3	4.3	1.1	2.0	1.8	2.1	4.9	2.3	5.9	21.3	24.4	0.7	4.3	6.2	2.1	153.7	17.9	16.3	7.9	8.1	20.7	0.9	4.8	2.2	3.3	4.1	11.7	176.4	16.0	7.3	0.3	0.5	0.4	0.0	113.7	89.5	0.0	115.2	156.0	1.0	1.1	0.0	0.2	4.2	5.4	19.7	0.3	7.1	0.4	10.5	0.9	0.0	0.2	73.6	0.6	0.0	32.9	5.2	298.4	46.1	1.2	5.7	0.3	0.0	42.3	0.1	0.1	0.3	2.3	0.0	0.2	6.6	1.6	0.0	0.5	0.3	1.4	8.6	14.7	0.0	0.5	0.6	0.6	9.5	0.2	0.5	0.3	8.4	1.0	0.7	0.6	1.7	0.1	0.3	0.2	0.0	0.4	31.6	0.3	28.9	12.1	23.3	0.0	13.1	0.0	2.4	0.0	0.0	20.0	3.5	0.1	0.0	5.2	2.8	10.2	1.4	0.2	21.9	2.4	2.8	3.9	6.0	6.8	4.2	5.3	4.3	1.1	5.9	7.9	4.8	7.3	0.9	0.0	6.6	0.0	5.9	9.9	2.6	7.7	0.0	0.1	1.1	1.4	1.6	4.3	2.2	42.3	0.0	0.1	0.2	0.1	0.0	0.6	0.1	109.9	10.4	24.7	1.8	18.7	0.8	0.5	0.3	10.7	2.0	191.9	208.0	0.1	61.8	0.8	26.1	0.0	0.5	0.6	4.1	15.5	20.7	0.3	1.5	55.3	3.6	16.9	11.7	0.0	7.2	1.0	0.1	0.6	0.6	0.0	0.3	2.8	0.0	0.0	0.8	0.1	0.0	1.4	3.6	0.0	0.2	18.2	58.7	0.4	3.4	0.1	1.0	0.8
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391396-57409333	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 137.6;skeletal muscle: 223.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 110.9;dendritic cells: 156.9;Erythroid cells: 280.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 95.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 140.6;U-698: 150.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favorable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.83e-1)"	11.4	10.8	4.8	26.9	6.1	137.6	12.9	11.3	10.4	16.8	13.8	71.9	8.8	38.8	0.9	16.9	29.1	5.1	62.3	4.3	9.7	16.2	16.6	21.2	43.7	7.0	6.9	1.1	28.0	10.9	1.9	12.3	5.5	7.2	27.2	4.2	0.6	19.8	12.0	223.8	9.1	40.1	8.7	4.6	66.3	23.1	38.4	6.4	26.8	9.5	33.0	12.3	43.3	13.7	6.4	20.1	20.4	9.7	25.1	0.0	1.6	56.3	6.5	1.6	13.5	3.5	84.2	20.6	140.6	54.1	1.9	13.2	18.3	8.0	8.0	2.1	29.0	34.5	118.0	7.6	52.6	6.0	57.8	54.2	1.9	3.8	5.7	1.1	1.9	9.2	52.5	100.9	24.6	1.6	87.8	42.7	58.5	36.9	10.7	25.5	82.0	23.6	114.2	10.1	9.2	40.9	26.3	15.2	50.5	24.7	8.7	28.3	79.4	17.0	4.4	42.6	6.0	27.6	60.1	86.8	150.7	1.1	40.3	4.2	0.0	0.5	2.2	3.1	1.8	1.9	3.2	2.5	2.1	1.0	3.3	3.0	2.8	0.7	3.5	1.7	1.3	4.7	2.1	4.8	6.1	11.3	10.4	4.3	9.7	7.0	6.9	1.1	7.2	4.6	6.4	6.4	13.9	3.2	5.2	10.1	110.9	9.1	28.3	7.9	13.6	1.0	15.8	21.0	42.5	8.6	6.6	1.8	0.0	1.9	156.9	41.6	9.8	6.2	4.2	54.2	5.2	11.9	62.8	280.4	2.5	5.0	5.8	8.8	12.2	21.5	8.8	31.5	10.4	6.0	9.6	0.0	1.3	56.4	12.2	8.1	18.9	4.0	4.4	27.6	1.8	2.8	5.8	12.8	54.6	4.5	4.6	5.9	35.4	6.0	52.8	18.8	2.8	16.4	22.5	1.4	6.6	20.6	7.6	2.4	13.2	9.1	8.4	2.3	81.0	13.3	34.0	18.5
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113564	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Spermatocytes: 52.3;Spermatogonia: 42.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.3;ovarian cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"A-431: 11.8;HeLa: 39.4;JURKAT: 18.0;SiHa: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057527	Uncertain					NA	NA					"HPA057527: AB_2683457"	"unprognostic (2.75e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	1.5	1.2	1.1	0.7	1.4	2.0	1.6	3.9	1.1	1.5	0.9	1.5	0.5	1.0	1.0	1.2	2.1	0.8	0.6	1.1	0.7	2.7	0.2	1.4	1.0	0.9	0.8	0.7	5.0	9.3	1.3	7.4	0.3	1.5	1.8	0.6	1.3	1.7	0.5	0.5	1.9	1.1	0.8	0.7	1.1	1.0	3.1	0.9	0.8	3.2	0.6	0.7	0.9	1.8	1.0	11.8	0.7	0.1	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	5.3	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.0	18.0	0.1	0.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	3.8	0.0	22.6	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.5	0.2	1.2	0.2	0.4	0.6	1.1	0.3	0.0	0.1	0.0	0.1	0.2	0.3	1.1	1.4	3.9	1.1	1.1	0.7	0.9	0.8	0.7	1.5	0.7	0.9	1.0	1.1	3.2	6.9	1.3	1.3	2.8	5.6	1.5	13.6	3.0	3.9	4.8	0.6	1.5	6.8	0.0	2.1	0.0	1.1	0.5	62.6	3.8	3.9	0.5	2.5	0.8	4.9	0.0	4.7	0.9	0.2	11.7	1.1	1.1	4.5	1.9	0.4	0.0	0.6	0.0	1.7	2.8	0.0	0.8	1.8	7.5	8.4	1.8	0.0	2.8	0.9	5.1	2.1	0.0	4.4	0.8	1.6	0.7	0.8	4.6	0.7	8.9	2.2	6.4	0.0	6.8	1.7	52.3	42.4	4.5	3.1	0.3	1.8	2.1	1.2	4.5
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859910-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 682.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055259	Approved		Approved	Nucleoli,Cytosol		No	No		44000	"Nucleoli, Cytosol"		"HPA055259: AB_2682764"	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	1966.1	1336.8	669.6	1218.4	669.0	2698.6	2023.7	650.4	974.2	2170.7	850.5	1828.9	1082.3	1698.5	417.8	2451.7	1916.5	856.0	1187.1	621.8	685.6	1210.4	1170.7	1362.3	2531.7	682.4	650.9	597.5	3658.0	3940.1	546.2	930.4	763.5	669.0	1610.2	725.2	207.6	2613.0	641.4	2554.0	3535.7	1736.3	692.4	711.6	2064.9	1944.6	353.3	721.5	1588.3	1409.7	1224.1	1500.5	1751.8	2182.3	680.8	2623.4	2001.4	1299.0	1847.0	1923.3	3152.4	3291.2	1559.5	1979.9	2038.9	1930.5	2789.2	2550.3	3921.7	3523.0	1365.1	805.3	1913.5	1555.9	3350.6	708.6	2020.7	4206.5	1833.5	1792.6	3238.9	3314.5	2660.3	1916.4	3952.5	4349.3	1127.8	2410.2	2094.2	2265.6	3157.8	2386.5	2462.6	1313.5	4085.3	3633.0	3514.7	3067.9	2909.3	3049.2	3210.9	1376.3	4708.0	1887.0	2464.1	1879.4	2817.6	554.3	3813.0	5042.2	637.7	1814.7	5079.9	1738.1	1244.6	1438.8	2512.2	2674.5	3251.9	3283.4	2639.9	1632.9	4270.0	1580.0	1247.5	4513.0	690.0	4974.8	4521.9	8679.3	14996.3	8499.1	6207.0	6569.7	15438.5	9988.2	7821.6	433.2	5415.3	3633.6	7634.4	8027.2	21239.5	669.6	669.0	650.4	974.2	621.8	685.6	682.4	650.9	597.5	669.0	711.6	721.5	680.8	1797.3	519.2	1033.4	1.3	6570.0	8683.5	6503.8	6346.6	5314.4	252.0	7203.4	8120.9	437.2	2077.4	2572.8	923.2	127.2	4676.6	3414.9	1440.2	2387.0	3503.1	57.0	1112.5	3101.7	2919.9	1842.7	2735.0	1.8	8949.1	8763.1	2652.7	2316.6	1639.3	1447.9	3627.9	2837.8	2144.2	3317.2	131.2	2.2	3965.3	1881.8	4748.0	8399.9	194.1	4165.1	3240.6	4747.4	1.9	6119.2	908.2	3084.5	1.5	2.5	5684.1	3130.7	1627.9	3619.6	6541.4	3169.3	3629.8	1019.5	499.6	1255.6	3061.1	4561.4	199.9	834.7	6806.4	11135.4	4659.3	4511.8	4057.7	4606.2	8094.9
RPS26	"eS26, S26"	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044697	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 494.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	665.7	1275.5	393.5	274.2	387.2	399.2	696.1	375.2	460.9	699.3	376.7	692.4	178.7	574.5	414.3	882.5	730.4	124.4	673.6	372.9	395.4	679.2	934.2	526.4	517.0	400.2	379.6	368.8	1129.9	1180.0	276.6	480.4	253.7	392.4	632.6	407.1	70.4	597.2	339.2	784.6	819.4	750.3	309.9	376.9	838.7	723.4	210.4	408.2	622.6	548.6	394.1	721.3	740.6	703.8	436.5	639.2	763.3	853.6	319.5	1153.3	1696.4	852.0	633.4	929.5	1027.7	596.0	1182.7	281.7	1408.3	383.5	670.6	339.5	293.2	970.5	544.0	698.1	558.9	1552.8	743.9	482.1	719.0	1062.3	490.5	392.2	1036.9	1705.6	544.3	614.0	404.0	794.3	989.6	517.2	458.1	845.1	983.2	371.8	886.0	839.7	766.7	1710.8	496.7	254.8	884.3	871.4	634.9	318.2	552.4	245.8	542.2	372.2	252.1	479.4	538.6	260.8	255.0	524.3	328.0	518.0	369.3	810.2	770.9	284.0	969.2	334.4	334.8	394.8	262.5	650.7	410.2	723.2	872.3	841.4	711.8	508.4	720.3	898.4	863.6	154.8	607.5	373.0	643.6	963.7	1264.1	393.5	387.2	375.2	460.9	372.9	395.4	400.2	379.6	368.8	392.4	376.9	408.2	436.5	1114.5	224.4	237.7	5.2	2483.4	1760.6	852.7	2533.9	3266.8	131.0	1968.1	2542.2	29.2	1425.5	985.7	430.4	62.6	1237.2	1377.0	1803.5	972.4	1031.5	85.4	862.0	876.0	992.0	860.5	1977.9	5.2	2625.0	2835.4	1006.2	1666.7	861.2	514.4	1242.7	1647.4	2125.4	1369.2	75.7	5.1	1406.6	732.4	1557.8	1925.7	57.3	295.4	1146.8	1462.1	6.5	754.7	706.4	563.4	6.6	7.1	1806.8	1756.4	221.5	2590.7	1221.2	2448.3	1503.0	557.4	193.1	309.0	719.1	935.9	305.9	304.0	4236.6	1814.2	1708.2	2103.6	1318.5	1411.0	1000.6
RPS27AP5		ENSG00000231767	"Ribosomal protein S27a pseudogene 5"		1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 16.3"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.6;SK-MEL-30: 4.2;THP-1: 4.7"									"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	0.2	0.3	0.2	0.8	0.2	0.7	0.5	0.1	0.6	0.2	0.1	0.2	0.8	0.5	0.0	0.2	0.2	0.1	0.2	0.2	0.3	0.3	0.1	0.1	1.1	0.2	0.2	0.1	0.7	0.0	0.0		0.2	0.2	0.2	0.0	0.3	1.0	0.1	1.1	0.1	0.5	0.0	0.2	0.5	0.3	0.1	0.3	0.0	0.1	0.0	0.3	0.0		0.2	1.0	0.4	0.2	0.6	0.3	0.0	2.5	0.1	0.5	0.0	0.3	0.0	0.7	0.2	2.5	0.0	0.2	1.0	0.1	0.3	0.0	0.9	0.5	0.4	0.4	1.9	0.2	0.7	1.3	0.3	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.5	0.9	4.6	1.1	0.1	0.2	1.0	0.3	0.6	0.3	1.3	0.8	1.6	0.2	1.5	4.2	0.1	1.0	4.7	0.5	0.6	1.2	0.8	2.4	1.5	1.1	0.9	0.8	0.7	0.1	1.2	0.9	0.5	2.0	1.3	2.8	4.2	3.5	2.2	1.8	3.8	4.4	4.5	0.3	3.0	1.0	1.6	2.5	5.6	0.2	0.2	0.1	0.6	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SBK2	SGK069	ENSG00000187550	"SH3 domain binding kinase family member 2"	P0C263	19	55528611-55537133	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"heart muscle: 67.0;tongue: 29.1"	"Group enriched"	"Detected in some"	6	"Early spermatids: 1.5;Late spermatids: 2.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;MCF7: 2.5;NTERA-2: 7.7;RH-30: 7.0;SuSa: 3.5;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030631	Enhanced					NA	NA					"HPA030631: AB_10602088"	"unprognostic (1.33e-1)"			"unprognostic (1.85e-3)"	"unprognostic (4.57e-1)"	"unprognostic (3.49e-1)"				"unprognostic (5.43e-3)"	"unprognostic (4.18e-3)"		"unprognostic (2.08e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-1)"			0.3	0.0	0.1	0.0	0.1	0.5	0.0	0.8	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.2	0.0	0.1	67.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.4	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.2	0.0	2.5	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.6	1.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	2.2	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.5	2.5	0.0	0.1	7.7	0.0	0.0	0.2	7.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	3.5	0.0	0.2	0.1	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCGB1C1	RYD5	ENSG00000188076	"Secretoglobin family 1C member 1"	Q8TD33	11	193078-194575	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;pancreas: 1.4;retina: 3.4;salivary gland: 1.1"	"Cell type enriched"	"Detected in single"	5	"Macrophages: 2.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Region enhanced"	"Detected in single"		"pons: 1.3"	"Group enriched"	"Detected in some"	32	"basophil: 5.0;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted - unknown location"	NA	NA															"unprognostic (5.09e-3)"								0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	3.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.5	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCGB1C2		ENSG00000268320	"Secretoglobin family 1C member 2"	P0DMR2	17	137569-139067	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 1.5;retina: 1.0"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 5.0"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA															"unprognostic (4.65e-2)"								0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36674020-36697839	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 24.1;fallopian tube: 35.6"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 9.6;Bipolar cells: 17.9;Endometrial ciliated cells: 5.7;Excitatory neurons: 10.8;Granulosa cells: 14.2;Inhibitory neurons: 17.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 1.2;HEK 293: 1.4;NTERA-2: 3.6;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA054814: AB_2682611, HPA070485: AB_2686272"	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		2.9	1.3	7.9	0.0	6.9	0.0	0.7	0.2	9.0	12.2	0.2	0.2	0.1	24.1	0.7	0.0	35.6	0.0	0.2	17.1	2.9	0.1	0.0	5.5	0.0	0.2	3.5	5.5	6.5	0.3	1.3	11.6	0.0	2.3	0.9	0.0	3.3	0.0	0.6	0.0	0.1	0.0	17.2	0.0	0.0	0.4	0.3	0.4	0.0	9.3	0.0	0.0	0.3	6.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	6.9	0.2	9.0	17.1	2.9	0.2	3.5	5.5	2.3	0.0	0.4	2.8	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	10.8	0.0	0.0	1.3	0.0	0.6	0.0	14.2	0.0	0.0	0.0	1.7	17.9	0.0	0.0	0.0	0.4	0.0	0.3	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50659255-50719802	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 81.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.7;Excitatory neurons: 29.6;Horizontal cells: 8.4;Inhibitory neurons: 32.9;Oligodendrocyte precursor cells: 7.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 81.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 5.2;THP-1: 2.4;U-138 MG: 2.7;U-2 OS: 7.3;U-87 MG: 2.9;U-937: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: AB_2674169"	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.0	1.2	22.8	0.0	30.9	0.3	0.1	2.8	81.4	0.4	0.0	0.1	0.0	0.4	0.1	0.0	2.4	0.2	0.1	41.7	4.7	0.0	0.0	0.0	0.0	0.9	0.3	41.3	0.2	0.0	1.6	1.1	0.1	8.5	0.1	0.0	5.3	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.5	7.4	0.3	0.1	0.0	0.0	0.1	0.1	12.6	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.8	0.0	0.1	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.5	0.1	0.1	0.5	0.8	0.0	0.0	5.2	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	2.4	1.6	2.7	7.3	0.0	0.0	0.0	0.0	0.0	2.9	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	30.9	2.8	81.4	41.7	4.7	0.9	0.3	41.3	8.5	0.0	7.4	12.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	4.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	29.6	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.4	32.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.1	0.0	7.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777242-45851753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.8;fallopian tube: 3.1"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.5;ovarian cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.0	0.2	0.5	0.1	1.0	0.1	0.0	2.5	0.9	0.9	0.0	0.0	0.0	0.3	0.3	0.0	3.1	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.8	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.3	0.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	2.5	0.9	0.5	0.7	0.8	2.8	0.8	0.9	0.3	0.3	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	1.8	2.1	0.0	0.0	0.0	1.9	0.0	0.0	28.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941702-44946071	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 30.1;choroid plexus: 10.5;parathyroid gland: 9.2;pituitary gland: 28.0;retina: 25.6"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 203.9;Horizontal cells: 185.1;Muller glia cells: 392.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 68.7;SCLC-21H: 63.1;SH-SY5Y: 25.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 38.7;hypothalamus: 19.5"	HPA067988			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.0	0.0	10.4	0.0	17.9	0.0	0.1	0.8	13.1	0.7	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	30.1	0.1	0.0	0.0	0.1	6.8	4.8	3.2	0.0	0.6	9.2	28.0	0.0	7.9	0.0	0.0	25.6	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	1.8	7.1	0.0	0.0	0.1	0.0	0.0	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.6	0.0	11.7	0.0	0.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	68.7	0.0	1.4	0.0	0.0	0.0	0.0	0.4	2.7	0.4	0.0	0.3	0.0	0.4	0.0	0.0	0.0	63.1	25.2	0.1	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.5	0.2	0.3	0.1	10.4	17.9	0.8	13.1	1.9	30.1	6.8	4.8	3.2	7.9	0.2	7.1	1.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	203.9	1.1	1.3	0.7	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.1	0.1	0.2	0.0	0.0	0.3	2.7	0.0	0.1	0.0	0.0	0.0	392.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.2	18.3	0.0	0.5	0.4	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867480-77067546	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.2"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 480.3;Inhibitory neurons: 417.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;fHDF/TERT166: 5.4;HaCaT: 2.7;SH-SY5Y: 4.1;U-2 OS: 4.4;U-251 MG: 2.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 51.3"	"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	Yes		180000	Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.1	3.0	1.7	1.5	1.5	0.0	1.2	0.0	6.2	0.7	0.0	1.4	0.2	0.1	0.0	1.0	1.9	2.2	0.3	5.7	0.7	0.0	0.0	3.6	0.4	0.0	0.6	1.9	1.7	0.1	0.0	1.9	0.1	0.4	1.0	0.6	3.2	0.5	0.3	0.0	0.2	0.9	3.1	0.0	0.2	1.5	0.3	0.0	0.0	0.0	0.0	0.3	1.6	0.6	1.0	1.2	0.0	4.7	0.0	0.0	0.0	0.0	0.4	1.5	1.1	0.4	0.0	0.1	0.0	0.0	5.4	0.0	2.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.1	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	4.4	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.0	6.2	5.7	0.7	0.0	0.6	1.9	0.4	0.0	0.0	1.0	0.0	54.5	0.5	35.6	0.1	0.0	0.0	0.1	0.0	20.7	2.8	1.7	1.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.2	1.9	0.4	0.0	0.0	480.3	0.0	0.1	0.8	0.0	0.2	1.3	0.9	0.0	0.0	0.1	0.0	417.3	0.2	0.0	0.0	0.0	2.3	0.6	0.1	0.0	8.4	0.0	0.7	0.0	10.6	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.3	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.1
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 51.7;fallopian tube: 24.9;ovary: 18.7;smooth muscle: 20.5"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 10.5;Peritubular cells: 29.0;Sertoli cells: 52.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"THP-1: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044596			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044596: AB_10797258"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.2	0.0	0.3	0.0	0.2	0.2	0.0	0.5	0.4	3.5	0.2	0.2	0.1	51.7	5.8	0.0	24.9	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.4	18.7	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	20.5	0.1	2.3	0.1	2.6	0.2	0.0	0.0	0.0	0.0	0.2	2.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.4	0.3	0.2	1.1	0.3	0.1	0.4	0.1	0.0	0.3	0.2	0.5	0.4	0.2	0.2	0.3	0.1	0.4	0.3	0.1	0.2	0.5	0.1	0.0	2.2	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.3	0.3	0.7	0.0	0.6	0.0	2.1	0.0	0.2	0.1	0.0	0.0	1.7	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	1.3	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	10.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.7	0.0	0.1	0.0	0.6	52.6	1.0	1.5	0.3	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.6
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 104.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.0"						"Secreted - unknown location"	NA	NA						"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	2.7	8.5	9.8	1.6	6.7	0.0	14.9	5.9	8.3	104.6	9.8	7.0	7.9	22.4	7.9	60.8	37.3	11.0	33.5	8.4	7.0	8.9	7.1	10.4	0.9	8.3	8.9	4.2	3.1	6.4	0.8	9.8	3.6	7.9	34.3	7.0	1.2	11.5	15.2	3.0	8.0	8.8	10.4	6.8	1.9	12.1	3.1	14.2	1.6	8.8	2.6	2.5	13.4	38.9	7.0	6.0	45.3	0.8	13.0	6.7	40.2	0.2	22.0	53.0	11.2	5.8	0.3	8.7	0.0	17.7	7.8	38.5	17.0	1.8	9.1	6.8	2.0	2.0	0.0	4.4	0.0	4.3	0.0	0.0	3.0	6.7	6.7	26.6	30.5	20.7	0.0	0.0	0.5	9.2	9.1	0.0	0.1	3.9	0.1	7.8	0.0	0.7	0.8	29.5	6.0	0.7	5.5	8.8	10.9	0.0	5.0	43.3	0.1	66.6	0.2	1.0	44.4	11.8	0.0	0.3	0.0	10.4	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	6.7	5.9	8.3	8.4	7.0	8.3	8.9	4.2	7.9	6.8	14.2	7.0	1.1	19.2	9.0	6.5	0.0	13.9	106.4	11.3	449.0	3.0	48.7	43.9	60.1	58.6	7.5	5.5	6.2	0.4	0.8	16.2	1.9	18.3	7.5	19.3	13.2	9.8	3.0	0.0	17.1	1.8	0.4	12.5	2.6	31.8	0.0	0.3	6.1	12.3	0.2	0.0	19.1	6.1	0.0	0.0	2.1	16.9	17.4	1.6	8.8	247.3	0.0	0.3	0.0	8.5	6.7	13.6	11.0	74.4	1.2	94.6	29.3	0.5	11.0	0.9	0.0	16.8	6.6	0.9	1.7	141.5	10.9	0.8	3.1	42.2	13.2	29.7
TMEFF1	"C9orf2, CT120.1, H7365"	ENSG00000241697	"Transmembrane protein with EGF like and two follistatin like domains 1"	Q8IYR6	9	100473149-100577636	"Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 28.7"	"Cell type enhanced"	"Detected in single"		"Endometrial stromal cells: 1.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;BEWO: 14.8;NTERA-2: 29.8;REH: 20.4;SCLC-21H: 25.4;SH-SY5Y: 16.9"	"Low region specificity"	"Detected in all"							HPA051501	Uncertain					NA	NA					"HPA051501: AB_2681509"	"unprognostic (1.96e-1)"	"unprognostic (2.30e-1)"		"unprognostic (9.69e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.02e-2)"		"unprognostic (3.59e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.04e-6)"	"unprognostic (1.30e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.44e-3)"	0.0	0.0	6.7	0.0	14.5	0.1	0.0	9.1	9.0	0.3	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.2	0.0	8.6	12.3	0.0	0.0	0.0	0.1	13.4	11.9	4.8	0.3	0.0	0.0	0.2	0.3	15.5	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	10.6	0.1	0.1	4.0	12.4	0.2	0.8	0.1	0.0	0.0	0.1	28.7	0.0	0.0	12.0	0.6	0.1	0.4	14.8	0.9	0.2	0.6	0.8	0.8	0.1	0.0	2.7	0.4	0.2	0.0	4.6	0.0	0.7	0.0	6.7	0.0	0.3	0.7	0.6	0.0	0.0	0.4	0.0	0.7	0.2	0.5	1.9	5.3	0.2	0.0	0.9	0.1	7.7	0.0	29.8	0.0	0.4	20.4	10.3	0.0	0.5	0.0	25.4	16.9	0.1	0.0	0.4	6.8	0.0	0.1	2.7	2.3	3.9	0.1	0.9	4.6	3.5	4.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.5	9.1	9.0	8.6	12.3	13.4	11.9	4.8	15.5	10.6	12.4	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1
TMEM221		ENSG00000188051	"Transmembrane protein 221"	A6NGB7	19	17435509-17448668	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 8.0;retina: 9.5"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 14.6;Muller glia cells: 49.2;Rod photoreceptor cells: 24.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;PC-3: 6.8;REH: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041580, HPA062945"	Supported		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA041580: AB_10795700, HPA062945: "	"unprognostic (3.60e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.51e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.14e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.47e-4)"	"unprognostic (2.37e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-1)"	0.5	4.2	3.3	0.2	3.3	0.1	1.2	3.0	4.5	0.8	2.5	0.6	0.1	0.6	0.7	0.5	2.7	0.2	0.5	3.4	3.4	0.5	0.4	0.3	0.2	3.5	2.9	3.3	8.0	2.2	5.4	1.7	0.1	2.9	1.3	0.0	9.5	0.8	1.0	0.2	0.4	0.4	0.1	3.1	0.4	0.4	0.5	3.2	0.5	0.7	0.1	0.1	0.4	1.0	3.2	0.5	1.5	0.6	4.6	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.9	0.0	0.4	0.2	1.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.2	1.0	0.3	6.8	3.9	0.1	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	3.3	3.0	4.5	3.4	3.4	3.5	2.9	3.3	2.9	3.1	3.2	3.2	0.5	0.0	0.5	1.0	0.1	0.0	0.1	0.0	0.0	1.3	0.3	0.3	0.3	1.5	0.0	0.0	14.6	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.0	2.0	0.0	0.0	2.2	0.0	0.2	0.0	0.2	3.3	0.0	3.7	1.7	3.9	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	49.2	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.5	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.1
TMEM238		ENSG00000233493	"Transmembrane protein 238"	C9JI98	19	55379244-55384292	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;stomach 1: 16.7"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 102.2;Breast myoepithelial cells: 233.7;Endometrial ciliated cells: 80.6;Glandular and luminal cells: 104.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 52.1;stomach cancer: 48.5"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 30.6;CAPAN-2: 18.3;HaCaT: 27.3;RPMI-8226: 19.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.90e-2)"	"unprognostic (7.93e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.33e-2)"	"prognostic favorable (8.84e-6)"	"unprognostic (1.78e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.17e-3)"	1.1	1.0	0.6	2.5	0.5	1.1	2.4	2.4	1.0	1.3	2.5	16.0	14.0	0.5	0.2	8.9	1.5	0.1	0.3	0.6	0.5	4.8	9.0	3.2	0.8	1.0	0.9	0.5	0.4	13.5	1.1	3.1	0.1	1.2	4.4	2.0	0.1	9.3	0.4	1.0	6.8	14.5	0.1	0.5	1.6	16.7	0.3	0.6	0.3	6.3	0.0	0.6	1.9	3.3	0.7	30.6	2.1	0.1	1.7	0.0	0.0	1.7	1.3	0.1	0.0	0.0	1.3	18.3	13.8	5.5	0.1	0.0	27.3	0.5	0.7	0.1	4.0	0.8	0.4	2.6	0.0	0.1	2.9	0.5	0.0	3.7	0.1	0.6	0.2	0.0	2.5	1.8	11.3	0.0	6.8	3.7	1.6	0.8	7.6	9.5	6.8	0.2	19.0	1.2	9.6	9.1	2.9	1.2	14.2	2.1	0.1	10.8	1.7	0.0	0.3	2.4	0.1	0.3	7.5	5.1	3.5	0.1	1.6	0.2	0.0	0.0	0.1	0.4	0.0	1.0	0.6	1.0	0.7	0.0	0.4	0.7	0.6	0.0	0.2	0.0	0.2	1.3	0.1	0.6	0.5	2.4	1.0	0.6	0.5	1.0	0.9	0.5	1.2	0.5	0.6	0.7	13.0	0.0	2.4	0.0	20.2	8.5	3.7	0.5	1.2	0.3	102.2	233.7	1.1	27.1	0.5	7.3	0.0	0.0	21.4	29.1	1.9	1.9	0.0	80.6	8.2	2.4	13.8	0.4	0.4	4.3	0.1	2.0	4.1	104.2	0.0	4.5	1.4	13.6	0.3	3.3	0.4	22.8	0.0	2.8	4.9	0.0	0.0	4.3	1.8	0.0	0.7	8.6	2.1	0.0	0.4	3.9	12.9	0.0	16.5	2.3	12.3	1.8	0.5	1.5	0.0	6.3	2.6	0.0	0.0	3.1	26.0	0.0	19.9	2.7	20.3	3.8
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371887-42396091	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.9;stomach 1: 14.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 17.7;Cholangiocytes: 24.3;Ductal cells: 16.1;Endometrial ciliated cells: 17.1;Gastric mucus-secreting cells: 23.4;Ionocytes: 16.2;Muller glia cells: 20.4;Respiratory ciliated cells: 39.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 274.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	0.2	0.3	3.4	0.2	3.3	0.1	8.8	3.6	3.7	6.3	1.5	0.2	1.3	0.7	0.0	0.2	23.9	8.7	0.0	2.9	3.3	2.4	0.5	3.4	0.5	4.1	3.7	2.7	0.0	3.0	0.0	1.5	0.2	3.2	0.4	0.1	4.0	9.3	0.4	0.1	0.1	1.1	0.0	2.7	0.4	14.6	0.0	3.4	0.9	2.9	0.0	0.4	1.0	0.0	2.5	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	32.9	0.0	66.2	26.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.0	14.0	0.0	1.5	3.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.8	1.5	0.0	0.0	33.9	1.6	0.0	0.0	3.2	0.3	0.1	0.0	1.7	0.0	0.2	0.7	274.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	1.7	1.8	0.0	0.0	0.3	0.9	0.3	0.0	0.5	0.0	0.8	0.5	3.4	3.3	3.6	3.7	2.9	3.3	4.1	3.7	2.7	3.2	2.7	3.4	2.5	0.1	12.8	3.7	2.3	0.4	0.3	2.3	8.1	0.0	0.2	17.7	9.9	0.6	24.3	10.8	7.3	0.0	0.0	0.1	1.4	5.9	16.1	1.4	17.1	0.4	0.2	0.0	2.7	0.0	13.8	0.1	1.3	23.4	5.2	0.0	0.2	0.4	0.0	0.1	0.0	0.0	2.0	16.2	0.0	0.5	0.6	0.3	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.1	11.8	1.4	0.0	0.4	2.4	2.9	0.0	39.8	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.1	2.5	5.0
TPBGL		ENSG00000261594	"Trophoblast glycoprotein like"	P0DKB5	11	75240774-75243704	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 9.9;testis: 4.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 16.9;Melanocytes: 3.6;Muller glia cells: 10.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.1"	"Region enhanced"	"Detected in many"		"medulla oblongata: 9.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HMC-1: 1.8;SCLC-21H: 1.8"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (1.55e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-14)"	"unprognostic (3.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	0.3	1.7	2.1	0.4	3.0	0.0	0.2	0.0	3.4	0.3	0.0	0.2	0.1	0.9	0.0	0.1	0.3	0.3	0.1	1.2	0.9	0.2	0.1	0.2	0.2	9.9	0.6	2.4	0.2	0.1	0.0	0.3	0.0	1.5	0.1	0.1	1.4	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.2	0.1	4.5	1.4	0.1	0.1	0.0	0.2	0.2	0.2	0.9	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.0	0.0	3.4	1.2	0.9	9.9	0.6	2.4	1.5	0.3	1.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	1.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0
UNC5A	"KIAA1976, UNC5H1"	ENSG00000113763	"Unc-5 netrin receptor A"	Q6ZN44	5	176810519-176880898	"Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 30.6;pituitary gland: 14.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 54.4;Inhibitory neurons: 19.4;Muller glia cells: 13.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 86.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071450			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA071450: AB_2686397"	"unprognostic (5.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.66e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.07e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.77e-5)"	"unprognostic (6.39e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.17e-2)"	0.4	7.6	10.2	0.3	13.5	0.5	0.8	2.1	30.6	0.3	0.0	0.1	0.4	0.4	0.2	0.1	0.6	0.2	0.2	16.0	2.3	0.1	0.1	0.3	0.9	2.6	0.8	12.8	0.1	1.8	0.0	14.8	0.0	4.1	0.2	0.0	3.1	2.6	0.0	0.0	0.4	0.1	0.1	0.0	0.1	1.0	0.7	1.2	0.1	0.5	0.0	0.0	0.2	0.1	11.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	3.5	0.0	0.0	0.0	2.5	10.1	0.0	86.4	3.9	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.2	13.5	2.1	30.6	16.0	2.3	2.6	0.8	12.8	4.1	0.0	1.2	11.1	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.7	0.6	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.1	0.9	0.0	0.0	54.4	0.0	0.0	0.0	0.0	1.6	0.0	2.0	0.0	0.0	0.0	5.0	19.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.7	0.0	13.9	0.0	7.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT10A		ENSG00000135925	"Wnt family member 10A"	Q9GZT5	2	218880852-218899581	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 7.0;skin 1: 8.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.2;Basal keratinocytes: 17.1;Basal respiratory cells: 15.5;Basal squamous epithelial cells: 30.1;Bipolar cells: 16.2;dendritic cells: 16.4;Plasma cells: 30.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 50.8;HaCaT: 140.1;HDLM-2: 58.7;RPTEC TERT1: 29.2;U-266/70: 69.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.1"	HPA013898	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA013898: AB_1858847"	"unprognostic (2.99e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (9.52e-2)"	"unprognostic (6.64e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	1.0	1.1	0.5	0.5	0.3	1.3	0.8	0.2	1.6	3.8	0.0	0.4	7.0	1.2	0.3	0.1	1.3	0.5	1.4	0.2	0.7	2.5	0.7	0.6	0.5	0.2	0.1	0.0	4.4	3.4	0.5	1.7	1.1	1.4	2.5	1.0	0.0	8.9	2.1	0.0	0.3	2.0	2.5	0.4	0.8	1.1	0.2	0.0	1.9	2.7	2.9	0.7	15.8	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	50.8	2.8	10.4	0.0	3.8	140.1	0.0	0.1	0.0	58.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	10.5	29.2	0.4	0.0	0.4	0.3	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	69.0	1.1	1.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	6.2	1.0	0.0	0.5	1.1	0.3	1.3	1.3	0.5	0.7	0.6	0.5	0.5	0.3	0.8	0.7	0.2	0.0	0.0	0.3	12.2	17.1	8.2	15.5	30.1	16.2	0.5	1.3	1.4	0.0	1.1	9.2	2.1	1.2	16.4	0.0	0.0	0.3	1.2	0.3	0.1	0.2	0.0	0.4	1.3	0.0	0.4	1.9	0.5	0.2	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.0	2.0	0.0	1.3	0.1	0.6	1.0	7.2	0.0	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.0	30.4	2.5	0.0	0.3	0.6	1.5	0.0	0.1	0.8	0.9	0.6	5.2	4.7	0.1	9.8	0.0	0.2	3.2
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859805-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 92.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 34.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	HPA070759	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA070759: AB_2732164"	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	3.3	0.6	0.8	0.1	8.1	0.0	3.6	0.2	3.1	3.9	0.6	5.7	0.1	2.4	0.0	1.3	3.2	0.0	2.8	0.7	1.2	1.1	0.3	0.3	0.1	4.0	0.8	0.5	3.1	0.8	0.0	2.0	2.0	2.1	3.1	0.0	0.1	1.1	0.1	1.1	2.6	2.8	0.0	0.4	7.2	2.7	3.6	1.7	0.0	1.1	0.0	0.1	2.0	3.7	0.1	0.0	0.0	0.0	1.2	0.0	0.0	34.4	0.0	0.0	0.0	0.0	3.3	0.5	0.0	3.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	5.0	1.7	0.0	0.0	3.7	0.1	4.7	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	8.1	0.2	3.1	0.7	1.2	4.0	0.8	0.5	2.1	0.4	1.7	0.1	2.5	0.0	0.0	0.0	1.6	0.5	21.0	1.1	0.6	3.5	1.4	8.5	0.6	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.1	3.4	0.4	3.1	5.9	0.0	0.0	0.2	0.0	1.6	2.0	0.0	0.1	0.0	0.4	2.5	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.3	4.5	0.0	0.3	1.8	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	3.1	5.5	0.0	0.0	0.0	2.0	92.1	0.3	15.5	16.9	0.3	0.2	0.1	0.7	0.2	0.1	0.0	1.3
WNT7A	Wnt-7a	ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880071	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;gallbladder: 2.3;placenta: 2.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2;ovarian cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.0	0.0	3.5	0.1	3.1	0.1	0.0	1.0	3.7	0.2	0.4	0.0	0.0	1.1	0.2	0.4	0.1	2.3	0.0	2.3	2.3	0.2	0.0	2.0	0.2	5.0	1.8	3.3	0.0	0.1	0.0	0.0	2.7	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	3.2	1.3	0.0	1.3	2.0	0.0	0.0	0.0	0.1	0.3	0.1	2.7	8.6	0.0	0.8	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	7.6	0.0	56.0	0.0	0.1	11.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	1.7	100.3	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.5	3.1	1.0	3.7	2.3	2.3	5.0	1.8	3.3	2.5	3.2	2.0	2.7	0.0	12.8	0.0	8.5	0.0	5.9	2.8	2.6	0.0	0.0	0.0	0.0	0.7	8.6	1.4	0.0	0.0	68.7	0.0	0.0	0.0	13.8	17.3	14.5	0.4	0.6	0.0	0.0	4.0	9.1	147.5	0.4	0.0	17.9	0.0	0.0	0.0	0.0	7.4	0.0	2.4	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	1.0	0.0	0.0	0.0	4.5	0.3	98.8	0.0	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	6.0	2.3	0.0	1.3	185.7	1.5	0.0	0.0	6.0
XAGE2	"CT12.2, GAGED3, XAGE-2, XAGE2B"	ENSG00000155622	"X antigen family member 2"	Q96GT9	X	52369021-52375680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 201.2"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 1027.3;Extravillous trophoblasts: 1890.1;Syncytiotrophoblasts: 1367.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 96.3;SK-BR-3: 22.7;SuSa: 27.9;T-47d: 20.1"									"HPA052507, HPA060900"	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA052507: AB_2681855, HPA060900: AB_2684383"								"unprognostic (1.21e-1)"		"unprognostic (9.67e-2)"	"unprognostic (1.49e-1)"				"unprognostic (4.47e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	201.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	96.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	22.7	1.2	27.9	20.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	38.5	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1027.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1890.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	1367.6	0.0	0.0	0.0	0.0
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;HMC-1: 3.5;THP-1: 2.4;U-937: 6.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain					NA	NA					"HPA003030: AB_2666758"	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	1.5	2.3	1.7	0.5	2.1	3.0	1.1	2.3	1.9	1.1	2.0	0.7	0.3	1.2	2.6	0.2	3.3	0.4	1.0	1.5	1.6	0.7	0.6	2.6	0.4	1.3	1.9	1.7	3.8	0.7	4.4	2.6	0.7	1.6	0.9	0.2	0.5	0.2	1.6	0.3	0.2	0.9	1.1	0.7	1.1	0.6	0.7	2.1	0.2	0.7	0.6	0.5	0.3	0.3	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	0.8	0.4	0.0	0.0	0.5	0.6	0.2	0.4	0.3	0.4	0.6	3.8	0.0	1.4	0.0	0.0	1.4	0.4	3.5	0.2	0.5	0.0	0.0	0.0	1.4	0.9	1.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	2.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.9	0.0	6.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.1	2.3	1.9	1.5	1.6	1.3	1.9	1.7	1.6	0.7	2.1	1.5	3.4	0.0	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.1	3.1	0.5	0.0	0.0	1.5	0.0	0.0	0.7	0.0	2.2	0.0	1.1	0.4	0.1	0.8	0.0	1.7	0.0	0.0	0.8	0.0	0.2	2.5	0.5	0.0	0.0	0.5	0.2	1.0	2.0	0.1	0.2	0.0	3.4	0.2	0.0	0.0	0.3	0.0	0.2	19.7	0.8	1.4	0.4	0.8	0.0	0.0	0.0	0.3	0.8	0.0	0.0
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773588	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 60.2;Distal tubular cells: 39.2;Hepatic stellate cells: 40.7;Kupffer cells: 56.8;monocytes: 37.1;Muller glia cells: 75.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 22.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 48.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 48.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.8;EFO-21: 13.5;HMC-1: 15.9;MCF7: 12.9;SK-BR-3: 12.7;T-47d: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	10.4	9.5	6.2	3.8	10.8	10.8	8.9	5.2	7.2	9.8	5.0	9.1	1.0	10.6	1.5	5.5	13.9	3.1	9.6	6.1	7.9	22.0	14.7	16.5	3.7	8.2	7.9	5.3	8.5	14.9	5.7	14.6	2.0	7.8	7.4	1.4	11.2	9.4	3.8	1.6	9.2	7.9	2.8	6.3	27.8	16.3	1.5	7.1	4.2	16.2	3.1	2.3	7.0	6.9	7.3	0.0	3.4	4.2	28.8	0.1	0.0	0.1	0.1	0.0	0.4	0.1	1.0	8.6	0.2	13.5	0.2	0.1	0.3	2.2	0.1	0.2	0.1	0.4	1.6	0.0	0.0	8.7	0.0	15.9	5.8	1.2	0.0	0.1	10.9	3.0	0.6	2.5	0.7	0.0	12.9	0.5	1.4	0.4	1.3	8.3	2.3	0.1	10.7	2.1	0.0	1.4	1.2	0.0	12.7	0.0	1.4	15.6	1.3	6.3	0.2	4.4	0.0	0.0	0.6	0.0	0.2	0.2	4.9	0.1	0.0	8.9	4.4	0.3	3.7	0.2	0.0	0.4	0.4	5.8	0.0	0.6	0.2	48.6	0.2	1.2	2.9	0.0	2.4	6.2	10.8	5.2	7.2	6.1	7.9	8.2	7.9	5.3	7.8	6.3	7.1	7.3	10.3	0.0	0.5	4.2	1.2	3.6	0.6	1.3	0.6	60.2	13.3	6.9	2.0	2.8	4.1	0.0	2.1	0.4	10.6	0.0	39.2	7.7	0.4	2.6	5.0	23.7	3.0	8.0	0.8	2.9	0.2	3.9	2.6	2.1	0.0	0.3	40.7	7.7	22.3	6.7	2.9	0.0	8.2	56.8	19.4	0.3	1.5	23.0	1.8	2.8	37.1	75.3	6.2	0.5	0.2	1.8	0.0	1.9	1.1	0.8	0.0	8.5	1.7	6.5	0.0	0.6	2.8	1.0	2.9	0.7	7.4	0.4	2.8	0.3	0.0	0.5
ZNF503	"FLJ45745, MGC2555, Nlz2"	ENSG00000165655	"Zinc finger protein 503"	Q96F45	10	75397830-75401764	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 62.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026848	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA026848: AB_10610704"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.63e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.63e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (3.50e-4)"	"prognostic favorable (1.97e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	13.2	40.2	7.2	3.2	9.4	2.0	9.3	4.2	4.9	31.6	1.3	14.1	8.2	44.4	10.4	20.3	24.0	2.4	8.0	7.4	6.2	25.6	7.2	14.3	1.5	12.5	8.1	3.8	46.7	25.6	4.6	4.8	3.3	8.1	17.7	1.8	1.4	9.6	17.8	3.6	5.3	8.6	7.8	9.7	8.1	16.5	2.5	8.7	1.1	7.9	2.1	1.0	13.9	18.3	7.1	5.2	4.9	1.1	6.3	10.6	7.1	1.6	4.6	2.8	1.9	1.7	7.5	20.4	0.0	13.4	4.6	1.1	9.4	0.7	4.9	1.4	0.0	115.1	0.0	12.4	24.8	8.5	6.1	12.9	19.1	4.8	3.5	2.0	16.6	0.5	0.5	0.1	0.2	2.6	2.7	0.2	18.8	0.1	3.8	149.2	0.0	5.6	0.1	2.8	4.1	4.1	5.2	8.5	0.6	27.1	1.0	1.0	4.2	3.9	14.6	16.3	30.7	13.0	0.0	0.0	0.0	44.9	27.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.4	4.2	4.9	7.4	6.2	12.5	8.1	3.8	8.1	9.7	8.7	7.1	27.2	38.5	11.6	2.3	1.7	27.1	35.6	15.0	255.0	23.7	7.7	42.3	20.4	10.0	10.1	40.5	20.9	0.5	2.1	0.8	58.7	45.9	0.1	53.2	72.2	41.0	3.6	5.3	12.6	34.7	0.3	60.1	18.3	48.1	6.3	2.7	44.6	10.3	13.5	6.7	3.2	6.7	10.2	27.4	30.5	2.0	59.7	30.7	24.9	13.1	8.2	7.7	0.0	4.0	0.7	33.2	1.5	49.2	3.9	19.7	13.4	32.5	1.7	26.3	39.5	10.2	78.1	0.2	6.0	189.3	13.9	0.3	4.0	24.5	9.7	14.3
